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Summary 
SUMMARY 
Nuclear domain 10 (NO 1 0) are punctate subnuclear structures that exist in most cell 
types. It has been suggested that ND 1 0 structures serve as the site for initial viral genome 
deposition and some viral proteins, such as the ICPO protein of HSV-l, have been shown 
to colocalise to, and subsequently induce the degradation of, proteins present in NDI0. 
However the exact function ofNDIO during HSV-I infection is still unknown. 
In this study, the potential role of ND lOin HSV -1 infection was investigated by 
assessing the efficiency of viral IE and E gene expression or viral replication in cultured 
cells in which the expression ofNDIO proteins was increased by IFN treatment or transient 
transfection methods. Furthennore, this study objective was also approached by using a 
human neuron precursor cell line (NT2) that naturally lacks one NDIO component, SpIOO, 
and was found to have abnormal ND 1 0 characteristics. The infectivity of HSV -I in NT2 
and differentiated hNT neuronal-like cells was investigated and the function of ICPO in 
these cells was studied in more detail. 
Treatment with IFN-a increased the number and size of NOlO, whereas heat-stress 
caused dispersal ofNDlO proteins, although this did not appear to affect HSV-I infection. 
Pre-treatment with IFN-a slightly inhibited HSV-l gene expression, however it was not 
clear whether this effect was mediated by the NDI0 proteins that are up-regulated by IFN. 
Examination of cells transiently transfected with plasmids expressing ND 1 0 proteins 
(either PML, Sp 100, SUMO-lor Ubc9) demonstrated that the expression of viral IE and L 
genes was not affected by high expression levels of NO to proteins. However, decreased 
viral gene expression was observed at an early time of infection in cells co-transfected with 
three plasmids expressing PML, Sp 1 00, and Ubc9 or with four plasmids expressing PML, 
Spl00, Ubc9, and SUMO-I. Notably, in cells transfected with multiple plasmids, the 
exogenous ND 1 0 proteins were sequestered in NO 1 0 to a greater extent than in cells singly 
transfected. These observations suggested that over-expression of NO 1 0 proteins, properly 
located in ND 1 0, confers a marginal resistance to HSV -1 infection at an early time of 
infection, but this effect was less clear at later times of infection. Furthermore, 
transcription from the ICP6 promoter induced by ICPO was strongly repressed by two other 
NDIO associated proteins, HPI and hDaxx, in a dose-dependent manner in the transient 
transfection assay. 
Summary 
Study of NT2 cells prior to induction of differentiation revealed atypical ND 1 0 
structures. There were fewer PML and hDaxx foci but those present were bigger in size 
and contained no detectable SplOO. In addition, a track-like distribution of PML was 
found in many NT2 cells and a high proportion of hDaxx foci were associated with 
centromeres instead of with ND 10. This is distinct from other cell types studied. 
Immunoblot analysis demonstrated that the expression of PML and levels of SUMO-I 
conjugated PML isoforms in NT2 cells were lower than in HFL cells. The normal ND 1 0 
pattern was restored in hNT neuronal- like cells obtained from NT2 after treatment with 
retinoic acid for six weeks. Moreover, both NT2 and hNT cells were poor hosts for HSV-I 
and even worse for ICPO-defective viruses. Immunoblot analysis and immunofluorescence 
assays revealed that in NT2 cells viral gene expression was restricted to IE genes: although 
expression of ICPO was higher than in HFL cells, the progression of viral infection (to the 
E gene stage) was much lower than in HFL cells. Studies of ICPO function in terms of 
induction of transcription, reactivation of the viral genome from quiescent infection and 
degradation of ND 1 0 proteins, found that these functions of ICPO were compromised in 
NT2 cells and differentiated hNT cells. 
Over-expression of SUMO-l (but not other ND 1 0 proteins) in NT2 cells inhibited the 
expression of ICPO by HSV-l by 3- to 5-fold at all infection times tested. Three mutant 
SUMO-l constructs with a single substitution mutation at residue Gly(96) or Gly(97) or 
with deletion of four amino acids in the C-terminus were made to determine whether 
SUMO-l modification contributes to this effect. Western blot analysis indicated that the 
C-terrninus of SUMO-I expressed from the Gly(97) substitution mutant was not cleaved 
by protease, ie the SUMO-I precursor cannot be processed to the mature form, and 
immunofluorescence assays showed that this resulted in the redistribution of ND 1 0 
proteins such as hDaxx and SplOO in Hep-2 cells. Although a larger proportion of the 
mature form of SUMO-I was produced in cells transfected with the other two mutant 
constructs, the distribution of ND 1 0 proteins was also affected. Analysis of viral infection 
revealed that NT2 cells transfected with the three SUMO-l conjugation mutant constructs 
had less resistance to HSV -1 infection than wild-type SUMO-l transfected NT2 cells, 
implying a role for SUMO-l modification in HSV-l infection in NT2 cells. 
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Chapter 1 Introduction 
Herpesviruses are nuclearly replicating, enveloped double-stranded DNA viruses with 
an icosahedral capsid. The hosts of these viruses are ubiquitous, including all groups of 
vertebrates, and the same host can be infected with multiple distinct types of herpes viruses. 
The family of herpes viruses consists of three subfamilies: alpha (0.)-, beta (Ph and gamma 
(y)-herpesvirus, each with unique properties. The alphaherpesvirus subfamily is 
characterised by a relatively short replication cycle, a broad host and cell range, efficient 
destruction of infected cells, and an ability to establish latent infection in sensory ganglia. 
The beta- and gammaherpesviruses differ in genome size and structure but both replicate 
more slowly and in a much more restricted range of cells. The betaherpesviruses 
subfamily can be maintained in a latent form in the kidney, secretory glands, and 
leukocytes. Gammaherpesviruses display specificity for lymphoid and epithelial cells and, 
at least in culture, have been shown to be associated with transformation of infected cells. 
To date, eight discrete human herpesviruses have been described, each causing 
characteristic diseases. Over recent years, human herpesvirus infections have become of 
increased clinical importance because of advances in organ transplantation techniques and 
because herpesvirus infections occur with increased frequency in HIV -infected and 
immunosuppressed individuals. Additionally, interest has increased in the development of 
human viruses as vectors for gene therapy. 
In this section, the classification of human herpesviruses and clinical aspects including 
symptoms, epidemiology and treatment of diseases caused by human herpesviruses are 
generally described. 
IA.I General introduction to the Herpesviridae 
The Herpersviridae consists of almost 100 members that infect a wide range of hosts 
including humans, horses, cattle, pigs, and fowl. Herpesviruses that infect humans are 
responsible for multiple syndromes involving many organ systems. Aside from a similar 
ultrastructural morphology and some similarities in lytic replication cycles, the only major 
feature shared by all these agents is the capacity to establish a type of persistent infection, 
known as latency, in which the viral genome is present but infectious virus is not produced 
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except during intermittent episodes of reactivation. Thus herpesviruses have been very 
important medically because they are common and produce diseases in a substantial 
minority of cases. 
IA.2 Herpesviridae classification 
According to the universal system of virus taxonomy established by the ICTV 
(International Committee on Nomenclature of Viruses), the Herpesviridae belong to group 
I as double-stranded DNA viruses. Herpes simplex virus type 1 (HSV-I) was classified as 
belonging to the family Herpesviridae, subfamily AJphaherpesvirinae, genus Simplexvirus, 
human herpesvirus type 1. 
There are now eight known members of the human herpesvirus family, grouped into 
three subfamilies based upon details of tissue tropism, pathogenicity, and behaviour under 
conditions of culture in the laboratory (Table 1.1). More recently, sequences of the 
genomes of these viruses have been published by (Baer et al., 1984); (Cha et al., 1996); 
(Chee et al., 1990); (Dargan et al., 1997); (Davison & Scott, 1986); (Dolan et al., 1998); 
(Gompels et al., 1995); (McGeoch et al., 1985); (Nicholas, 1996); and (Renne et al., 
1996). 
IA.3 Clinical aspects 
IA.3.1 a-herpesviruses: Herpes simplex viruses (subtypes I and 2) 
Initial episodes of oro facial HSV infection are nearly always caused by HSV -1 but 
may also be caused by HSV-2 (Lafferty et al., 1987). When symptomatic, infectious virus 
replicates in susceptible epithelial cells and initiates the formation of an inflamed lesion, 
usually around the mouth, commonly called a "cold-sore". Recurrent vesicle lesions 
normally persist for around 2 days, then become pustules or ulcers, followed by the 
formation of a crust within 3-4 days. Lesions usually heal after 8-10 days (Spruance et al., 
1977). 
HSV -2 is usually sexually transmitted and is clinically manifested in the genital or 
adjacent area as primary or recurrent infection. HSV -1 usually causes orofacial disease, but 
is becoming an increasingly common cause of primary genital infection, as the causative 
agent of20-60% of genital infection in the UK (Kinghorn, 1994). Symptoms are caused 
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Table 1.1 The human herpesviruses 
Subfamilies members (commOD Dames) systematie .... e poome size (1m) 
~herpesviruses 
Herpes simplex virus type 1 (HSV -1) HHV 1 152 
Herpes simplex virus type 2 (HSV-2) HHV2 155 
Varicella zoster virus (VZV) HHV3 125 
p-herpesv;ruses 
Human cytomegalovirus (HCMV) HHV5 230 
Human herpesvirus type 6 (HHV -6) HHV6 159 
Human herpesvirus type 7 (HHV -7) HHV7 145 
,..herpesv;ruses 
Epstein-Barr virus (EBV) HHV4 172 
Human herpesvirus type 8 (HHV -8) HHV8 160-170 
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by a direct cytopathic effect of the replicating virus destroying tissue, causing ulceration. 
Such ulceration reduces an important barrier of protection against acquiring HIV infection. 
Population subgroups at high risk of HIV infection are often already infected with HSV at 
the time HIV infection was initially diagnosed, thus genital herpesvirus has become a 
significant cofactor in HIV transmission (reviewed by Brugha et al., 1997). 
Herpes simplex viruses also cause conjunctivitis, keratitis, and encephalitis through 
an aetiology not yet understood (Whitley et al., 1977). Around two-thirds of neonatal 
infections in the USA are asymptomatic. HSV -1 infection localised to the skin, eye, and 
mucous membranes is rarely fatal, however without appropriate antiviral treatment, 
localised infection in the new-born may proceed to disseminated infection and/or 
meningoencephalitis which is often life threatening (Whitley et al., 1991, Whitley et al., 
1988). 
lA.3.2 a-herpesviruses: Varicella zoster virus (VZV) 
Unlike other herpesvirus infections, VZV regularly produces symptoms in the 
majority of children who acquire it. Primary infection with VZV generally presents in 
childhood with a rash, known as chickenpox, which is usually present 14 days after 
infection. Periodic reactivation from the latent state from neuronal ganglia causes a 
significant shingles lesion at the relevant dermatome often accompanied by severe pain 
that can persist for months (Arvin, 1996, Dueland, 1996). 
lA.3.3 p-herpesviruses: Human cytomegalovirus (HCMV) 
In cytological examination, enlargement and fusion of macrophages, termed 
cytomegaly, is a characteristic of HCMV infection. Infection with HCMV is ubiquitous 
among adult populations, although the primary infection is often asymptomatic. 
Additionally, HCMV infection is an important cause of serious congenital and neonatal 
disease, which can be fatal to newborns. In the foetus, severe infection of HCMV causes 
mental retardation and lor hearing loss. If the immune system is immature (as in the 
foetus), or is compromised by immunosuppressive drugs, HCMV frequently causes gut 
ulceration or retinitis (reviewed by Alford et al., 1990). Furthermore, HCMV may trigger 
the immune system of transplant patients to cause rejection of the transplanted organ 
(Arbustini et al., 1996). 
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lA.3.4 p-herpesviruses: Human herpesvirus 6 (HHV -6) 
Compared to the viruses noted above, less is known about HHV -6 and HHV -7. There 
are two close variants ofHHV-6, HHV-6A and HHV-6B which share greater than 97% of 
similarity of DNA sequences in some regions, although they are only 75% identical in the 
immediate early region of the HHV -6 viral genome (Di Luca et ai., 1996). HHV -6 is shed 
as infectious viral particles in the saliva and is ubiquitous in the population; up to 90% of 
adults in the UK are infected with HHV-6 (Griffiths, 2001). Primary infection occurs in 
childhood, when it is associated with exanthem subitum, a common childhood illness 
characterised by a high fever and skin rash (reviewed by Ablashi et ai., 1991). 
lA.3.5 p-herpesviruses: Human herpesvirus 7 (HHV -7) 
As with HHV-6, HHV-7 is shed as infectious viral particles in the saliva and is 
ubiquitous within the population. HHV -7 has been associated with roseola in infants 
(Hidaka et ai., 1993). 
lA.3.6 'Y-herpesviruses: Epstein-Barr virus (EBV) 
In 1964, Epstein, Achong and Barr discovered that HHV-4 is the pathogenic agent of 
a unique lymphoma disease (Burkitt's lymphoma), which was first described by Denis 
Burkitt in African children of Uganda (Epstein et ai., 1964). In subsequent studies, HHV-
4 was also designated Epstein-Barr virus. Most EBV infections, particularly in childhood, 
are asymptomatic, and whatever the syndrome induced, primary infection with EBV 
foHows infection and replication of virus in the nasopharynx (reviewed by Crawford, 
2001). Following the primary asymptomatic infection in the nasopharynx, EBV ultimately 
infects B lymphocytes. These become latently infected and enable transmission to other 
individuals. If this transmission occurs in adolescence or later, the virus causes infectious 
mononucleosis, a debilitating disease commonly known as glandular fever. 
Besides Burkitt's lymphoma, EBV is now suspected to be a pathogenic agent in other 
non-Hodgkin's lymphomas (e.g. AIDS-associated, post-transplant) and Hodgkin's disease, 
in nasopharyngeal carcinoma (NPC), and gastric adenocarcinoma, and in leiomyosarcomas 
associated with immunosuppression (reviewed by Hildesheim & Levine, 1993, McClain et 
ai., 1995). Although these diseases are rare in most popUlations, their incidence is elevated 
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in certain groups: NPC is an important source of cancer morbidity in southern China, and 
Hodgkin's disease is one of the most frequent malignancies affecting young adults 
(reviewed by Glaser & Jarrett, 1996, Hildesheim & Levine, 1993). 
lA.3.7 y-herpesviruses: Human herpes virus (HHV -8) 
HHV-8, also called Kaposi's sarcoma-associated herpesvirus (KSHV), is a relatively 
recently discovered gamma-herpesvirus identified by molecular cloning techniques that 
used Kaposi's sarcoma tissues as the starting material (Chang et al., 1994). HHV-8 is 
relatively widespread, with up to 25% of the adult population having antibodies to HHV-8 
lytic proteins and this percentage rises to 90% in HIV -infected men (Lennette et al., 1996). 
HHV-8 is the etiologic agent of Kaposi's sarcoma of AIDS patients and is associated with 
primary effusion lymphoma as well as the lymphoproliferative disorder multi-centric 
Castleman's disease (Corbellino et al., 1996). 
lA.4 Epidemiology 
HSV primarily infects epithelial tissue through the mucosa and abraded skin. HSV-l 
is widespread and usually acquired in childhood. Almost all primary HSV infections 
occurring before the age of 10 are due to HSV -1, and by the age of 60 years, 60-80% of the 
US popUlation is HSV -1 seropositive (Nahmias et al., 1990). 
HSV-2 infection occurs later in life, and its incidence rates are relatively low; the 
popUlation of HSV -2 seroprevalence in the USA is 30-50% and is under 5% in the UK 
(Griffiths, 2001, Kinghorn, 1994). 
HSV can be transmitted from infected mothers to neonates, however, the incidence 
rate is low; 3 per 100000 births according to a report from a UK annual estimate during 
1987 -1988 (Jeffries, 1991). Transmission of infection from mother to baby usually occurs 
during vaginal delivery (85% of transmissions) and is dependent on the prevalence of 
genital viral shedding at the time of delivery (Whitley, 1993). Intrauterine and postnatal 
transmissions are rare, 5% and 10% respectively (Whitley, 1993). 
Either type of HSV may cause conjunctivitis, and keratitis, although HSV -1 is the 
cause of 78%-98% of cases (Gerdes & Smith, 1983). There are only limited data (1 case 
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per 200,000 population in USA) on the incidence of HSV encephalitis (Whitley et al., 
1977). 
IA.S Treatment 
A range of anti-viral agents has become available since the 1980s, however no 
treatment is currently available to eliminate HSV infection. Acyclovir (9-[(2-
hydroxyethoxy) methyl] guanine, Zovirax), a synthetic acyclic purine-nucleoside analogue, 
was introduced in the early 1980s and has been shown to produce a clinical benefit in 
primary genital herpes when administered either intravenously or orally (Mindel et al., 
1982). Acyclovir reduces the clinical severity of disease episodes, shortens their duration, 
prevents complications and reduces symptomatic viral shedding, but does not eliminate the 
infection (Kinghorn, 1993). Even after 20 years of use, resistance to acyclovir is not yet a 
significant problem in clinical practice because the viruses that escape from control of this 
drug are profoundly debilitated and acyclovir continues to be the mainstay of treatment 
(Corey, 1993). 
Acyclovir is a particularly effective inhibitor of herpes simplex virus replication in 
vitro and in vivo (Elion et al., 1977, Schaeffer et al., 1978). The efficacy and antiviral 
specificity of the acyclic nucleoside analogues is due in part to their selective 
phosphorylation in virally infected cells (Biron et al., 1985, Elion e/ ai., 1977). The HSV 
thymidine kinase enzyme (tk) phosphorylates acyclovir, conv.erting it to a mono-
phosphorylated form, which is then phosphorylated further by cellular kinases before it is 
incorporated into newly synthesised DNA resulting in the arrest of DNA synthesis and 
leading to subsequent DNA fragmentation (Moolten, 1986, Reardon & Spector, 1989). In 
addition to acyclovir, precursor drugs, valaciclovir (converted to acyclovir) and 
famciclovir (converted to penciclovir), have been licensed and have better oral 
bioavailability than acyclovir and penciclovir respectively (Balfour, 1999). 
Therapeutic vaccines may also be useful in the control of genital and neogenital HSV 
infection, although no vaccine with proven efficacy against a human herpes simplex virus 
has yet been developed. More recently, three types of prophylactic vaccine are in clinical 
trial: an adjuvant subunit using viral surface glycoprotein gB and gO antigens, a 
replication-incompetent viral mutant, and DNA vaccines (Bernstein & Stanberry, 1999, 
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Corey et al., 1999, Stanberry, 1995). Additionally, genetically attenuated HSV mutants 
and vectors are in pre-clinical development. 
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18 HSV·1 biology 
The herpes simplex viruses were the first human herpesviruses to be discovered and 
are also the most intensely investigated (reviewed by Roizman & Sears, 1996). HSV -1 is a 
common and effective human pathogen capable of establishing both lytic and latent 
infectious life cycles. HSV -1 is a nuclear replicating virus with a linear double-stranded 
DNA genome, encoding at least 84 different proteins during lytic (productive) infection. 
However, in the latent phase of infection, only a limited group of transcripts are expressed. 
The mechanism of the switches between productive and latent infection is not fully 
understood, and is the subject of much current research. 
In this section, the virion structure, the HSV-l genome, and general aspects of both 
lytic and latent infection are briefly described. 
IB.I Virion structure and composition 
As with other herpesviruses, the HSV-1 virion is composed of an outer trilaminar 
lipid envelope containing the viral glycoproteins, an amorphous tegument, an inner 
icosahedral capsid shell, and a DNA-containing core. The diameters of the complete 
particle and the capsid are around 180 nm and 100 nm respectively (Morgan et al., 1968). 
Located centrally in the virion, the double-stranded DNA genome is condensed into 
the apparent shape of a torus (Furlong et al., 1972). The folded DNA molecule lies 
enclosed in an icosahedral capsid assembly of 162 capsomers, of which 150 are hexameric 
and 12 are pentameric. The hexamers are located on the faces and edges of the capsid and 
the pentamers are at the vertices (Booy et al., 1991). 
The nucleocapsid, formed by capsid plus enclosed DNA, is embedded in the 
tegument. The tegument contains some twenty distinct structural proteins of various 
functions that are thought to influence the process of infection (Rixon, 1993). The outer 
surface of the tegument is enclosed in the viral envelope - a trilaminar lipid membrane of 
host origin decorated with 12 or more different HSV membrane proteins (Schrag et al., 
1989). 
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IB.2 The HSV-I genome 
The HSV-l virion contains a double stranded linear genome of 152 kilobase pairs 
(kb) with a G+C content of 68% (McGeoch et ai., 1988). The DNA of HSV -1 consists of 
two covalently linked segments, designated L (long) and S (short). At the termini of the 
genome and at the junction of the L and S segments are one or more additional copies of a 
400 base pair (bp) unit termed the a sequence (Wadsworth et ai., 1975). The L and S 
segments each contain a unique sequence, UL (unique long) or Us (unique short), and in 
turn these are flanked by large inverted repeats termed b (bounding Ud and c (bounding 
Us). Thus, as shown in Fig. 1.1, UL is flanked by the sequences ab and its inversion b'a', 
around 9.2 kb each, whereas Us is flanked by the sequences a'c and its inversion c'a, 6.6 
kb each (McGeoch et aI., 1988). Up to now, at least 84 genes have been variously 
identified, sixty-five mapping in UL, fourteen in Us and two copies of five genes in the 
repeat sequences. These encode proteins that are either structural (contained in the capsid, 
arrayed in the surrounding tegument or as glycoproteins anchored in the envelope) or 
nonstructural (often enzymes required for DNA replication and gene expression). The 
name of each open reading frame refers to genes by their location in the genome, e.g. UL 1-
56, Us I-II. Nonetheless, some encoded proteins are assigned multiple names, usually 
referring to their respective genomic location, function, or molecular weight. For instance, 
the UL48 gene encodes a viral transactivator referred to variously as VP16 (Virion Protein 
16), ex.TIF (ex. gene Trans-Inducing Factor), ICP25 (Infected Cell Protein 25) or Vmw65 
(Virus protein of molecular weight 65 kDa). 
IB.3 The HSV -I life cycle 
In humans, HSV-l causes two kinds of infection, lytic and latent. Initially, acute 
infections by HSV -1 principally involve ectodermally derived tissue such as skin, mucous 
membranes, and corneal epithelia. The virus attaches and binds to the epithelium cells, 
enters by fusion with the cell membrane and then starts replication and gene expression. 
Lytic (productive) infection results in the production of more virions that cause cell death. 
After the initial infection and many rounds of viral replication at body surfaces, virus 
particles ascend by retrograde axonal transport in nerve axons to associated somas in 
sensory ganglia. Viruses in the infected neuron nucleus may replicate to produce progeny, 
or may enter a non-replicating latent state in which the viral genome is sequestered and no 
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Fig. 1.1 Schematic representation of the HSV-1 genome. 
(A) The approximately 152 kb genome is divided into UL and Us sequences illustrated as 
solid lines and major repeat elements (TRL and IRL, IRs and TRs) as filled boxes. The 
location of the L and S segments are marked. Terminal a sequences and the internal, 
opposite orientation a' sequence are indicated. The filled quadrangles represent terminal 
sequences ab and e'a inverted and repeated internally to b'a'e. (B-D) Below the genome 
representation, the sizes (kb) of the major genome regions (B), the numbers of genes (C), 
and distribution of viral genes (D) proposed for each are listed. 
If 
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free virus can be detected (Stevens & Cook, 1971). However, the molecular mechanisms 
by which one of these options is followed have yet to be elucidated. 
1B.3.1 Lytic infection 
The process by which HSV -1 enters the cell, replicates and is released from infected 
cells is called lytic infection as illustrated in Fig. 1.2. In tissue culture, the HSV -1 lytic 
cycle is completed within 24 hours. The initial stage is attachment to the cell surface 
receptor followed by fusion of the envelope with the cytoplasmic membrane. Once inside 
the cell, the viral DNA is released from the capsid into the nucleus and is transcribed and 
replicated. Finally, mature virions are released from the cell. Death of the infected cell 
eventually ensues. 
1B.3.1.1 Adsorption and penetration 
Viral surface glycoproteins inserted in the envelope mediate attachment and 
penetration of HSV -1 into cells. The HSV -1 viral particle firstly attaches to the cell 
surface through the interaction of virion glycoproteins with cell surface receptors such as 
heparan sulphate proteoglycan (reviewed by Shukla & Spear, 2001). In alphaherpesviruses, 
11 glycoproteins have been described so far; they are glycoproteins B (gB), gC, gD, gE, 
gG, gH, gI, gJ, gK., gL and gM and a twelfth (gN), the product of the pseudorabies virus 
(PrV) UL 49.5 gene, is predicted (Ions et al., 1996). Several of these molecules exist as 
homomeric multimers, such as gC, gB, gD (Claesson-Welsh & Spear, 1986, Handler et al., 
1996, Kikuchi et al., 1990), or form heteromeric complexes with other glycoproteins, for 
example gH:gI; gM:gN (Johnson & Feenstra, 1987, Jons et al., 1998). 
In the course of HSV -1 infection, glycoprotein C is required for efficient binding of 
virions to the cell surface (Herold et al., 1991). Additionally, it has been proposed that gB 
is the most prominent glycoprotein involved in the interaction with cell surface 
glycosaminoglycans (GAGs), principally heparan sulfate. A mutant virus in which the 
heparin sulphate-binding domain of gB is deleted displays reduced penetration kinetics and 
reduced plaque size, implicating a potential role for gB interactions with GAGs (Laquerre 
et al., 1998). However, no one virion protein has been found to be solely responsible for 
attachment to the cell surface; mutant viruses expressing neither gC or gB bind to cells in 
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Fig. 1.2 Replication of HSV -1 during lytic infection. 
The initial stage of infection is adsorption of HSV -1 virion to the cell surface through the interaction 
of viral glycoproteins in the viral envelope with host cell receptors in the cytoplasmic membrane 
(marked as letter 1 in white). The envelope and membrane fuse and the vi ral nucleocapsid is 
released into cytoplasm and the viral DNA is then uncoated and imported into the nucleus (labeled as 
2). Early transcription and mRNA are synthesised by host enzymes (labeled as 3). The resulting 
early gene products are used in viral DNA replication (4). Further RNA transcripts are required for 
synthesis of viral capsid, envelope proteins and glycoproteins. The newly produced capsid subunits 
are assembled and the viral D A is packaged into the capsid (as labeled in 5). The latter are 
enveloped by budding through the nuclear membrane and eventually egress [Tom the infected cell. 
(Adapted from Ackermann. H-W. , Berthiaume, L. , and Tremblay, M. , Virus life in Diagrams, CRC 
Press, 1998, 52.) 
13 
Chapter 1 Introduction 
tissue culture extremely inefficiently (Herold et ai., 1994, reviewed by Shukla & Spear, 
2001). 
After the initial adsorption, HSV -1 enters cells by a fusion between the virion 
envelope and the cell membrane. Several lines of evidence show that glycoproteins B, D 
and H:L are essential to mediate fusion (Cai et ai., 1988, Forrester et ai., 1992, Ligas & 
Johnson, 1988, Roop et ai., 1993). Furthermore, according to cross-linking studies on 
HSV-l virion, Handler et ai. proposed a concept that the processes of receptor-binding and 
membrane fusion are mediated by a functional complex of these molecules rather than by 
their independent action (Handler et ai., 1996). Nevertheless, this view is difficult to 
reconcile with the concept, reported by Rodger et ai. that the absence of one glycoprotein 
did not alter the outcome of cross-linking reactions between the remaining molecules 
(Rodger et ai., 2001). More recently, a transfection study designed to reconfirm these 
arguments has shown that fusion requires the expression of all four glycoproteins on the 
same membrane and that they appear to act in cis during the fusion process (Browne et ai., 
2001). 
Subsequent penetration of virus requires the interaction of gO with specific cell 
surface receptors such as the herpesvirus entry mediator (HVEM) (Montgomery et aI., 
1996), nectin-l and nectin-2 (which are sometimes designated Hve A, Hve Band Hve C 
respectively) (Geraghty et aI., 1998, Warner et aI., 1998). Most recently, the 
crystallographic structure of HSV-l gO in the absence or presence of Hve A has been 
determined (Carfi et ai., 2001). The C-terminal trunctated gD protein (containing residues 
1-285) was expressed in baculovirus system and the purified gD protein was prepared for 
formation of the gDlHve A complex. It has been revealed that the structure of the free 
form of the gO protein is different from that of gDlHve A complex, suggesting that gO 
may change conformation upon binding Hve A. 
Following envelope fusion with the plasma membrane and subsequent penetration, 
viral capsids are transported to the nuclear membrane in a process mediated by the cell 
cytoskeleton (Kristensson et ai., 1986). The ONA is then released into the nucleus through 
nuclear pores, followed by genome circularisation to form an episome. 
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IB.3.1.2 Viral gene expression 
During lytic infection, following penetration into the nucleus, viral gene expression 
occurs in a temporally regulated pattern and genes are classified as alpha (a), beta (/3) and 
gamma (y) (Clements et al., 1977). The first set of genes (a, immediate-early, or IE genes) 
is transcribed by cellular RNA polymerase II (Ben-Zeev & Becker, 1977, Costanzo et al., 
1977) with the participation of a virion tegument protein VP 16, which is released from the 
tegument after uncoating of the viral capsid. VP 16 acts in trans together with the cellular 
octamer DNA-binding protein, Oct-l and another cellular factor known as HCF also called 
Cl (Scarr et ai., 2000, Wilson et al., 1993). The mode of action of VP16 is quite well 
understood and is described in more detail in a later section. The expression peak of IE 
genes is at 2 to 4 hour post infection, although most IE proteins continue to accumulate 
throughout infection. Functional IE proteins are required for the fully efficient synthesis of 
all the later classes of virally encoded proteins. The products of at least three IE genes 
function as transactivators of P or early (E) gene expression, which peaks at 5 to 7 hours 
and is detectable as early as 2 hours post infection. "Many of the products expressed from 
E genes are enzymes or factors that are required for replication of the viral genome. After 
the onset of viral DNA replication, the temporal program of viral gene expression 
continues with the appearance of the y or late (L) proteins, which generally comprise the 
structural proteins: tegument proteins, envelope glycoproteins, and proteins necessary for 
nucleocapsid assembly and genome packaging (Roizman & Sears, 1996). The details of 
viral gene expression are discussed in more detail in section 1 C. 
IB.3.1.3 DNA replication 
HSV -1 DNA replication begins shortly after the appearance of the E gene products 
and can be detected as early as two hours post infection and continues up to at least 
fourteen hours post infection (reviewed by Roizman & Sears, 1996). Replication of viral 
DNA takes place in large globular replication compartments (Quinlan et al., 1984, Rixon 
et al., 1983) that initially form adjacent to subnuclear domains called NDI0 (further details 
are described in section IE, and Ishov & Maul, 1996, Maul et ai., 1996). 
Seven viral gene products, all located in the UL segment, have been described to be 
absolutely necessary for HSV-l DNA replication (reviewed by Challberg & Kelly, 1989). 
The functions of these proteins have been defined as a DNA polymerase (UL30) and its 
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processivity factor (UL42), a single-stranded DNA binding protein (ICP8, also known as 
UL29), an origin-binding protein (UL9), and components of a helicase-primase complex 
(UL5, UL8, UL52) (reviewed by Challberg & Kelly, 1989). In transient transfection 
assays, these molecules are sufficient for amplification of a cotransfected plasmid 
containing a viral origin of replication (Challberg, 1986, Wu et al., 1988). 
As illustrated in Fig. 1.3, parental viral DNA in the nucleus is hypothesized to 
replicate first via a theta-mode intermediate, then by switching to a rolling circle 
mechanism that produces long head-to-tail concatameric viral genomes (reviewed by 
Boehmer & Lehman, 1997, Roizman and Sears, 1996). The HSV-l genome contains three 
origins of DNA replication: one copy of OriL is located between UL29 and UL30 genes 
within the UL segment, and two identical copies of oris map in the 'c' inverted repeat 
region (IRs) of the S segment. However neither copy of oris is essential for viral growth in 
cultured cells since deletion of one or both copies of oris has no effect on viral DNA 
replication (Roizman & Sears, 1996). Initially, the UL9 protein (94 kDa), containing 
helicase activities, binds to its recognition DNA sequence as a homodimer (Lee & 
Lehman, 1999) through its N-terminal part (Elias et al., 1992). It has been shown that 
ICP8 interacts with the extreme C terminus ofUL9, greatly stimulating its DNA-dependent 
ATPase and DNA helicase activities (Boehmer et al., 1993). UL9 protein, together with 
ICP8 (128 kDa) (that binds single-stranded DNA with a 5-fold greater affinity than double-
stranded DNA (Lee & Knipe, 1985), can unwind the two strands of the template DNA 
specifically, permitting entry of the DNA replication machinery (Lee & Lehman, 1997). 
Subsequently, a 'primosome' (DNA Helicase-Primase complex), which consists of a 1: 1: 1 
association of the UL5, UL8 and UL52 gene products with a molecular weight of around 
270 kDa, associates with the origin to create an initiation bubble in the theta (9) mode of 
replication (Fig. 1.3). A host DNA polymerase, DNA polymerase a.-primase, has been 
implicated to playa role in the theta phase (Lee et ai., 1995). DNA synthesis occurs when 
this initiation 'bubble' associates with a complex of the DNA polymerase (product of 
UL30 gene) and VL42. It has been reported that stimulation of DNA polymerase activity 
requires UL42, a protein that possesses double-stranded DNA binding activity, since the 
HSV-l DNA polymerase lacks DNA binding activity (Gottlieb et al., 1990). DNA 
synthesis occurs continuously along one strand and discontinuously on the other strand. 
The growth of the DNA replication fork is maintained by the major DNA-binding protein 
ICP8. This results in the production of head to tail concatamers that accumulate in the 
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Fig. 1.3 Model for the replication of the HSV -1 genome in which an initial transient 
phase of theta replication is followed by a rolling circle mode, the predominant mode 
of HSV -1 DNA replication. (modified from Lehman and Boehmer, 1999) 
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replication compartments (Quinlan et ai., 1984). The HSV-l genome also encodes a set of 
enzymes involved in nucleic acid metabolism such as thymidine kinase, ribonucleotide 
reductase, uracil-DNA glycosylase and dUTPase (reviewed by Boehmer & Lehman, 
1997). 
1B.3.1.4 Virion assembly: capsid assembly and DNA packaging 
The overall process of virion assembly begins when the newly replicated viral DNA is 
cleaved from its concatemeric form to unit-length genomes and is packaged into pre-
formed, immature capsids, which then acquire an envelope derived from the inner nuclear 
membrane upon exit from the nucleus (for details, see below). 
The three-dimensional structure of the HSV-l capsid has been determined at 8.5 A 
res01ution by Chiu and co-workers (Zhou et ai., 2000). The capsid is composed of a major 
capsid protein called VP5 and three 1ess abundant proteins, VPI9C, VP23 and VP26. At 
approximately the same time as DNA replication, capsid assembly initiates with the 
association of the capsid shell and scaffold proteins, pre-VP22a (encoded by the UL26.5 
gene), resulting in immature spherical procapsids whose composition is identical to that of 
the outer shell of the mature capsid (Newcomb et ai., 1999, Trus et ai., 1996). Procapsids 
contain an unprocessed internal scaffold protein core formed by pre-VP22a, the major 
component of the procapsid that is not present in the mature capsid (Newcomb et a/., 
1996). Maturation of the procapsid involves the prote01ytic processing of the scaffold by 
its associated protease. The UL26 gene product undergoes autoproteolysis to form VP24 
and VP21 and the proteolytic activity also modifies pre-VP22a to VP22a by c1eaving at the 
pre-VP22a C terminus, where pre-Vp22a binds to VP5, resulting in the release of the 
internal scaffold from the capsid shell (Homa & Brown, 1997). The procapsid is then 
ready for genome packaging. At the time of DNA packaging, the scaffold protein VP22a 
is expelled and only the protease VP24 remains inside the mature capsid (Gao et ai., 1994). 
Three types of capsid, designated A (empty), B (intermediate), and C (mature) have 
been isolated from infected cells by velocity sedimentation of nuclear lysates (reviewed by 
Homa & Brown, 1997). C capsids containing the viral genome can mature to become 
infectious virions. B capsids contain the proteolytically processed forms of the internal 
scaffold (see below). A capsids are believed to be by-products of DNA packaging and are 
incapable of maturation into infectious virions. 
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DNA packaging involves the participation of DNA, empty capsids, and additional 
HSV -I-encoded proteins. Studies on temperature-sensitive mutants have shown that seven 
gene products; UL6, UL15, ULl7, UL25, UL28, UL32, and UL33, are required for the 
DNA cleavage and packaging processes, however the individual functions of the 
packaging proteins are unclear. 
1D.3.1.S Nucleocapsid envelopment and virus egress 
The processes by which enveloped virions are transported from the perinuclear space 
through the cytoplasm to the extracellular space are not well understood, primarily because 
many viral proteins and cellular factors have been described as being involved in 
membrane fusion. More recently, a comparative ultrastructural study reported that after 
intranuclear assembly, progeny nucleocapsids exit by budding at the inner leaflet of the 
nuclear membranes into the perinuclear space, resulting in the acquisition of a primary 
envelope (Granzow et aI., 2001). Additionally, results from immunogold labelling with a 
TGN (trans-Golgi network)-specific antibody showed that the secondary envelopment of 
released nucleocapsids occurs at the membranes of the trans-Golgi area. Finally, egress of 
virus progeny occurs by exocytosis of virus-containing vesicles. Another model of egress 
has been illustrated by Skepper et al. using immunogold labelling to track the distribution 
of gO, which was expressed as a fusion protein with an ER (endoplasmic reticulum) 
retrieval signal (KKXX) in its C-terminus. Most ER-tagged gD was found between the 
inner and outer nuclear membranes, whereas very little of the protein was present on 
extracellular virus particles, implying that the primary envelope acquired from nuclear 
membrane might be lost during egress and that the mature virion must obtain an envelope 
from a post-ER cytoplasmic compartment (Skepper et al., 2001). 
1B3.2 Latent infection 
Herpes simplex viruses are best known for their ability to remain latent in humans for 
the lifetime of the host. During latency, HSV DNA persists in an extrachromosomal state, 
the most likely physical form of which is a circular episome. Latent infection is 
characterised by the absence of viral antigens and of infectious virus. Any latent infection 
can be viewed as having three separable phases: establishment, maintenance, and 
reactivation. 
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Virions enter sensory neuron endings and are transported to the cell bodies in sensory 
ganglia where latent infection is established (Stevens & Cook, 1971). However, the 
precise mechanism for the establishment phase is unclear since the neurons in which the 
virus replicates during the first several days after infection obscure the events taking place 
in the neurons committed to maintaining the virus in a latent state. 
During maintenance of the latent infection, viral DNA is maintained as a circular 
episome, most lytic cycle genes are transcriptionally and functionally quiescent, and only a 
limited number of viral genes will be expressed, so that the cytopathic results of productive 
infection do not occur. It is suspected that failure of IE transcription results in an inability 
to activate the productive cascade. This concept is supported by the observation that 
latency can be efficiently established following infection of mice with in1814, a HSV-l 
mutant that abolishes the interaction ofVP16 with Oct-l and RCF, resulting in reduced IE 
gene expression (Ecob-Prince et al., 1993, Valyi-Nagy et al., 1992). 
Successful reactivation of herpesvirus replication results in the appearance of 
infectious virus at the site of the initial primary infection. The mechanisms involved in the 
induction of reactivation remain poorly understood. Reactivation of HSV -1 in humans can 
be induced by many different non-specific stimuli including abrasion to the skin, fever, 
exposure to UV irradiation, stress and possibly hormonal irregularities. 
183.2.1 LATs and their potential role in HSV-llatency 
• LATs 
During latent infection, HSV -1 gene expression is restricted to a family of RNAs 
known as the latency-associated transcripts (LATs) (Deatly et al., 1987, Stevens et al., 
1987). The LATs are transcribed from a region located within the long repeat (Rd region, 
mapping antisense to the IE ICPO gene (Fig. 1.4A). As shown in Fig. 1.4B, the full-length 
8.3-kb LAT transcript (also called the minor LAT) accumulates to low levels in latently-
infected neurons, while 2.0- and 1.5-kb introns processed from the full-length transcript 
(termed major LATs) are more abundant (reviewed by Wagner & Bloom, 1997). The most 
abundant 2.0-kb LAT is a branched lariat and is neither capped nor polyadenylated (Devi-
Rao et al., 1991, Rodahl & Haarr, 1997, Wagner et al., 1988). Further RNA processing to 
remove 500 bp from within the 2.0-kb LAT sequence results in the production of the 1.5-
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Fig. 1.4 A diagram illustrating the relative positions of sequences within the HSV-l 
genome encoding the ICPO and LAT transcripts. 
(A) A schematic diagram of the HSV -1 gemone. The LA Ts and the uO gene are encoded 
by diploid genes that map to the repeat regions (IRL and TRL). The horizontal lines drawn 
underneath represent the IRL and IRs regions in which relative positions of LA T and ICPO 
transcripts are shown. The coding region of ICPO is between residue 124256-120882, 
consisting of three exons marked as filled grey boxes and two introns shown as lines. The 
black box demonstrates the location of the RING finger region in the exon 2. 
(B) LA T transcripts. The 8.3-kb primary LA T transcript (minor LA T) is at residues 119461 
to 121237. Stable 2- and 1.5-kb RNA species, the intron regions derived from the 8.3-kb 
primary LAT transcript, accumulate to high levels in latently infected tissue which map 
toward the 5' end of the 8.3-kb transcript. 
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kb LAT (Alvira et 01., 1999). The 2.0-kb LAT is detected both in productive and latent 
infection, whereas the I.S-kb LAT is detectable only in latently infected neurons (Spivack 
& Fraser, 1988). There are a number of reports suggesting that the LATs might express 
protein, but as yet these have proved controversial and are not widely accepted. 
• LATs facilitate reactivation from latency 
The existence of the LATs has been known for many years (Stevens et 01., 1987) and 
it has been speculated that they may playa central role in viral latency, but the function of 
the LAT gene remains uncertain. Investigations using mouse models have shown that the 
LA Ts are not absolutely required for the establishment or maintenance of a latent infection 
or for reactivation (Block et 01., 1990, Javier et 01., 1988, Steiner et 01., 1989). However, it 
has been suggested that LA T mutants reactivate less efficiently from latent infection from 
cultured trigeminal ganglionic neurons (TO) (Block et 01., 1993), and that a 348-bp region 
located downstream of the LAT promoter plays a significant role in enhancing reactivation 
in a rabbit model (Bloom et at., 1996). This finding was supported by further observations 
using a mouse model in which reactivation is induced by thermal stress (Thompson & 
Sawtell, 1997). Analysis of the frequency of hyperthermia-induced reactivation from 
HSV-l wild type strain KOS and LAT-mutant virus revealed that the LAT mutants exhibit 
a reduction (at least 80%) in reactivation frequency in mouse TO (Sawtell & Thompson, 
1992). 
• LATs increase establishment of latency 
Although several lines of evidence imply that LATs may play a direct role in 
reactivation from latency, the biological role of LATs in latent infection is still debatable. 
Most recently, more results support the view that LATs may facilitate the establishment of 
latent infections and this increase is responsible for efficient reactivation (Thompson & 
Sawtell, 1997, Thompson & Sawtell, 2001). A new approach, CXA (contextual analysis), 
was employed to quantifY the percentage of neurons that harboured the viral genome in 
latently infected TO neurons (Sawtell, 1997, Sawtell, 1998, Thompson & Sawtell, 1997). 
Thomson and Sawtell reported that the number of neurons retaining viral genomes was 
reduced by approximately 3-fold in ganglia ofLAT mutant infected mice compared to that 
of wild type KOS strain infected mice (Thompson & Sawtell, 1997). Consistently, this 
finding was also observed using a strain 17+ based LAT mutant (Thompson & Sawtell, 
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2001). Additionally, increasing the level of establishment of latency by the LAT -null 
mutants resulted in an increase in the frequency of reactivation, suggesting that LA T is not 
required for efficient in vivo reactivation (Thompson & Sawtell, 1997). However the 
mechanism by which the LA Ts facilitate establishment of latency is not yet known, and the 
controversial views of the role of LA Ts in reactivation still need to be clarified. 
• LA Ts promote neuronal survival 
The advantages ofCXA are not only that it is possible to determine how expression of 
LAT is related to genome copy-number in individual neurons, but also that neuronal death 
after infection can be quantified. Using CXA, it was observed that after 30 days of latent 
infection more than 50% of TO neurons were lost in mice infected with LA T null mutant 
virus, while less than 20% of TO neurons were lost following wild type infection. This 
result suggested that the LAT gene can increase neuronal survival and enhance the 
establishment of latency in the mouse model (Thompson & Sawtell, 2001). Based on these 
findings, and together with several recent observations, they hypothesized a new model 
that when a high copy number of virions enter a neuron, expression of the LAT gene in 
neurons prevents progression to lytic infection mediated by repression of IE gene 
expression (Thompson & Sawtell, 2001). In this model, the LAT is viewed as a repressor 
of IE expression, and this is supported by the observations of Mador et al. (1998) using a 
neuronally derived cell line, constitutively expressing the major 2.0-kb LAT. They 
reported that replication of HSV-l was reduced by at least 160-fold at a multiplicity of 
infection (MOl) of 0.1, and accumulation of mRNA expressing the IE genes ICPO, ICP4 
and ICP27 was reduced compared to that in a control transformed cell line (Mador et al., 
1998). These findings imply that LAT may repress viral replication by reducing the IE 
gene mRNA levels and thereby increasing the establishment ofHSV-l latency in neuronal 
cells 
• LA Ts prevent apoptosis 
Recently, LATs have been suggested to playa potential role in apoptosis of infected 
neurones in a rabbit model (Perng et al., 2000). These authors found that in rabbit TO 
extensive apoptosis occurred when latently infected with a LA T mutant virus, but not with 
wild type virus. They suggested that the LATs promote neuronal survival after HSV-I 
infection by reducing apoptosis. This conclusion, however, is difficult to reconcile with 
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the observation from other researchers who reported that LATs prevented the destruction 
of TG in a mouse model, but there was no significant evidence to demonstrate that LAT 
null viruses induce more extensive apoptosis in infected neurons as measured by the 
TUNEL assay (Thompson & Sawtell, 2000, Thompson & Sawtell, 2001). 
lB.3.2.2 Animal models for the study of HSV latency 
The broad host range of HSV -1 has allowed the use of several animal models for the 
study of viral pathogenesis, neuropathology, neuroinvasiveness, and latency. As described 
previously, the most appropriate model for latency must allow establishment of a stable 
latent infection and virus reactivation, which should be similar to that seen in humans. 
Two animal models, the rabbit and the guinea pig, approximate to this ideal situation, 
although there are some limitations in both models. 
It has been reported that by infection of rabbit eyes, HSV -1 establishes latent infection 
in TG and infectious virus can be recovered from latently infected TG only when 
cultivated with feeder cells (Nesburn et 01., 1972, Nesbum et 01., 1967). Despite the high 
expense, the rabbit system could mimic human infection in broad detail and may be an 
appropriate model for the study of reactivation. 
The guinea pig model has been promising for the study of vaccine efficiency and other 
aspects of experimental pathogenesis (Wagner & Bloom, 1997). Vaginal inoculation of 
female guinea pigs with HSV -1 causes significant primary infection and infectious virus 
can be recovered from the recurrent vesicular lesion in the vaginal area (Landry & Bull, 
1992, Stanberry et 01., 1982). However, it has been reported that reactivation can not be 
reliably induced in this model (Bratcher et 01., 1993). 
The mouse model has been used extensively due to the relatively lower cost, although 
this system suffers from the lack of efficient in vivo reactivation of virus. To date, at least 
two murine models have been well established and frequently applied to the study of 
latency. 
• The footpad/dorsal root ganglion model 
The mouse footpad model was the first in vivo latency system to be developed (Stevens 
& Cook, 1971, Walz et 01., 1974). This system is analogous to genital infection of HSV-l 
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in humans, and is particularly useful for the study of HSV-2 infection. HSV inoculation of 
a mouse rear footpad results in a local cutaneous infection and following anterograde 
transfer of virus through the peripheral and central nervous system, which is followed by 
the establishment of latency in spinal ganglia. The latent infection can be reactivated by 
explant culture of dissected dorsal root ganglia (DRG) with feeder cells (Stevens & Cook, 
1971). 
• Mouse eye/trigeminal ganglion model 
In this model, HSV-l resides in a latent state in the TG after infection of the cornea via 
scarification (Sawtell & Thompson, 1992, Walz et al., 1974). As in the footpad model, 
latent HSV can be recovered by co-cultivation of explanted ganglia. Additionally, Sawtell 
and Thompson developed a modified method by which the latent HSV genome can be 
reactivated by hyperthermia treatment followed by preparation of the TG for detection of 
the viral genome or other expressed markers, often by sensitive quantitative PCR. Without 
the requirement for further culture of the explanted ganglia, this model is considered closer 
to an in vivo method and offers another way for modelling reactivation in the mouse 
(Sawtell & Thompson, 1992). 
l.B.3.2.3 In vitro models of latency 
Animal models have proved invaluable for the study of HSV-l pathogenesis and 
latency, however this system is costly, time consuming and ethically restricted. To 
overcome such difficulties, there have been several reports of promising in vitro models 
applied for latency studies. For instance, using fibroblasts, neuroblastoma, or primary 
cultures of sensory neurons, latency can be established by limiting virus replication and 
spread by using antiviral agents or replication-defective viruses (Block et al., 1994, Harris 
et ai., 1989, Wilcox & Johnson, 1987). 
• Primary neuronal culture 
The most well-studied neuronal model system is that of Wilcox and colleagues in 
which acyclovir (ACV) is used to establish latent infections and nerve growth factor 
(NGP) is employed to maintain latency (Wilcox & Johnson, 1987, Wilcox et al., 1997). 
Dorsal root ganglia of a IS-day embryonic or neonatal rat were plated on coverslips and 14 
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days later ACV was added to the medium. The cultures were infected with HSV -1 after a 
further 12 hours. After several days, the cultures are free of infectious virus and LA Ts are 
detected in a large proportion of cells in an MOl dependent manner (Wilcox et al., 1997). 
The latent viral genome can be reactivated by withdrawal of ACV, and NGF deprivation 
by adding 1% of rabbit anti-mouse NGF serum (Wilcox & Johnson, 1987). 
More recently, a modified model was developed by Arthur et al. (2001). The activity 
of the LAP (LAT promoter) was stably maintained in up to 83% of primary rat dorsal root 
neurons infected with defective viruses (gHTK") with a reporter gene (lacZ) driven by 
LAP for at least three weeks. In addition, IE promoter (ICPO) activity could be reactivated 
from over 50% of latently infected neurons by NGF withdrawal or treatment with 
trichostatin A (TSA), an inhibitor of histone deacetylases (Arthur et al., 2001). 
• Primary TG cell cultures 
Several groups have described a primary TO cell culture model as an alternative model 
for studying HSV-l reactivation (Halford et al., 1996, Moriya et al., 1994). In the model 
of Moriya et al. (1994), latently infected mouse TO are dissociated and maintained in a 
latent state by using BVareU, an inhibitor of HSV replication. These cultures can be 
induced to reactivate by heat shock, similar to the in vivo heat shock system described in 
section IB3.2.2 (Sawtell & Thompson, 1992). 
More recently, Halford and colleagues established TO cell monolayers from 
dissociated infected mouse TG in the presence of ACV. After removal of ACV and NOF 
from the medium, reactivation oflatent HSV-l could be induced in up to 75% ofTG cell 
cultures by heat shock at 43°C for 3 hours (Halford & Schaffer, 2001) or treatment with 
dexamethasone (Halford et al., 1996). However, the results of Halford et al. indicated that 
TO cell cultures may have spontaneous levels of reactivation during pre-heat stress 
treatment (Halford et al., 1996). 
While this model clearly has promised in the study of a . number of molecular and 
biochemical parameters, the disadvantage of primary TG cell culture is that preparation of 
dissected ganglia is inconvenient and the samples often contain heterogeneous groups of 
cells. 
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• Fibroblast cell lines 
Another system used cultured cells derived from either human B cells or fibroblast 
cultures, infected by defective virus. Instead of using an inhibitor of viral replication, 
Preston et al. established latent HSV infection with replication-impaired viral mutants 
lacking VP16 and/or ICPO function in cultured human fibroblast (Harris & Preston, 1991, 
Jamieson et al., 1995, Preston & Nicholl, 1997). It has been shown that the quiescent virus 
can be reactivated by provision of exogenously-expressed ICPO (Samaniego et al., 1998, 
Stow & Stow, 1989), therefore this system has been exploited to investigate the role of 
ICPO in the reactivation process (Everett et al., 1998b, Harris & Preston, 1991). 
• Neuronal cell lines 
As studies with fibroblasts or lymphocytes may not be representative of neuronal cell 
viral latency following natural infection, several groups have developed a model based on 
PC12 cells to investigate the establishment of latency in a neuronal-like environment in 
vitro (Block et al., 1994, Danaher et al., 1 999b). PC12, a rat pheochromocytoma tissue 
culture line, can be neurally differentiated by exposure to NGF. Differentiated PC12 (Nd-
PC12) cells, when cultured on collagen-coated plates in the absence of serum, can be 
maintained as a non-dividing culture for up to seven weeks (Danaher et al., 1999b). In the 
presence of NGF, most of Nd-PCI2 cells can harbour HSV-l in a cryptic and non-
productive state that is reversible when NGF is removed from the culture (Block et al., 
1994). However, in situ analysis of long-term infected cultures revealed that LAT was 
expressed in only a proportion of the cells (Block et al., 1994). More recently, Danaher et 
al. (1999) reported a modified system in which, by transient pre-treatment with ACV prior 
to infection, non-productive infection was established in all the cells in the culture, and 
ACV was not need for maintenance of the quiescent infection. After withdrawal of ACV, 
the quiescent infection state can be reactivated by treatment of forskolin at a high 
frequency (92-100%) in the culture (Danaher et al., 1999b). Additionally, the reactivation 
in response to forskolin treatment can be detected in 50-100% of quiescently infected 
cultures up to 7 weeks post-ACV withdrawal. This group further characterised that in this 
system, after establishment of a quiescent infection with the transient use of ACV, 
reactivation could also be induced by heat stress (42°C, 3 hours) (Danaher et al., 1999a). 
After the heat stress, the IE gene product ICP4 was expressed by 3 h post treatment, 
whereas other viral gene products (ICPO, ICP27, UL30, and ULI8) were detected at 24 h 
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post induction at high levels (Danaher et al., 1999a). These data imply that ICP4 may play 
an early role of co-ordinating reactivation from quiescent infection. This model has 
appealing features for studying gene expression during the establishment, maintenance and 
reactivation phases ofHSV-l quiescent state in cultures of rodent neuronally-derived cells. 
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1C Regulation of HSV-1 gene expression 
As described in section IB3.1.2, HSV-l genes are categorised as immediate early (IE), 
early (E), and late (L), based on the time of their expression. Since this classification was 
first described in the early 1980s, the regulation of gene expression has been intensively 
studied, particularly the mechanisms that regulate this orderly and efficient expression of 
viral genes. Several lines of investigation have made a clearer picture of the temporal 
regulation of HSV gene expression, but a complete understanding of the mechanisms that 
tum on and tum off specific genes at the times required for efficient virus replication is 
lacking. Many recent studies have shown that some HSV proteins interact with cellular 
proteins. This indicates that virus-cell interactions play an important part in viral gene 
regulation by diversion and redirection of key cellular factors. 
In this section, regulation of HSV -1 genes by HSV -1 polypeptides, as well as HSV-l 
host cell interactions and their effect on viral gene expression, will be discussed. 
lC.l Activation of IE gene expression 
IE genes were originally defined as genes whose expression occurs in the absence of de 
novo protein synthesis. The transcription of IE genes during the earliest stage of infection 
is stimulated by the virion transactivator protein VP16 (reviewed by O'Hare, 1993). As 
illustrated in Fig. 1.5, IE promoters contain several cis-acting elements: a TATA box, Spl 
binding sites, T AA TGARA T elements, and in some instances binding sites for ICP4. 
Activation of IE genes is initiated by the fonnation of a tri-partite complex consisting 
ofVP16 and the cellular proteins Oct-l and HCF (Host Cell Factor). VP16 first binds HCF 
and subsequently the VP16IHCF complex associates with Oct-I. The complex then binds 
to the TAATGARA T elements and activates gene transcription. A major factor in this 
binding is the presence of DNA binding domains within Oct-l that recognise sequences 
overlapping the T AA TGARA T motif. The C-tenninal region of VP 16 is responsible for 
the transactivation function while other regions of the protein are required for DNA 
binding and protein-protein interactions (reviewed by Flint & Shenk, 1997, Roizman & 
Sears, 1996). The conserved core region (residues 1-412) has been demonstrated to be 
required for fonnation of the tri-partite complex (Liu et al., 1999). Analysis of the crystal 
structure of the VPl6-core region revealed a seat-like structure which has been suggested 
to fonn a DNA-binding surface involved in DNA recognition (Liu et al., 1999). It has 
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A. Immediate-Early Promoters 
TAATGARAT 
SP1 and other (ICP4 binding site) 
transcription factor binding sites 
B. Early Promoters 
SP1 SP1 
transcription factor binding sites 
C. Late Promoters 
Downstream 
activation site 
Fig. 1.5 Schematic representation of the cis-acting elements for IE, E, and 
L HSV -1 promoters. 
(A) Expression of IE genes i regulated by various cis-acting elements 
including the viral IE specific regulating element (TAATGARAT), TATA 
box, binding sites for PI and other transcription factors, and in some 
cases, binding sites for ICP4. 
(B) Early promoters con ist of a TA TA box, and binding sites for various 
transcription factors. 
(C) Late promoters have a TAT A box, an initiator element (I nr) at the start 
of transcription, and in some promoters, a downstrean1 activation site. 
(adapted from Weir, 2001) 
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been reported that during HSV infection, HCF binds to VP16 to promote a stable 
interaction with Oct-1 (Hughes et aJ., 1999) and it may also act as a nuclear import factor 
for VP16 (La Boissiere et aI., 1999). 
1 C.2 The potential roles of IE polypeptides in the regulation of gene expression 
Five IE proteins have been identified: ICPO (Vmwl10), ICP4 (Vmw175), ICP22 
(Vmw68), ICP27 (Vmw63), and ICP47 (Vmw12). Fig. 1.6A shows the locations of the IE 
genes in the HSV-l genome: IE genes a22 (IE4) and a47 (lE5) are located in Us region, 
a27 (IE63) lies in UL region, and aO (lEI) and a4 (IE3) map in the invert repeat regions 
with two identical copies. Four of five IE proteins (ICPO, ICP4, ICP22, and ICP27) playa 
role in controlling the order of expression of viral genes during infection (Fig. 1.6B). How 
each of these proteins functions in regulating the cascade of viral gene expression is not yet 
fully understood, however numerous investigations have characterised at least part of their 
distinctive roles. 
ICPO, the aO, IE-lor RL2 gene product, is a phosphoprotein with an apparent 
molecular weight on SDS polyacrylamide gels of 110 kDa. It has been found to be a 
potent transactivator of expression of all classes of viral genes, as well as of cellular and 
other heterologous genes. There are no specific promoter sequences required for this 
activity in transient transfection assays. In some systems, the action of ICPO is synergistic 
with lCP4, since in the presence of ICP4, the level of transcription in a transient assay is 
increased up to 20-fold higher than that with either transactivator alone (Everett, 1984b). 
Details relating to this function ofICPO are discussed in section ID. 
ICP4, the a4, IE3 or Rsl gene product, is another phosphoprotein with an apparent 
molecular weight of approximately 175 kDa. It is an essential protein for lytic replication 
of HSV -1, since in its absence infection does not proceed beyond IE gene transcription 
(Preston, 1979, Watson & Clements, 1980). As ICP4 ts mutant viruses overexpress IE 
products, it was suggested that ICP4 represses IE gene expression, including that of itself 
(DeLuca & Schaffer, 1985, Preston, 1979). 
Several lines of evidence have proposed that this transactivation is mediated through 
the interaction of ICP4 with DNA and the TBP-containing general transcription factor 
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Fig. 1.6 A schematic diagram showing the location of IE genes on the genome of HSV -J and 
regulation of gene expression by viral proteins. 
(A) The approximate relative positions of HSV -1 IE and VP16 genes on the HSV -1 genome 
are illustrated. The direction of the arrows represent the direction of translation of each gene 
product. 
(B) The role of four IE proteins in gene regulation is shown. ICPO can transactivate 
promoters of the IE, E and L genes. ICP4 is essential for the activation of transcription of E 
and L promoters but can be a negative regulator for IE promoters. ICP27 is essential for 
efficient expression of L gene products. ICP22 also contributes to efficient expression of L 
gene products (modified from Everett, 2000). 
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TFIID (Gu & DeLuca, 1994). The cellular high mobility group factor 1 (HMGl) might 
facilitate this interaction by means of its ability to bend DNA (Carrozza & DeLuca, 1998). 
However neither the mechanism of activation nor repression is completely understood. 
ICP22 is a 68 kDa protein expressed from the 0.22 (IE4, Usl) gene. The function of 
ICP22 in viral gene regulation is relatively unclear. While it is non-essential for infection 
in many cell culture systems (post & Roizman, 1981), ICP22 deletion mutants express 
reduced levels oflCPO and a subset of viral late genes (Sears et al., 1985). 
The C-terminus of ICP22 is also encoded by a second overlapping transcript 
designated as Us1.5 (Carter & Roizman, 1996). Analysis of the C-terminal domain that 
exists in both ICP22 and Us1.5 has shown that this region is necessary for optimal 
expression of several L genes and virus mutants lacking these domains are also avirulent in 
animal models of infection. Recently, it has been reported that ICP22 is responsible for 
inducing aberrant phosphorylation of the large unit of RNA polymerase II, however the 
significance of this interaction is not yet clear (Long et al., 1999, Rice et al., 1995). 
ICP27, a 63-kDa phosphoprotein, is encoded by the 0.27 (IE2, UL54) gene. As with 
ICP4, it is essential for normal virus growth (Sacks et al., 1985). ICP27 has been 
implicated in the switch from IE to E and L gene expression during viral infection 
(McCarthy et al., 1989). Transient transfection assays have shown that ICP27 alone can 
transactivate the expression of gB (Rice & Knipe, 1988) and act in synergy with both ICP4 
and ICPO to repress expression of IE and E promoters as well as to activate expression 
from L promoters (Sekulovich et al., 1988). 
ICP27 performs multiple-functions that contribute not only to transcription but also to 
the post-transcriptional regulation of gene expression. It has been shown that ICP27 
inhibits host cell pre-mRNA splicing which effectively shuts off host protein synthesis 
(Hardy & Sandri-Goldin, 1994, Sandri-Goldin & Mendoza, 1992). Most recently, ICP27 
has been reported to interact with several cellular proteins, including at least one which 
inhibits splicing. This suggests a possible mechanism for ICP27-mediated inhibition of 
splicing (Bryant et al., 2000, Bryant et al., 2001, Wadd et al., 1999). Since only four viral 
transcripts expressed during HSV -1 infection contain introns, splicing inhibition might to 
be benefit to viral transcripts over most cellular transcripts. 
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Furthermore, ICP27 has been reported to mediate the export of intronless viral RNAs, 
but has no effect on the export of cellular mRNAs (Koffa et ai., 2001, Sandri-Goldin, 
1998, Soliman et aJ., 1997). It was initially proposed that ICP27 affects nuclear export of 
viral RNAs via Crm I-dependent and -independent pathways (Soliman & Silverstein, 
2000). However, most recently, investigation of ICP27 by microinjection into Xenopus 
laevis oocytes demonstrated a new model of the role of ICP27 in viral mRNA export 
(Koffa et 01., 2001). ICP27 has been found to bind directly to REF (RNA and export 
factor binding protein) and RNA and form a complex with REF and TAP. Additionally, an 
ICP27 mutant defective in REF-binding failed to stimulate viral mRNA export. These 
observations provide evidence that the function of ICP27 in the export of viral mRNA is 
via a TAP pathway and interaction with REF. 
1 C. 3 Activation of E gene expression 
It has been established many years ago that functional ICP4 is necessary for the 
activation of both E and L gene expression (Watson & Clements, 1980). Additionally, the 
temporal regulation of E gene expression has been described to be mediated not only by 
ICP4 but is also dependent on cis-acting elements in Early promoters. Studies of the 
activation of E gene expression were extensively done using the thymidine kinase (tk) 
UL23 gene. The original work in a Xenopus oocyte system illustrated that the tk promoter 
contains similar regulatory elements to those in an eukaryotic promoter. These are a 
TATA element, two Spl binding sites (GC boxes) and a CAAT element (Fig. 1.5B). No 
additional cis-acting element was identified during viral infection (Coen et al., 1986). It 
was found that the TAT A box was necessary for the accurate initiation of transcription and 
that the presence of upstream elements, the eAA T motif and GC boxes, enhanced 
transcription. These upstream elements are important for the regulation of tk gene 
transcription. Besides these elements, analysis of gO gene promoter revealed that cap-site 
region is necessary for E promoter activation; deletion of this region moderately decreased 
gD gene expression (Everett, 1984a). In absence of Sp 1 binding sites and CAA T motif, tk 
was still expressed, but only if ICP4 is present (Imbalzano et 01., 1991). These findings 
strongly suggest that the TATA element and ICP4 may play an essential part in the 
activation of E gene expression. Furthermore, Cook et aJ. described that the TAT A 
element appears to influence the strength of expression rather than the timing (Cook et ai., 
1995). In contrast to IE promoters, E promoters do not appear to contain virus-specific cis-
34 
Chapter J Introduction 
acting regulatory elements (Everett, 1984a); how the transcription machinery differentiates 
between E and L genes to regulate temporal expression is still perplexing. 
IC.4 Activation of L gene expression 
Viral DNA replication constitutes a major switch in the program of HSV-l gene 
expression. True HSV -1 late genes, also called y2 genes, require DNA replication for any 
accumulation of their mRNAs, whilst the expression of leaky-late genes, also referred as 
yl genes, can be detectable in the absence of viral DNA synthesis, however the maximal 
expression of y 1 genes requires DNA synthesis. 
As mentioned previously (section lC.2) functional ICP27 is required for L gene 
expression and is involved in multiple ways including transactivation and post-
transcriptional regulation. Additionally, ICP4 is necessary for the activation of L gene 
expression, however the L genes are silent before DNA replication even at the time ICP4 is 
present. Further studies have proposed that another viral protein, ICP8, might be involved 
in regulation ofL gene expression (Chen & Knipe, 1996, Gao & Knipe, 1991, McNamee 
et al., 2000). As ICP8 is an essential protein for DNA replication, the reduced levels of L 
gene expression seen during infections with ICP8 virus mutants might be due to the 
decreased level of DNA replication resulting from defective ICP8. However, a cell line, 
stably expressing an ICP8 mutant (d105) protein, inhibited wild type virus DNA 
replication by 5-fold, and late gene expression by 50 to 100-fold, suggesting a direct role 
oflCP8 in stimulating late gene expression (Gao & Knipe, 1991, McNamee et al., 2000). 
As with IE and E genes, the cis-acting element of L promoters consist of a TAT A 
box, but no additional upstream elements from the T AT A box have been found (Fig. 1.5C) 
(Imbalzano & DeLuca, 1992, Johnson & Everett, 1986). Elements located at the start of 
transcription and further downstream appear to be necessary for maximal expression from 
these promoters. For instance the presence of a sequence related to the eukaryotic initiator 
element (lor) in the gC promoter has been described to increase mRNA expression by a 
modest amount (Steffy & Weir, 1991, Woerner & Weir, 1998). Moreover, the promoters 
of some L genes, such as UL38 and gC, appear to contain another regulatory element 
downstream from the start of transcription called the downstream activation sequence 
(DAS) (Guzowski et al., 1994, Petroski & Wagner, 1998). Analysis of the promoter 
region ofUL38 has shown that deletion of the DAS, located between position +20 and +33 
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within the 5' non-translated region, from the UL38 promoter strongly decreased RNA 
expression to less than 10% of the wild-type level (Guzowski et ai., 1994, Petroski & 
Wagner, 1998). The structural differences between E and L promoters imply a possible 
mechanism of how the transcription machinery distinguishes E from L genes in the course 
of infection. 
1 C.S The role of vhs in HSV -host cell interactions and viral gene expression 
As viral gene expression is reliant on the transcription machinery of host cells, the 
virus has evolved various mechanisms that alter the cell to divert key cellular constituents 
from their normal uses and to redirect these components to the viral genome for its own 
needs. It is clear that some fundamental changes take place within the cell during 
infection, and one of the best characterised of these is the virion shutoff of host protein 
synthesis. 
During lytic infection, HSV -1 causes the shutoff of host cellular protein synthesis 
soon after entering cells. The shutoff phenomenon was classified into two stages: early 
(primary or virion-associated) shutoff, and delayed (secondary) shutoff. The early shutoff 
is mediated by the virion host shutoff protein (vhs) and does not require de novo viral gene 
expression, whereas the delayed shutoff is induced by the IE protein ICP27 (Read & 
Frenkel, 1983, Sandri-Goldin & Mendoza, 1992). The role of ICP27 in host shutoff has 
been described previously (see section 1 C.2). 
The UL41 gene product vhs is expressed as two forms, a 58-kDa and a 59.5 kDa 
highly phosphorylated form (Read et ai., 1993). The major 58-kDa vhs protein is a 
structural component, forms a complex with VP 16 that is packaged into the tegument of 
HSV -1 particles and is then delivered into cytoplasm upon fusion of the viral envelope 
with the host cell membrane allowing it to exert its effects immediately upon infection 
(Smibert et ai., 1992). Vhs has been described as degrading both cellular and viral 
mRNAs of all three kinetic classes, resulting in the shutoff of protein synthesis (Kwong & 
Frenkel, 1987, Oroskar & Read, 1987, Oroskar & Read, 1989). The shutoff of expression 
of host genes may allow better utilisation of the translational machinery of the infected 
cells for translation of newly synthesised viral mRNAs. However, why does vhs affect 
viral RNA? One reasonable explanation of this discrimination of viral mRNA decay is 
that the presence of vhs likely facilitates rapid transition of viral mRNAs from one 
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temporal class to the next. Vhs mutants have been found to fail to shut down host cell 
protein synthesis and exhibit prolonged synthesis of IE and E proteins (Kwong et al., 
1988). 
Many lines of evidence imply that vhs is either itself an RNase or mediates a 
ribonuclease activity by interacting with other cellular enzymes. Zelus and coworkers 
reported that vhs, obtained from partially purified virions or synthesised by in vitro 
translation, possesses an endonuclease activity, strongly implying that vhs protein itself is 
a ribonuclease (Zelus et al., 1996). Karr and Read (1999) further elucidated the pathway 
of vhs-induced mRNA degradation by using a RNase protection assay. The kinetic data 
showed that in infected cells, vhs degrades sequences near the 5' end of the TK mRNA 
much more efficiently than those at the 3' end (Karr & Read, 1999). In contrast, TK 
mRNA was more stable and this decay rate difference was not observed in cells infected 
with a vhs mutant virus (Karr & Read, 1999). It has been speculated that the features of 
mRNAs i.e. a 5' cap or a 3' poly(A) tail, may playa role in selectively targeting mRNA for 
degradation, since vhs rapidly destabilises most viral and cellular mRNAs, while it does 
not affect tRNA and rRNA during viral infection. However Zelus et al. (1996) reported 
that the RNase activity of vhs, observed in in vitro reactions using virion extracts, cleaved 
both capped and uncapped RNAs. Moreover, the results from an in vitro assay, by which 
the susceptibilities of polyadenylated and non-polyadenylated identical mRNA to vhs-
induced degradation were compared, demonstrated that both types of mRNA were 
degraded efficiently in extracts infected with wild type HSV -I (Karr & Read, 1999). 
These observations imply that in vitro degradation of mRNA requires neither as' cap nor a 
3' poly(A) tail. More recent work found that vhs produced in a budding yeast system did 
not lead to global mRNA degradation and the cell extracts of yeast only exhibited a little 
vhs-dependent endonuclease activity. However, the addition of a rabbit reticulocyte lysate 
(RRL) to the cell extracts restored its function (Lu et al., 2001). These observations imply 
that the vhs-dependent RNase activity requires one or more mammalian factors. In 
addition to the effect on shutoff protein synthesis, vhs has been recently described to playa 
potential role in a decrease in viral replication as well as viral virulence, and immuno-
evasion from a non-specific host defence mechanism (Suzutani et al., 2000). 
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10 ICPO (History) 
The ICPO protein, encoded by the 0.0 genes, was first described as an IE gene product 
in 1974 by Honess and Roizman (Honess & Roizman, 1974). The 0.0 genes are located at 
the repeat sequences that flank the UL region of the HSV-l genome (Fig. 1.6A) (Perry et 
al., 1986, Preston et al., 1978). Little was known of the role of ICPO in virus infection 
until the early 1980s, when it was found that ICPO was a potent transactivator of viral gene 
expression in transient transfection assays; in synergy with ICP4, the level of 
transactivation was 12 to 60-fold more effective than that obtained with ICP4 alone 
(Everett, 1984b). Further studies defined ICPO as a potent promiscuous transactivator of 
gene expression of all three classes of HSV-l viral genes and a number of cellular genes 
(Gelman & Silverstein, 1985, Mavromara-Nazos et al., 1986, O'Hare & Hayward, 1985). 
Although it has been found that ICPO expression is not essential for HSV-I replication in 
cell culture, ICPO null mutant viruses demonstrate reduced expression of IE proteins and 
impaired viral replication at low multiplicities of infection (Stow & Stow, 1986, Sacks & 
Schaffer, 1987). Moreover, several lines of evidence have shown that ICPO-defective 
mutant viruses are unable to induce the reactivation of latent virus in an in vitro system, 
indicating another potential role ofICPO in HSV-l infection (reviewed by Preston, 2000). 
Most recently, the possible functions ofICPO in HSV-l infection have been illustrated 
through its interaction with cellular proteins and its effects on cell cycle regulation. It has 
long been noted that in infected cells, ICPO is located at discrete subnuclear structures that 
are known as nuclear domain 10 (ND 1 0) (Everett & Maul, 1994, Gelman & Silverstein, 
1986, Maul & Everett, 1994). Further studies found that newly synthesised ICPO initially 
accumulates at ND 1 0 and then disrupts these structures within a few hours (Everett & 
Maul, 1994, Maul & Everett, 1994). Later it was found that ICPO strongly interacts with a 
. 
135-kDa cellular protein designated USP7 (previously named HAUSP), a member of the 
ubiquitin specific protease family (Meredith et al., 1994), and that ICPO causes the 
proteasome dependent degradation of two major ND 10 proteins, thus bringing about the 
destruction of ND 1 0 (Everett et al., 1998a). These activities have recently been attributed 
to the E3 ubiquitin ligase activity conferred by a zinc-binding RING finger domain within 
the N-terminal segment of the protein (Boutell et al., 2002). Finally, it has been 
demonstrated that ICPO affects proteins involved in cell cycle regulation, such as cyclin D3 
and CENP-C (Everett et al., 1999a, Kawaguchi et al., 1997b), implying that ICPO might 
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playa direct role in the regulation of the cell cycle. This suggestion was further supported 
by the finding that ICPO blocked the G 1 to S phase progression, and that HSV -1 infection 
caused dividing cells to become blocked in mitosis in an ICPO-dependent manner (Hobbs 
& DeLuca, 1999, Lomonte & Everett, 1999). 
The interactions described above have been intensively studied and are likely to be 
crucial to the understanding of both lytic and latent infection. In this section, the details of 
each aspect: the characteristics of the ICPO transcript and polypeptide, the potential role of 
ICPO in HSV -1 infection, and the interaction of ICPO with particular cellular proteins will 
be discussed in turn. 
ID.I The aO gene and transcript structure 
The diploid 0,0 gene, 3.6 kb in size, was mapped to the long repeat region of the viral 
genome (Fig. 1.1, 1.6A). In the IRL region, the transcription of the 0,0 gene starts at 
residue 124256 and poly(A) signals 'AATAAA' are located at 120693 and 120734 
(McGeoch ef 01., 1988). As, illustrated in Fig. 1.4A, the 0,0 gene located in IRL region is 
partially overlapped in the same orientation by the gene encoding ICP34.5 transcripts and 
in the opposite orientation in part by the gene expressing LATs. 
Among over 80 HSV -1 genes, only four genes contain introns; one of these is the 0,0 
gene that contains two introns separating three coding exons. The three exons (1-3) are 
located at residues 124,108-124,052 (codons 1-19), 123,286-122,620 (codons 20-241), and 
122,483-120,882 (codons 242-775), respectively (McGeoch et 01., 1988). After splicing of 
the pre-mRNA, the transcript encodes a predicted protein product of 775 amino acids. 
Since it has been described that both introns contain in-frame stop codons, it could be 
predicted that more than one species of ICPO-related protein product could be generated if 
alternative or incomplete splicing of the ICPO pre-mRNA transcripts occurred. For 
instance, if either the first or the second intron of ICPO pre-mRNA was not spliced out, 
premature termination of translation would occur, resulting in a truncated translation 
product of 72 or 262 residues, respectively. In fact, the predicted 262-residue protein to be 
expressed after incomplete splicing was detected at low levels in BHK cells infected with 
wild type virus and mutant virus llOC4 (which lacks the first intron), but not in cells 
infected with mutants 110C7 or 11 OC 1 which lack the second or both introns, respectively 
(Everett et 01., 1993c). In addition, the amount of this truncated form of ICPO varied 
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among cell types, i.e. there were only trace amounts in Vero, HeLa and HFL cells (Everett 
et 01., 1993c). The significance of this alternatively spliced }CPO protein remains to be 
determined, especially since more recent experiments have shown it to have ubiquitin E3 
ligase activity. 
ID.2 ICPO peptide structure and its functional domains 
Although the full-length ICPO transcript encodes 775 residues with a predicted 
molecular weight of 78,452 Da, the molecular weight of}CPO polypeptides as measured by 
mobility in SDS-PAGE is approximately 110 kDa (Honess & Roizman, 1974). This 
difference between the predicted and observed molecular weights may be due to post-
translational phosphorylation of a serine-rich region between residues 554-591 
(Ackermann et 01., 1984), or it could be due to structural characteristics imparted by the 
RING finger (see below). 
}CPO can be detected in both the nucleus and the cytoplasm dependent on the time of 
the infection. During infection, }CPO initially accumulates at 2 h post infection (hpi) in 
punctate structures in the nucleus, known as NO 1 0, but by 8 hpi, }CPO is present in both 
the nucleus and the cytoplasm and the punctate nuclear domains are no longer visible 
(Everett & Maul, 1994). Details of the interaction of }CPO with NOlO proteins are 
provided in the later sections. 
As described previously, ICPO has multiple functions, including transcriptional 
activation in transient transfection assays, activation of gene transcription during the lytic 
cycle, and reactivation of latent viral genomes. Using mutational analysis combined with 
functional studies, four main functional domains of ICPO protein have been revealed as 
shown in Fig. 1.7A. 
Mutational analysis of the functional domains of ICPO has shown that a cysteine-rich 
region in the N-terminal region (residues 106-150) is required for }CPO function (Everett, 
1987, Everett, 1988a, Everett, 1989). This particular motif of cysteine and histidine 
residues (C3HC4) is highly conserved in the corresponding proteins of other (l-
herpesviruses and has been classified as a member the RING finger family (Cheung, 1989, 
Freemont, 1993). Furthermore, some clusters of acidic and basic residues have been found 
throughout the ICPO protein and among these regions a highly basic cluster between 
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A. The localisation of the functional domains within ICPO 
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Fig. 1.7 Schematic of the functional domains within ICPO. 
(A) Mutational analysis combined with functional studies of ICPO have revealed the 
presence of four main functional regions, including the RING finger domain, a nuclear 
localisation signal (NLS), a USP7 interaction domain and a C-terminal multimerisation 
domain. The positions of these domains within the primary amino acid sequence of 
ICPO is indicated by the numbers shown above. 
(B) Arrangement of secondary structure in the RING motif within Eg63 (homologous to 
ICPO) of EHV -1. NMR revealed that this motif consists of a triple-stranded ~-sheet, and 
two tums of a-helix. Conserved cysteine (C) and histidine (H) residues are mapped onto 
their approximate position as indicated (modified from Everett et al., 1993b) 
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residues 501-506 has been implicated in the nuclear localisation of ICPO. Moreover, the 
C-tenninal domain from residues 594-633 has been demonstrated to be required for the 
interaction of ICPO with USP7 (Everett et al., 1997, Meredith et al., 1995, Meredith et al., 
1994). Finally, it has been reported that ICPO purified using a baculovirus system exists as 
a multimer in solution and extensive studies have shown that the region spanning residues 
633-775 is required for multimerisation (Ciufo et al., 1994, Everett et al., 1991, Meredith 
et al., 1995). Details of the significance of these domains for the effects of ICPO are 
provided below. 
ID.2.1 RING finger 
ID.2.1.1 The structure of RING finger 
Metal-chelating domains such as zinc finger domains characteristically contain various 
combinations of cysteine and histidine residues. However, the conserved C3HC4 motif of 
ICPO is distinct from the well known C4 or C2H4 classes of zinc-fingers and it has been 
tenned the C3HC4 or RING domain. The RING finger motif was initially identified in the 
protein encoded by the human gene RING 1 (Really Interesting New Gene 1) on 
chromosome 6 (Freemont et al., 1991). The consensus sequence of RING finger motifs 
has been described as C-X2-C-X (9-39)-C-X (1-3)-H-X (2_3)-CIH-X2-C-X (4-48)-C-X2-C, where 
X can be any amino acid, although there are distinct preferences for certain types of amino 
acid at particular positions (Saurin et al., 1996). In the case of ICPO, this motif lies 
between the residues 116-156. RING finger domains have been sub-divided into RING-
HC and RING-H2 classes, depending on whether a cysteine or histidine occupies the fifth 
co-ordination site (reviewed by Freemont, 2000). Some other zinc finger-like domains 
have been found to be present in a subset of RING finger proteins. These are composed of 
larger motifs such as the RBCC subgroup (now termed TRIM; TRIpartite Motif) 
containing a RING finger, two B boxes, and a helical Qoiled-Qoil motif, and the TRAF 
subgroup consisting of a RING finger, a large number of putative zinc fingers (cysteine-
Ihistine-rich regions), and a TRAF (tumour necrosis factor receptor-associated factor) 
domain. Many proteins containing the RBCC motif are proto-oncoproteins e.g. PML, 
while the most proteins in the TRAF family are involved in signal transduction pathways 
(reviewed by Jensen et al., 2001). 
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As the C3HC4 motif has been predicted as a metal chelating domain, the structure of 
the RING finger was characterised by Everett et al. (1993). RING finger region peptides 
of ICPO and two other homologous proteins in VZV (gene 61) and EHV -I (gene 63) were 
overexpressed, purified, and analysed for their zinc content by atomic absorption 
spectroscopy and their concentration was determined by amino acid analysis (Everett et 
al., 1993b). The most reliable results were obtained with the EHV-I gene 63 protein 
RING domain (the other proteins tended to aggregate in solution) which was found to 
contain between 1.4 (± 0.4) and 3.7 (± 1.4) atoms of zinc per molecule (Everett et al., 
1993b). While some proteins containing RING finger domains have been implicated in the 
recognition of nucleic acids, no significant DNA or RNA binding of either full length or 
RING domain ICPO was found in gel retardation assays (Everett et al., 1993b). 
Since the RING domain of ICPO, purified from a bacterial expr~ssion system, 
appeared aggregated or incompletely folded, only the secondary structure of this domain of 
the soluble equivalent protein of EHV-l was studied (Barlow et al., 1994, Everett et al., 
1993b). NMR (nuclear magnetic resonance) analysis of the secondary structure of the 
RING domain of the EHV-l gene 63 protein (Eg63), overexpressed and purified using an 
E. coli system, revealed that starting from the N-terminus, this motif consists of an 
irregular loop, two strands of ~-sheet, two turns of a.-helix, a second irregular loop, and the 
third strain of the ~-sheet (Fig. 1.7B) (Barlow et al., 1994, Everett et al., 1993b). 
Furthermore, two zinc atoms are co-ordinated at either end of the helix, which extends 
basic and polar side chains into solvent. The spacing between His 1 and Cys 4 leads to an 
observed inter-zinc distance of approximately 14 A, which is highly conserved among 
members of the RING finger family (Fig. 1.7B). 
tD.2.1.2 The RING finger family 
Over two hundred proteins have been discovered containing a RING finger. The 
members in this family are derived from a wide range of eucaryotes including vertebrates, 
plants, and a number of DNA viruses, insects, and yeast (reviewed by Freemont, 1993). 
Many of these proteins have been implicated in regulatory events including transcription, 
DNA repair, inhibition of apoptosis, or site specific recombination, however up until 
recently no known function has been assigned to the RING finger motif (reviewed by 
Freemont, 1993, Freemont, 2000). 
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Since first proposed in 1998 by Bacbmair, further studies have demonstrated that a 
large number of RING finger proteins are implicated in mediating E2-dependent 
ubiquitination (reviewed by Freemont, 2000). These investigations have shown that RING 
finger proteins can specifically interact with an E2 ubiquitin conjugating enzyme, thereby 
mediating ubiquitination, implying that the RING finger domain can act as an E3 ubiquitin. 
ligase. Details of the process of ubiquitination and how the RING finger of ICPO is 
involved in ubiquitination are discussed in a later section (lD.4.4). 
ID.2.1.3 The role of the RING finger domain in the function of ICPO in HSV-l 
infection. 
Results from a series of experiments have demonstrated that the RING finger domain 
is crucial for ICPO function in HSV-l infection, in terms of viral growth, establishment of 
latency and reactivation of the latent viral genome (Everett, 1989, Harris et a/., 1989, 
Wilcox et 01., 1997). 
Single-step growth experiments have demonstrated that compared to wild type virus, 
the ICPO RING finger mutant virus (FXE) reduced the yield of virus progeny by 1000-
fold, indicating that the RING finger region oflCPO is important for viral growth at least in 
cell culture (Everett, 1989). In the in vitro latency systems, it was found that the FXE 
mutant failed to reactivate a HSV-2 latent genome, indicating that the RING finger region 
is required for reactivation (Harris et a/., 1989). A recent report from Wilcox et al. (1997) 
showed that in the in vitro neuronal model (DRG culture), establishment of latency by 
virus FXE was decreased by at least 10-fold as measured by cell expression of LATs and 
the amount of viral DNA in neuronal culture during latency. Additionally, after 
establishment of latent infection, induction of reactivation by NGF deprivation in neuronal 
culture infected with FXE was much less than that with wild type virus (Wilcox et al., 
1997). These results indicate that a RING finger is required for the function of ICPO in 
latent infection. 
ID.2.1.4 Role of RING rmger domain for the function of ICPO in transcriptional 
regulation. 
As described previously, ICPO can stimulate gene expression either by itself or 
synergistically with ICP4. Studies of a number of ICPO deletion mutants in transient 
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transfection assays showed that the RING finger domain was essential for the activation of 
HSV-l genes by ICPO (Cai & Schaffer, 1989, Everett, 1987, Everett, 1988a). Further 
analysis of single amino .acid substitutions in a potential RING finger helix region (at 
residues: lysine 144, tryptophan 146, glutamine 148 and asparagine 151) was carried out to 
investigate the effect of this region on ICPO function in detail. The results demonstrated 
that substitution of residues 144, 148, 151 affected ICPO activation of gene expression, and 
that lysine 144 had the most substantial effect, which is similar to that of the RING finger 
deletion mutant, FXE. These observations imply that the helix region of the RING finger 
is responsible for the transcriptional activation function of ICPO (Everett et al., 1995). 
ID.2.I.S The RING finger domain of ICPO is essential for disruption of NDIO and 
induced degradation of other cellular proteins. 
At early stages of HSV-l infection, ICPO localises to NDIO structures and the 
disruption 'of these structures occurs a few hours post infection (Maul et al., 1993). ICPO 
has been shown to be absolutely required for this effect (Maul & Everett, 1994). The 
observation that punctate PML staining was retained in cells infected with the RING finger 
mutant virus FXE demonstrated that the RING finger domain is necessary for the 
disruption of NOlO proteins but not for the location of ICPO to NOlO (Maul & Everett, 
1994). 
ICPO also triggers the degradation of a number of cellular proteins such as PML, 
Spl00, CENP-C, and CENP-A (Everett, 1999, Everett ef al., 1999a, Everett et al., 1998a, 
Lomonte et al., 2001, Parkinson et al., 1999). Subsequent investigations revealed that the 
RING finger domain of ICPO is absolutely essential for the induction of protein 
degradation. The interactions of ICPO with cellular proteins as well as the involvement of 
the RING finger in the effects are described in more detail in section ID.4. 
ID.2.2 Nuclear localisation sequence (NLS) 
A highly basic region ofICPO from residues 501-506 has a similar sequence to the SV 
40 large T antigen nuclear localisation motif (Everett, 1988a). In a transfection assay, 
immunofluorescent staining of ICPO deletion mutant p 11 OD8 construct in which residues 
475-548 were deleted, revealed a cytoplasmic expression pattern of ICPO, implicating a 
nuclear localisation sequence (NLS) located in this region (Everett, 1988a). In the viral 
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context, ICPO expressed from D8 virus did not penetrate the nucleus at low multiplicities 
of infection. However at a higher mUltiplicity of infection, ICPO staining was found in the 
nucleus at later stages, indicating that defective nuclear targeting can be overcome when 
D8 proteins are highly expressed (Maul & Everett, 1994). In addition, insertion of a 
oligopeptide (VRPRKRR) at residue 500 of an ICPO mutant in which residues 500-506 
were deleted resulted in the restoration of ICPO nuclear localisation phenotype, suggests 
that the highly basic region at residues 500-506 might promote nuclear targeting (Mullen et 
al., 1994). However a previous finding described a cytoplasmic pattern of ICPO when 
expressed from p liOn 16, a large C-terminal deletion mutant construct that retains the 501-
506 region (Everett, 1988a). These observations imply that this basic motif alone is not 
sufficient for nuclear localisation and that residues on its C-terminal side are also required. 
This region has also been implicated in the regulation of gene expression and the 
efficiency of viral infection. Deletion of the NLS motif demonstrated a lower 
transactivation ability of ICPO in the presence of ICP4 (Everett, 1988a). Furthermore, the 
D8 mutant virus caused a moderate reduction of viral protein synthesis resulting in a lesser 
yield of viral progeny in single-step infection as well as inefficient plaque formation in 
tissue culture (Everett, 1989). 
ID.2.3 The USP7 interaction domain 
Glycerol gradient centrifugation showed that ICPO extracted from infected cells 
sedimented in a high molecular weight complex that contained a cellular protein of 
approximately 135 kDa. This was later identified as a novel ubiquitin specific protease 
named USP7. Further results obtained from GST pull-down experiments revealed that the 
C-tenninus of ICPO (residues 594-775) bound strongly and specifically to USP7 in all cell 
types tested (Meredith et al., 1994). An extensive characterisation of this domain 
narrowed down a region between residues 594-633 that was required for the interaction of 
ICPO with USP7 (Meredith et al., 1995). 
Characterisation ofICPO mutant viruses demonstrated that deletion virus D12,lacking 
the sequences involved in USP7 binding, had greatly reduced viral growth (Meredith et al., 
1995). This domain has also been implicated as being important for the stimulation of 
gene expression, as the ICPO expressed from the pllOD12 construct (deletion of residues 
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594-633) showed significantly reduced ability to activate gene expression in transfection 
assays (Everett, 1988a). 
ID.2.3 MultimerisatioD domain 
Everett et al. initially described that ICPO exists as a dimer or as a higher order 
oligomer in solution according to the sedimentation rate of purified ICPO on glycerol 
gradients compared to that of known standards (Everett et al., 1991). Observations by 
subsequent studies using in vitro translated polypeptides and GST-fusion proteins 
indicated that a region between residues 617-712 is required for fully efficient 
multimerisation and that the 60 residues on either side of this region were also involved 
(Ciufo et al., 1994). This result was confirmed by the finding that a protein containing the 
C-terminal residues 633-755 expressed in an E. coli. system was purified as a dimer or a 
trimer, implying that the multimerisation domain of ICPO lies between 633 and 775 
(Meredith et al., 1995). 
Additional studies revealed another functional domain within the region between 
residues 633 and 755. Maul et al. (1994) reported that in immunofluorescence assays the 
expression pattern of ICPO in cells infected with mutant virus 013, which lacks C-terminal 
residues 633-680, revealed a nuclear diffuse phenotype instead of the normal punctate 
staining pattern indicating that this region is essential for the binding ofICPO to NDIO. 
The C-terminal multimerisation domain has been reported as being important for the 
transactivation ability of ICPO. A reduction in the level of transcription was found in cells 
transfected with the construct lacking this region (Everett, 1988a). However, the level of 
requirement of the multimerisation domain varied for different promoters and cell types. 
In addition, a number of mutant viruses, including 013, D14, D15, in which the C-
terminus region at residues 633-680, 680-720, 723-767 were deleted, respectively, showed 
a lower growth efficiency than wild type (Everett, 1989). Taken together, the C-terminal 
oflCPO is important for viral gene expression and viral growth. 
ID.3 Role of ICPO in HSV-l infection 
The principle functions of ICPO have been assessed both in transient transfection 
systems and during HSV -1 infection. These studies have focused on the effect of ICPO on 
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viral growth, gene expression, reactivation and interaction with cellular proteins as 
discussed below. 
ID.3.1 ICPO is not essential for viral growth at high virus inputs 
Studies using mutant virus, d11403, containing a 2-kb deletion within both copies of 
the aO gene, found that the mutant virus was able to grow in BHK cells, but that the yield 
of virus was 20- to lOO-fold lower than that of wild type HSV-l (Stow & Stow, 1986). 
The efficiency of plaque formation by dl1403 varied between the different cell types 
tested; Vero and human foetal lung cells (HFL) were much less efficient in supporting the 
growth of dl1403 than BHK cells. Surprisingly, the protein profiles generated by dl1403 in 
time course experiments at a high MOl (5 pfulcell) were qualitatively similar to that of 
wild type HSV-l. In addition, replication and encapsidation of viral DNA in cells infected 
with dl1403 were not significantly different from that in cells infected with wild type virus. 
Consistent observations were reported by Schaffer's group using two different ICPO 
mutant viruses, the dlxO.7 virus, containing a deletion of 0.7-kb in both aO genes, and the 
dlx3.1 virus, containing a 3.1-kb deletion removing the majority of the transcriptional 
regulatory signal and coding sequences (Sacks & Schaffer, 1987). Although both mutants 
grew in cell culture, the yields were 10- to lOO-fold lower than those of wild type HSV-l 
irrespective of the cell types used. These findings imply that although ICPO is not 
absolutely essential for productive infection in the majority of cell lines, this protein plays 
a significant role in viral growth, as demonstrated by the impaired ability of the mutant to 
replicate. 
The role of ICPO in HSV-l infection was studied in more detail by Everett (1987) 
using strategies involving a series of mutant viruses with defined lesions in ICPO, different 
cell types and various amounts of virus inputs. These assays illustrated that the reduction 
in plaque-forming efficiency by ICPO mutants is dependent on cell type, the position of the 
mutation as well as mUltiplicity of initial virus input (Everett, 1989). At a high multiplicity 
of infection, all mutant viruses gave similar levels of gene expression to wild type virus, 
whereas less viral gene expression was observed in cells infected with mutant viruses at a 
lower multiplicity, especially in HFL cells. These results strongly suggest that the 
presence of ICPO confers a strong selective advantage for the earliest stage of low 
multiplicity infections in certain types of cells. 
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Consistent with the requirement of ICPO for viral infection at low multiplicities, Cai 
et al. illustrated that in Vero cells transfected with infectious viral DNA of an ICPO-nulJ 
mutant, virus production was delayed for 2 days and the level of de novo synthesis of the 
virus was reduced (Cai & Schaffer, 1989). Additionally, at a very low multiplicity of 
infection (0.004 pfu per cell), they found that 90% or more of the ICPO coding sequence 
was required for efficient replication of HSV -1. 
Although ICPO confers a significant growth advantage on the virus, especially at low 
MOIs, further experiments using the osteosarcoma line U20S found that the function of 
ICPO is dispensable, even for low MOIs (Yao & Schaffer, 1995). In contrast to the equal 
plating efficiencies of wild type viruses on Vero and U20S cells, the plating efficiencies of 
the ICPO-null mutant virus 7134 was increased by lOO-fold in U20S cells compared to 
Vero cells. Transient transfection of U20S cells with reporter gene constructs containing 
IE, E, and L gene promoters followed by chloramphenicol acetyltransferase (CAT) assay 
revealed enhanced basal levels of expression from IE and E, but not the L promoters 
tested, in this cell line. These observations strongly support the argument that the 
requirement of ICPO in HSV -1 infection varies between cell types and also implies that 
there may be a cellular activity in U20S cells that substitutes for the function of ICPO at 
low MOIs. Alternatively, U20S cells may lack a factor that in the absence of ICPO is able 
to repress viral gene expression. 
ID.3.2 ICPO activates the transcription of viral genes 
The function of ICPO in HSV-l infection was first shown as that of a potent 
transactivator of gene expression in transient transfection assays (Everett, 1984b). The 
experiments were designed to investigate the role of IE gene products in terms of 
transactivation of viral E promoters. In HeLa cells, ICP4 stimulated expression from the E 
gD promoter, but this effect could be increased by a further 20-fold in the presence oflCPO 
(Everett, 1984b). Later investigations from other groups showed that ICPO can 
independently stimulate expression from the HSV-l thymidine kinase promoter (Gelman 
& Silverstein, 1985, O'Hare & Hayward, 1985). A number of further studies revealed that 
ICPO is able to transactivate promoters from all three classes ofHSV-l genes (Chen et al., 
1991, Everett, 1984b, O'Hare & Hayward, 1985, Quinlan & Knipe, 1985). 
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The transactivation function of ICPO appeared not to be limited to HSV -1 promoters 
but rather has a non-specific nature. A variety of heterologous viral promoters including 
the SV40 early promoter, HSV-2 38K promoter, and the HIV long tenninal repeat have 
been reported to respond to ICPO (Everett, 1988b, Mosca et al., 1987, O'Hare & Hayward, 
1985). In addition, it has been shown that ICPO can induce transcription of some cellular 
genes, for example the rabbit f3-globin promoter and the human s-globin promoter (Everett, 
1985). Observations from transient expression assays led to the conclusion that ICPO 
alone is a potent and promiscuous activator of both viral and cellular gene expression and 
can act in synergy with ICP4. 
Recently, the level at which ICPO activates viral gene expression was defined by 
comparing the activation levels of promoters representing the major kinetic classes of viral 
genes (such as tk, ICP8, gC) in both transient expression assays and during HSV-l 
infection (Jordan & Schaffer, 1997). The levels of transcription and translation were 
determined by quantitative RNase protection and CAT assays respectively. The 
experiments utilised transfection in the presence or absence of ICPO, and cells infected 
with wild type (KOS strain) or ICPO null mutant, n212 viruses. In both transfection and 
infection experiments at all multiplicities tested, the levels of mRNA and protein were 
significantly lower in the absence of ICPO. Changes in the levels of CAT activity were 
approximately proportional to change in the levels of CAT mRNA in cells infected with 
wild type or n212. Taken together, these findings indicate that ICPO activates gene 
expression by increasing the amount of mRNA and it has no significant effect on the 
efficiency of translation in both transient transfection assays and during infection. 
It has been reported that mutants of ICPO that are defective in transactivation function 
are also defective in promoting viral growth, indicating that the ability to activate gene 
expression reflects the requirement for ICPO in viral growth (Everett, 1989, Sacks & 
Schaffer, 1987) 
ID.3.3 ICPO is essential for reactivation of HSV-I from quiescent infection 
The potential involvement of ICPO in the establishment or reactivation of HSV -1 from 
latency was indicated initially by Russell et al. (1987) in an in vitro system. In this model 
three HSV-I mutant viruses including two ICP4 mutants (tsK and inI411) and the ICPO 
deletion mutant dl1403 were able to establish a latent infection in HFL cells as efficiently 
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as wild type HSV-I and HSV-2 at 42°C, a temperature preventing the onset of lytic 
infection. These observations imply that the presence of ICPO is not an absolute 
requirement for establishment or maintenance of latent infection in vitro. Cultured cells 
quiescently infected with HSV-2 could be induced to reactivate the resident virus if 
superinfected with wild type HSV-I, but not if the ICPO deletion mutant dl1403 was used. 
This indicates that ICPO is specifically required for the reactivation of quiescent genomes 
(Russell et a/., 1987). As illustrated in Fig. 1.4, the 3' part of the LA T region is 
complementary to the 3' end of the ICPO gene. Since the region deleted from d11403 
includes large portions of both the ICPO and LAT genes, phenotype of d11403 could be a 
consequence of the loss of LAT function. Therefore, HSV -1 mutants with more precise 
deletions in ICPO were employed to investigate this issue in more detail (Harris et a/., 
1989). The establishment and reactivation of HSV-2 latent infection was set up in the 
same way as by Russell et a/. (1987). The results demonstrated that adenovirus 
recombinants expressing ICPO were able to reactivate HSV -2 latent genomes, implicating 
a direct role of ICPO in reactivation from latency. In addition, superinfection with the 
ICPO deletion mutant virus D 14 (deletion of residues 680-720) caused reactivation of 
quiescent virus, but deletion of the ICPO RING finger domain in mutant FXE eliminated 
the ability of the superinfecting virus to reactivate the quiescent HSV -2. These results 
indicate that sequences in the 3' end of the LAT region are not necessary to induce 
reactivation in this system, but that the RING fmger domain of ICPO is essential for this 
process. 
The role ofICPO in latency has also been extensively investigated in the mouse model. 
Lieb et al. (1989) initially approached this study using a mouse ocular model. Three ICPO 
deletion mutants, d11403, dlxO.7 and dlx3.1 (described in section ID3.l) were tested for 
their ability to establish latency in mouse ganglia. It was found that all three mutant viruses 
were able to replicate in ganglia, although with a reduced efficiency. The dlxO.7 and 
dlx3.1 mutant viruses failed to reactivate from the explanted trigeminal ganglia of infected 
mice, implying that ICPO might play an important role in establishment and/or reactivation 
from latency (Leib et al., 1989). However, Clements and Stow (1989) demonstrated a 
contrary finding that ICPO is dispensable for the establishment and maintenance of latency, 
and for reactivation from latently infected mouse ganglia. The assays by footpad route and 
intracranial inoculations revealed that dl1403 exhibited a much lower virulence than the 
wild type 17+ strain. After footpad inoculation, the mutant virus established latency in 
51 
Chapter 1 Introduction 
sensory ganglia and by 20 days post-explantation, reactivation occurred from an average of 
3.4 explanted ganglia/mouse (Clements & Stow, 1989). However, reactivation of d1l403 
was delayed compared to the wild type virus. 
For these different findings in the reactivation phenotypes of ICPO mutants derived 
from the wild type strains KOS (dlxO.7 and dlx3.1) and 17+ (d11403), the authors 
suggested that the differences might be due to strain-specific variations or reflect residual 
activities of the undeleted portion of ICPO and LAT genes. However, it is more likely that 
the apparent discrepancies reflect differences in the latency models used and other criteria 
such as the exact multiplicities of infection and the methods of explant co-cultivation used. 
Later work from Schaffer's group has proposed strong evidence supporting a role for ICPO 
in the establishment and reactivation of latency (Cai et at., 1993). A series of ICPO 
mutations which express ICPO with C-terminal truncations, all of which express nearly 
wild type 2.0-kb LAT, were constructed and characterised for their ability to establish and 
reactivate from latency in a mouse ocular model. All of the mutants entered and 
reactivated from latent infection less efficiently than wild type virus, and reactivation 
frequencies correlated well with the levels of transactivating activity induced by the 
individual ICPO mutant polypeptides. In addition, the defective reactivation of an ICPO-
LAT -double mutant virus, 7134, from latency could be restored by insertion of one copy of 
aO gene into the 7134 viral genome. These findings indicated a role for ICPO distinct from 
the role ofLAT in the establishment and reactivation of latency. 
More recently, Halford and Schaffer demonstrated that a reduction in the size of the 
inoculum (from 2 x 106 to 2 x 105 pfu per eye) of ICPO null mutants coupled with transient 
immunosuppression of mice, enabled ICPO null mutants to reach wild type levels of viral 
load in the TG of latently infected mice (this model was described in section IB.3.2.3) 
(Halford & Schaffer, 2000). Based on this procedure, the role of ICPO in reactivation was 
determined by comparison of the reactivation efficiencies of two ICPO null mutants, n212 
and 7134 with that of wild type in four different assay systems in which the TG were either 
treated with or without ACG followed by various reactivation methods such as heat stress 
or superinfection with ICP4- (ICPO+) mutant virus (Halford & Schaffer, 2001). The results 
showed that superinfection with the ICP4- virus, expressing ICPO, resulted in the 100% 
reactivation of TO cultures latently infected with KOS, n2l2, or 7134. Moreover, with 
reactivation by means of heat shock, two ICPO mutants reactivated inefficiently from 
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latently infected TG cells, strongly implying that ICPO is required for inducing efficient 
reactivation of the HSV-I genome from latency. 
ID.4 The effects of ICPO on cells and cellular proteins. 
ICPO has been proposed to interact with a number of cellular factors representative of 
a variety of cellular pathways, including components of cellular transcriptional 
(Kawaguchi et ai., 2001, Lees-Miller et ai., 1996), translational (Kawaguchi et ai., 1997a), 
protein degradation (Boutell et ai., 2002, Everett et ai., I 999a, Everett et ai., 1998a, 
Everett & Maul, 1994), and cell cycle control pathways (Hobbs & DeLuca, 1999, 
Kawaguchi et ai., 1997b, Lomonte & Everett, 1999). It has been assumed that the 
potential interactions of ICPO with cellular factors might contribute to its functions in 
HSV -1 infection via effects on host cell metabolism and pathways. The details of these 
interactions are described below. 
ID.4.1 ICPO induces the destruction ofNDI0 
Gelman and Silverstein (1985) first observed the localisation of ICPO in punctate foci 
in the nucleus of infected cells, but it was not until later that Maul and co-workers (1993) 
defined that early in HSV-I infection ICPO colocalised with the punctate subnuclear 
structures known as NDI0 (nuclear domain 10). Details of NDI0 constituents, their 
effects on cellular processes and their fate in response to viral infection are discussed in 
section 1 E and reviewed by Negorev & Maul (200 I )and Sternsdorf et ai. (1997). 
It was found that the colocalisation of ICPO with NDIO was transient, since at later 
times of infection ND 1 0 structures were disrupted and the constituent proteins dispersed in 
infected cells (Everett & Maul, 1994, Maul et ai., 1993). ICPO was reported to be 
sufficient for this effect, as NDI0 structures were retained in cells infected with d11403, 
the ICPO deletion mutant, but not in those infected with wild type virus at a later time of 
infection, 6 hpi (Maul & Everett, 1994). Western blot analysis of infected cell extracts 
revealed that several high-molecular-weight isoforms of PML, one of the most well known 
NDI0 constituents, were lost or reduced in quantity, implying that loss of the bands might 
correlate with the disruption ofNDlO during HSV-l infection (Everett et ai., 1998a). A 
variety of evidence strongly suggests that the high molecular weight PML isoforms 
comprise covalent conjugates with another ND I 0 constituent, the small ubiquitin-like 
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protein SUMO-l (Duprez et al., 1999, Muller & Dejean, 1999, Sternsdorf et al., 1999). 
The loss ofPML and its isoforms did not occur in cells infected with ICPO mutant viruses, 
particularly the RING finger deletion mutant FXE, and the effect could be inhibited in wild 
type virus infections by the addition of proteasome inhibitors (MG132 and lactacystin) 
during infection (Everett et al., 1998a). These observations indicate that the degradation of 
PML isoforms requires fully functional ICPO and is also dependent on an active 
proteasome-dependent proteolysis pathway. 
ID.4.2 ICPO interacts with ubiquitin-specitic protease USP7 
As described in section ID.2.3, ICPO immunoprecipitates with USP7 via an 
interaction with sequences in the C-terminal region of ICPO between residues 594-775 
(Meredith et al., 1995, Meredith et al., 1994). 
Analysis of expressed sequence tag libraries from a variety of tissues demonstrated 
that USP7 is expressed in a wide variety of cell types and tissues, such as human brain, 
liver and placenta. The function of USP7 is unclear, however one function of USP 
enzymes is to cleave ubiquitin adducts from substrate proteins, thereby protecting the 
substrates from proteasome degradation and recycling free ubiquitin. Alternatively, USP 
enzymes cleave ubiquitin precursor molecules, again producing free ubiquitin for use in 
proteasome-dependent degradation. Results from indirect immunofluorescence assays, 
using an anti-USP7 rabbit serum (r206), showed that USP7 is predominantly a nuclear 
protein with a microspeckled nuclear staining pattern (Everett et al., 1997). Double-
staining with antibodies for USP7 and PML revealed that accumulations of USP7 were 
associated with a proportion ofNDIO. 
Definition of the minimal region of ICPO required for the interaction with USP7 
demonstrated that ICPO residues 594 to 646 are sufficient for binding to USP7 and residues 
618-631 are essential for this interaction in vitro (Everett et al., 1999c). Interestingly, in 
the region between residues 618 and 638, 7 charged residues are precisely conserved in the 
equivalent protein ofHSV -2. Binding studies of a number of single and double amino acid 
substitutions in this region revealed that lysine 620 and lysine 624 of ICPO were critical for 
USP7 binding. 
Transfection studies using mutants of ICPO that are unable to bind to USP7 
demonstrated that all exhibited reduced activation of gene expression. For instance, 
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activation of gene expression in transfected cells expressing the M1 (K620R, K624R) and 
M4 (K620R) mutants was reduced to the same level as that observed with a RING finger 
deletion mutant. These observations strongly suggest that the ability to bind to USP7 
contributes to the activation of gene expression induced by ICPO in transient transfection 
assays. In addition, in single-step growth curve experiments, the yields of virus progeny 
from cells infected with mutant viruses derived from constructs M 1 and M4 were reduced 
by approximately lO-fold at 16 and 24 hours post infection. Taken together, specific 
single or double point mutations in ICPO can reduce USP7 binding to background levels 
and also cause significant growth defects, indicating that the ability of ICPO to bind to 
USP7 is important for its biological functions (Everett et al., 1999c, Meredith et al., 1995). 
ID.4.3 ICPO interferes with the cell cycle progression 
It has been reported that the impairment of plating efficiency and synthesis of viral 
proteins characteristic of the ICPO null mutant virus 7134 can be overcome by plating the 
virus on a synchronised Vero cell monolayer 8 h after release from growth arrest. This 
corresponds to a stage in the cell cycle between GoIG I and S phase (Cai & Schaffer, 1991). 
Further studies demonstrated that CAT expression driven by the ICPO promoter (but not by 
the E and L promoters tested) was enhanced 10- and 3-fold in Vero and NB41A3 (mouse 
neuroblastoma) cells transfected at 6 and 2 h post release from growth arrest, respectively 
(Ralph et al., 1994). These observations suggest that a cellular function may be expressed 
during the transition of growth-arrested cells from Go into the G) phase of the cell cycle 
that can functionally substitute for the transactivating activity oflCPO. 
Another line of studies showed that ICPO may interact directly with the cell cycle 
regulatory machinery since it has been found to bind to and stab lise cyclin D3 (Kawaguchi 
et al., 1 997b). This interaction was abolished by replacement of the aspartic acid at 
position 199 with alanine (mutant D199A) (Kawaguchi et al., 1997b). A subsequent study 
used two recombinant viruses, R7801 (expressing wild type ICPO and also cyclin D3) and 
R7916 (expressing the 0199A substituted ICPO and cyelin D3) to investigate the potential 
effect of this interaction and the role of cyclin 03 in the biology of ICPO (Van Sant et al., 
2001). The results demonstrated that early in infection with R7801, ICPO colocalised with 
cyclin 03 in the vicinity of NOlO structures, whereas the 0199A substituted ICPO 
remained in NO 1 0, and did not eolocalise with cyclin D3. Furthermore, in cells infected 
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with recombinant virus expressing cyelin D3, ICPO was translocated to the cytoplasm from 
the nucleus more efficiently than wild type virus infections. These results indicated that 
the interaction of ICPO with eyclin D3 might be responsible for the stabilisation and 
activation of G I-phase cyclins by activating cdk4 (cyclin-dependent kinase 4), localising 
cyclin D3 to the vicinity of ND I 0 structures, and the acceleration of the translocation of 
ICPO from the nucleus to cytoplasm. Although the net effect of this interaction is unclear, 
it was shown that failure to bind cyclin D3 correlated with reduced replication in quiescent 
HEL (human embryonic lung) cells implying that interaction of ICPO with certain D-type 
cyclins contributes to viral replication (Van Sant et al., 1999). 
More recently, a number of studies demonstrated that ICPO possesses the ability to 
inhibit the progression of the cell cycle (Hobbs & DeLuca, 1999, Lomonte & Everett, 
1999).' Hobbs and DeLuca (1999) reported that infection with the mutant virus d106, in 
which IE gene expression is restricted to that of ICPO, caused cell cycle arrest at both the 
GlIS and G21M transitions, whereas mutant virus dl09, which does not express any viral 
proteins, failed to induce this phenotype. These data indicate that functional ICPO is able 
to induce cell cycle arrest. Consistent with the above findings, Lomonte and Everett 
(1999) demonstrated that transfected cells expressing an EGFP-ICPO fusion protein 
became stalled at the G liS phase boundary. Infection of synchronised cells in the S phase 
or G2 with wild type HSV -1 resulted in a block of the infected cells at an unusual stage of 
mitosis named pseudo-prometaphase (Everett et al., 1999a). The dysregulation of the cell 
cycle in mitosis was shown to be caused by the ICPO induced proteasome-dependent 
degradation of CENP-C (Everett et 01., 1999a), a centromeric protein component of the 
inner kinetochore plate which is essential for cell division (Earnshaw & Rothfield, 1985). 
Most recently, ICPO-induced degradation of another centromere protein, CENP-A, has 
been shown to contribute to mitotic arrest of HSV -1 infected cells (Lomonte et 01., 200 I). 
The 17-kDa CENP-A protein is a histone H3-like protein associated with the nucleasome 
structure in the inner plate of the kinetochore (Sullivan et al., 1994). As with CENP-C, the 
CENP-A protein was degraded by ICPO via a proteasome-dependent pathway in infected 
cells (Lomonte et aI., 2001). Taken together, all the observations described above imply 
that HSV-I is able to influence and is influenced by cellular factors involved in the G1/S or 
mitotic phases of the cell cycle. 
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ID.4.4 ICPO has ubiquitin E3ligase activity in vitro 
As previously described in this section (section IDA), ICPO has been reported to bind 
strongly to USP7 and has also been implicated in triggering degradation of a number of 
cellular proteins via a proteasome-dependent pathway. In addition, several studies have 
described that a variety of RING finger proteins are involved in the ubiquitin-proteasome 
pathway by acting as ubiquitin E3 ligases (reviewed by Freemont, 2000). Recently, two 
laboratories have published evidence that ICPO possesses E3 uhiquitin ligase activity in a 
variety of in vitro assays (Boutell et 01., 2002, Van Sant et 01., 2001). The ubiquitin-
conjugation pathway involves three enzymes, E 1, E2 and E3. Protein ubiquitination 
initialises with the formation of a thiol-ester linkage between the C-terminus of ubiquitin 
(Ub) and the active site cysteine of E 1 (Ub activating enzyme) and then its transfer to a 
similar thioI-ester linkage on an Ub conjugation enzyme (Ubc or E2). Cells express only 
one E 1 enzyme, but there are several different E2 enzymes that are related by their 
possession of a conserved active site domain. E3 Ub ligase proteins have been defined by 
their ability to stimulate the activity of E2 enzymes and in some cases to confer substrate-
specific ubiquitination activity. E3 Ub ligases facilitate the formation of isopeptide bonds 
between the C-terminal glycine of Ub and the side chain amide group on lysine residues 
either on the target protein, or on the last Ub of a protein-bound poly-Ub chain. 
Boutell et 01. demonstrated that in in vitro reactions containing free ubiquitin, Eland 
E2 (UbcH5a or UbcH6) enzymes, addition of purified proteins including His-ICPO 
(expressing full length ICPO), GST262 (a GST fusion protein incorporating ICPO residues 
1-262) or GST241 (containing ICPO residues 1-241) strongly induced the accumulation of 
poly-ubiquitin chains (Boutell et 01., 2002). ICPO mutant derivatives of these constructs 
containing a variety of mutations in the region of the RING domain failed to stimulate E2 
enzyme activity. These observations indicate that ICPO acts as an E3 Ub ligase and that 
the RING finger region is absolutely required for this activity. Moreover, 
immunofluorescence staining of transfected cells revealed that ICPO sequestered a 
proportion of co-expressed UbcH5 and UbcH6 in the ICPO foci in both the nucleus and in 
the cytoplasm of many cells. However no substantial interaction between ICPO and the E2 
enzymes was found in GST-pull down assays. On the other hand, the conclusion of Van 
Sant et 01. (2001) that ICPO has in vitro E3 Ub ligase activity was based on the observation 
that the activity of E2 enzyme cdc34 was stimulated by a GST-ICPO fusion protein 
containing C-terminal residues 543-768. This region does not include the RING finger 
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domain of ICPO, therefore they suggested that ICPO uses an alternative region for its E3 
ligase activity. These results conflict with the observations of Boutell et ai. (2002). 
ID4.S Interaction with proteins involved in the regulation of transcription and 
translation. 
ICPO has been implicated in the regulation of transcription and translation through 
interactions with or affect on cellular factors involved in gene expression. Parkinson et al. 
(1999) demonstrated that in the course of HSV-l infection, expression oflCPO alone was 
sufficient for degradation of the catalytic subunit of DNA-dependent protein kinase (DNA-
PK). DNA-PK is a multi-functional nuclear enzyme that plays a part in double-stranded 
DNA break repair, V(D)J recombination, and possibly in the regulation of transcription by 
RNA polymerases I and II (Lees-Miller et ai., 1996). As in the previously described 
examples of PML and Sp 1 00, the RING finger domain of ICPO was found to be required 
for the induction of degradation of DNA-PK via a proteasome-dependent pathway 
(Parkinson et aI., 1999). Recently, two other proteins, BMALl and elongation factor 10 
(EF-lo) that are involved in transcription and translation regulation respectively, have been 
identified to interact with ICPO in the yeast two-hybrid system (Kawaguchi et al., 1997a, 
Kawaguchi et al., 2001). These studies suggested that the C-terminal region of ICPO 
interacts with EF-l0 (Kawaguchi et ai., 1997a). EF-10 is expressed as a cytoplasmic 
protein and is a subunit of EF-l, a complex of factor that mediates the elongation of 
polypeptide chains during translation (reviewed by Merrick, 1992). Although ICPO is 
initially expressed as a nuclear protein and many actions of ICPO occur in the nucleus, 
however as described previously, at later stages of infection ICPO is translocated into the 
cytoplasm. These findings indicate that the translocation of ICPO into the cytoplasm might 
enable ICPO to interact with EF -10. The effects of this interaction are not fully understood, 
although some results demonstrated that a HSV-l viral protein (ULl3) mediated 
hyperphosphorylation of EF-Io (Kawaguchi et aI., 1998), an effect that. has been 
associated with efficient translation (Wasserman et ai., 1982). 
Most recently, Kawaguchi and coworkers (2001) reported that ICPO also interacts 
with the transcription factor BMAL 1 in the yeast two-hybrid system. BMAL has been 
described as a basic helix-Ioop-helix-PAS transcription factor (Hogenesch et at., 1997). 
Subsequent studies using GST-pull down assays revealed that residues encoded in exon II 
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of ICPO were able to interact with full length BMAL1, and that BMALI residues between 
95 and 450 containing the bHLH and PAS domains appeared to be important for this 
interaction. Furthermore, co-expression of ICPO and BMALI increased reporter 
(luciferase) gene activity in transient transfection assays by approximately 5-fold 
compared to ICPO and BMALI alone, indicating that ICPO might form a transcriptionally 
active complex with BMALI in mammalian cells. Finally, since during viral infection the 
BMAL I is more stable in cells infected with wild type HSV -1 than in those infected with 
ICPO null mutant viruses, these workers suggested that ICPO may mediate stabilisation of 
this protein. 
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1 E. ND10 structures and their interactions with viral proteins 
The nucleus in eukaryotic cells contains several discrete domains or sub-structures, 
such as the relatively well characterised nucleolus, Cajal (or coiled) bodies and ND 1 0, and 
several less well understood foci characterised by discrete accumulations of various 
particular cellular proteins. These domains appear to be involved in distinct cellular 
processes including DNA replication, transcription, pre-mRNA processing, and ribosome 
assembly (reviewed by Spector, 2001). The structures that later became known as NOlO, 
PML nuclear bodies or PODs were initially described as punctate nuclear foci by Bernstein 
et al. (1984) using sera from patients with primary biliary cirrhosis for immuno-
fluorescence analysis (Bernstein et al., 1984). NDlO appeared similar to small dense 
structures, termed nuclear bodies, which had been recognised by electron microscopy. The 
interest in NO 1 0 increased dramatically when one of the principal protein components was 
identified as PML, a protein that is disrupted by chromosomal translocations that cause 
promyelocytic leukaemia (reviewed by Piazza et al., 2001). 
The designation of ND lOis derived from their appearance as nuclear dots or domains 
and the initial finding of approximately 10 nuclear dots per cell in several human cell lines 
by immunofluorescence analysis (Ascoli & Maul, 1991). However the number of NDlO 
varies, ranging from 5 to 30 per nucleus, considerably dependent on cell type and other 
factors (reviewed by Sternsdorf et al., 1997, Negorev & Maul, 2001). 
To date, at least six proteins, including SpIOO, PML, SUMO-I, hOaxx, BLM and 
NDP55 have been found to be present in NDIO constantly (reviewed by Negorev & Maul, 
2001). Apart from these six constituents, a number of proteins have been reported to 
transiently associate with ND 1 0 (Table 1.2). Details of ND 1 0 constituents are discussed in 
greater depth in separate sections below. 
With the list of proteins associated with ND 1 0 growing fast, ND 10 have been 
implicated in regulation of gene expression (Valli an et al., 1998), cell transformation (Le et 
al., 1998), growth control (Mu et al., 1994), and cellular stress response (Maul et al., 
1995). To date, the role of NOlO is poorly understood. However, NOlO structures have 
been demonstrated as preferential sites for deposition of incoming viral genomes and for 
the development of replication compartments (Ishov & Maul, 1996). Furthermore, several 
viral oncoproteins and transactivators have been found to affect the stability of NO 10 
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Table 1.2 Proteins present at ND 10 
Proteins present 01 ND J 0 al elldoKeIlOIlS levels of expressioll 
PM L essential in NOlO formation ; in SUMO-modified form recruits Oaxx; interacts with eBP, pRb, p53 ; considered a co-repressor 
SplOO interacts with HPI ; NO 10 are limited in their capacity to recruit SpIOO. 
Oa\X recruited by SUMO- modified PML; binds to an increasing number of proteins. 
BLM low relative amount ofBLM is stationed in NOlO. 
SUMO modifies PML and SplOO covalently changin1$ their capacity to bind other proteins. 
NOP55 uncharacterised protein(s); potentially a protem modification recognised by Mab 138; increase after heat shock. 
Profeim COl1llifiollal(r pre.\e111 ill or al N D J () 
TRFl /2 
.'\B~l 
P95/nihrin 
Mrcll 
RAD5 1 
RAD52 
present in a subset of NO I 0 containing telomere repeats in cells depending on an alternative telomere maintenance mechanism. 
These proteins colocalised with PML Ul telomerase-negative immortalised cells during the late S/Gr phase of the cell cycle. 
Repl. factor A 
\\R,\ 
ENP-t 
HPI 
SplOOC 
HMC2 
CBP 
pRb 
USP 
PA28 
removes SUMO from PML. 
interacts with Sp 100 but is present in NO lOin variable amounts depending on the cell cycle phase. 
present in some NO I O. 
Ulteracts with Sp 100B. 
interacts with PML, found in some cell type but not others. 
phosphorylated form found by some groups and not by others; possibly cell cycle related colocalisation. 
at or beside some NOlO; probably cell cycle dependent. 
proteosomal activator; increased recruitment to NDIO by IFN-y exposure .. 
proteosome only after application of prot eo some inhibitors or after IFN-y as immunoproteosomes. 
RFP interacts with PML and associates with a subset of NO I O. 
CAPDH interaction with PML is RNA dependent. 
elF-4 interacts with PML. 
PLZF no interaction with PML but side by side localisation in nucleus. 
HSF2 heat shock transcription factor 2 after overexpression in lower number of cells, mostly cytoplasmic. 
Tax recruited into NOlO when PML is overexpressed. 
P53 in specific cells, after overexpression or proteosome inhibition or beside NO t 0 with T-ag down regulation. 
ISC-20 after overexpression of a fragment 
Mutant ataxin PML but not the other NO 10 proteins are located in ataxin-I aggregates after polyglutarnine tract extension. 
PKM Mx interaction kinase after transient expression. 
Int6 
PAX3 
Spl 
FISTIHIPK3 
hGCNP 
Spl40 
BRACt 
in some cells possibly by binding to overexpressed Oaxx. 
interacts with PML' 
after overexpression interacts with Oaxx. 
besides NOlO upon transient overexpression. 
after overexpression with some NO I O. 
breast cancer protein I beside NO I 0 upon tran~ient Qverexpression. 
Adaptedfrom Negorev & Maul, 2001 
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structures and composition (reviewed by Everett, 2001). These observations indicate that 
NO 1 0 proteins might potentially affect viral infection. Relevant aspects of NO 1 0 biology 
are discussed in later sections. 
tE.t Dis(overy ofNDtO 
Visualisation of nuclear structures by electron microscopy has discovered a variety of 
nuclear bodies. The atypical sphere subnuclear structure described by Bernstein (1984) 
was later known as NOlO through the studies of Ascoli and Maul (1991). Their 
experiments, set out to screen over 1,700 human autoimmune sera in immunofluorescence 
assays, revealed a novel nuclear domain with an average of 10 dots per nucleus, hence the 
name NO I o. Double-staining immunofluorescence experiments demonstrated that ND I 0 
structures were stably attached to a nuclear matrix component but separate from 
chromosomes, kinetochores and centromeres (Ascoli & Maul, 1991). 
tE.2 Proteins present at NDtO 
The anti-ND 1 0 autoimmune antibodies, used in a series of biochemical fractionation 
experiments followed by western blot analysis, first discovered a 55kDa protein (NDP55) 
as a component ofNDlO (Ascoli & Maul, 1991). However this protein has not yet been 
further characterised. Using the sera of patients with primary biliary cirrhosis, SplOO was 
identified earlier than NDP55 (Szostecki et al., 1990), but its NDI0 localisation was not 
confirmed until double-staining was performed with sera against NDP55 and SplOO 
(Stuurman et al., 1992). A third constituent was demonstrated to localise to NDI0 in 
immunofluorescence assays using the monoclonal antibody 5EIO that was later found to 
recognise PML (Stuurman et al., 1992). SUMO-l was found to interact with PML in the 
yeast two-hybrid system (Boddy et al., 1996). Subsequent studies demonstrated that 
SUMO-I covalently modifies both PML and SplOO and co-localises with these proteins in 
NDI0 (Muller et al., 1998a, Sternsdorf et al., 1997). Another NDIO component, hDaxx, 
was initially shown to have a nuclear localisation similar to that of NO 1 0 and was further 
identified as a PML-interaction protein through yeast two-hybrid screening (Ishov et al., 
1999, Li et al., 2000). Similarly, BLM had a NDIO-like nuclear distribution in most cells 
(Neff et al., 1999) and was later defined as a component ofNDlO (Yankiwski et al., 2000). 
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Four relatively well characterised NDI0 proteins including PML, Sp100, SUMO-I, and 
hDaxx are discussed individually below. 
IE.2.1 PML 
IE.2.1.1 PML and APL 
PML (ProMyelocytic Leukaemia) was initially discovered as the part of a fusion 
protein with retinoic acid receptor a resulting from a t( 15; 17) reciprocal chromosome 
translocation in most patients with the hematopoietic malignancy acute promyelocytic 
leukaemia (APL) (de The et at., 1991). This chromosome translocation fuses the retinoic 
acid receptor a (RAR-a.) gene to the N-terminal part ofPML (Goddard et al., 1991), and in 
consequence ND 1 0 domains are disrupted and form large numbers of small scattered 
speckles (described as a microspeckled pattern), distributed both in the cytoplasm and the 
nucleus (Daniel et al., 1993). The PML-RARa fusion protein is sufficient for 
transformation of cells and induction of leukaemias (AItabef et al., 1996). Retinoic acid 
and AS203 treatments, which have been effectively applied in clinics, results in destruction 
of the PML-RARa fusion protein and restoration of normal ND 1 0 distribution (reviewed 
by Zhang et al., 2001). 
IE.2.1.2 The structure ofPML transcripts and polypeptides 
Sequence analysis has revealed that the PML gene consists of nine exons, and at least 
seven PML isoforms are produced as a consequence of alternative splicing of the 3' exons 
(reviewed by Jensen et at., 2001). However, little is known about the functions of the 
PML splice variants at present. The promoter region of PML harbours IFN-stimulated 
response elements (ISREs) and IFN-y activation sites (GAS) mapped at 100-500 bp 
upstream of the start codon (Stadler et at., 1995). Furthermore, it has been shown that 
transcription 'of PML is up-regulated by IFNs and that the PML-ISRE element alone is 
sufficient to mediate type I and type II IFN-enhanced gene expression. 
The structure of PML protein contains several domains, listed in the direction from 
the N- to the C- terminus: a zinc-binding RING finger domain (residues 45-105); two Il-
boxes (Bl and B2 at residues 124-166 and 184-23, respectively); and a predicted alpha-
helical Coiled-hoil domain (residues 229-323). This arrangement of domains is present in 
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a number of other proteins and has been designated the RBCC motif, or more recently 
termed the TRIM (Tripartite Motif) motif (reviewed by Jensen et a/., 2001). In addition, 
three lysine residues have been found to be SUMO-l modification sites (at residues 65, 
160, and 490) that are present in all PML isoforms, and a bipartite NLS signal (overlapping 
the SUMO-l modification site at residue 490) is located in exon 6. The gene structures 
and position of these domains are illustrated in Fig. 1.8. Extensive structural and 
functional analyses of PML have showed that several cellular and viral proteins interact 
specifically with certain PML isoforms, implying that the different domains of PML 
mediate its distinct functions (reviewed by Jensen et a/., 2001). 
Immunofluorescence analyses demonstrated that mutations in the conserved zinc-
binding residues of the PML RING finger disrupted formation ofND10 in vivo (Borden et 
a/., 1996, Kastner et a/., 1992). In addition, it was found that the RING finger ofPML was 
important both for its localisation to NOlO and its PML-PML oligomerisation (Boddy et 
a/.,1997). Furthermore, the domains ofPML necessary for the ND10 formation have been 
shown to correlate with its transformation suppressing effects (Fagioli et a/., 1998, Mu et 
a/., 1994), apoptosis (Zhong et a/., 2000) and anti-viral activities (reviewed by Regad & 
Chelbi-Alix, 2001). 
The two B-boxes, adjacent to the RING domain, contain conserved zinc binding 
residues in a cysteine-rich region that have been reported to be important for ND 1 0 
formation, but not in PML-PML oligomerisation (Borden et a/., 1996). Together with the 
RING finger, the B-boxes have been shown to mediate the growth suppressor function of 
PML (Fagioli et a/., 1998). Moreover, PML has been shown to colocalise with the 
retinoblastoma protein (PRb) and this interaction was abolished when PML with deletions 
in the B-boxes region was used in co-immunoprecipitation experiments, indicating that B-
boxes play an indispensable role in this interaction (Alcalay et a/., 1998). 
The coiled-coil regions of PML are thought to be important for PML multimerisation 
(Peng et a/., 2000). Deletion analysis of PML revealed that the coiled-coil domain was 
required for the transcriptional repression by PML (Vallian et a/., 1997). However an 
intact RBCCrrRIM motif of PML is essential for optimal function of PML in NO 1 0 
formation, PML growth suppressor, apoptotic and antiviral activities (reviewed by Jensen 
et a/., 2001). 
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45-105 124-166 184-230 229-323 NLS 
Fig. 1.8 The functional domains ofPML. 
The N-terminal region of PML contains the RBCC motif: RING finger domain 
(residues 45-105), two B-boxes (residues 124-166, 184-230) and Coiled-Coil 
domain (residues 229-323). A nuclear localisation signal has been mapped near 
the C-terminus of PML as indicated. SUMO-I modified sites at amino acid 
positions 65, 160, and 490 are indicated. 
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lE.2.1.3 PML and its potential functions 
The exact function of PML has yet to be characterised, however it has been 
implicated in growth suppression (Mu et al., 1994) and transformation suppression, 
transcription repression (Vallian et al., 1997), apoptosis (Pearson & Pelicci, 2001) and 
inhibition of viral infections (reviewed by Regad & Chelbi-Alix, 2001). 
• A growth suppressor 
This potential function of PML was initially described by Mu et al. (1994). In 
transient transfection experiments, expression of PML in APL-derived NB4 cells 
significantly reduced the number of colonies growing on soft agar (Mu et al., 1994). 
Additionally, PML was also found to suppress oncogenic transformation of rat embryonic 
fibroblasts (REF) and NIH3T3 cells by co-expression of oncogenes including Ha-ras and 
mutant pS3 or Ha-Ras (RasVI2) and c-myc. These observations implicate PML in growth 
suppression. 
The role ofPML in tumorigenesis was further conclusively demonstrated by Wang et 
al. using a PML knockout mouse model. PML -/- mice, pre-treated with the tumour 
initiators DMBA followed by TP A, developed more papillomas suggesting that PML may 
function as a tumour suppressor (Wang et al., 1998). 
• A transcriptional repressor 
Chang and coworkers first discovered that transient expression of PML repressed 
transcription from specific promoters including those of the human multi-drug resistance 
(MDRI) and epidermal growth factor receptor (EGFR) genes (Mu et al., 1994). Further 
studies from the same group proposed that the negative regulation of EGFR transcription 
by PML might result from the interaction ofPML with Spl that leads to disruption ofSpl 
DNA binding activity and subsequently affect the activation of the EGFR promoter by Sp 1 
(Vallian et al., 1998). PML has also been reported to interact with the non-phosphorylated 
fraction of the pRb protein in NO I 0, and it displayed an inhibitory effect on pRb-regulated 
transcriptional activation of glucocorticoid receptor-responsive promoters (Alcalay et al., 
1998). Functional analysis revealed that the coiled-coil (dimerisation) domain was 
essential for this interaction. Additionally, recent studies by Wu et al. (200 I) demonstrated 
that the transcription function ofPML is associated with histone deacetylase (HDAC). The 
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PML isoform, containing 633 residues, directly interact with all three isoforms of HDAC 
genes in GST pull down assays and the basal transcription of PML was shown to be 
repressed by a HDAC specific inhibitor, implying that HDAC activities may contribute 
(Wu et al., 2001b). 
• Induction of apoptosis 
Quignon et al. (1998) reported that overexpression of PML in SV40 large T-
transformed REF (rat embryonic fibroblast) cells resulted in a 40-fold reduction of colony 
formation and induced morphological changes that were associated with a moderately 
positive TUNEL assay, suggestive of induction of apoptosis. This apparent PML-induced 
cell death led to the appearance of cytoplasmic shrinkage features, rather than the typical 
DNA cleavage type of apoptosis. This apoptosis was not blocked by caspase inhibitors 
suggesting that PML triggers caspase-independent apoptosis (Quignon et al., 1998). At the 
same time, studies on PML-/- knockout mice from Pandolfi's group also implicated PML 
in an apoptotic pathway, but they concluded that PML was a mediator of caspase-
dependent cell death, since it was required for activation of caspase 1 and caspase 3 upon 
treatment with several exogenous apoptosis-inducing stimuli (Wang et al., 1998). The fact 
that such different experimental models were used, one depending on overexpression of 
PML in vitro, the other one investigating the removal PML activity in vivo, and both 
methods using distinct stimuli that might trigger different pro-apoptosis pathways, 
provides an explanation for the paradoxical findings. More recently, Pandolfi's group 
provided further evidence for the involvement of ND 1 0 proteins in apoptosis (Zhong et al., 
2000). These results demonstrated that the overexpression of hDaxx, a ND 1 0 constituent, 
which has been shown to function as a pro-apoptotic protein enhancing Fas-mediated 
apoptosis, induced cell death in PML+/+ cells, but not in PML-/- cells (Chang et al., 1998). 
PML is also required for the ND 1 0 localisation of Daxx because of a direct interaction 
between Daxx and SUMO-! modified PML, indicating that the interaction of PML and 
Daxx might contribute to a novel nuclear pathway for apoptosis. 
• A potential role of PML in anti-viral Infection 
Several groups have demonstrated that PML might mediate an anti-viral response as 
part of the host-cell defence system. Chelbi-Alix et al. (1998) initially showed that over-
expression of PML diminished infections by vesicular stomatitis virus (VSV) and 
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influenza A virus. Most recently, PML has also been found to induce resistance to 
lymphocytic choriomeningitis virus (LCMV), human foamy virus (HFV) and the 
herpesvirus HCMV in cell cultures (reviewed by Regad & Chelbi-AIix, 2001). 
Considering that expression of PML, like some other ND I 0 proteins, is induced by IFNs, 
these results imply that PML may contribute to the antiviral state induced by the interferon 
pathway. The details of the function of PML in viral infection are included in section 
lE.5. 
1E.2.1.4 Proteins that interact with PML 
A growing number of other proteins have been reported to interact with PML, such as 
SUMO-l (Boddy et al., 1996), Ret RING finger protein (Rfp) (Cao et al., 1998), p53 
(Fogal et al., 2000), pRb (Alcalay et al., 1998), BLM (lshov et al., 1999), and Daxx (Li et 
al.,2000). As previously referred to in this section, interaction with PML appeared to be 
important to the function and recruitment of p53, pRb and Daxx, into NDI0 structures 
implicating PML in the maintenance of NDIO. Interestingly, recent studies have shown 
that PML (Boddy et al., 1996; Muller et al., 1998a) and p53 (Gostissa et al., 1999) are 
covalently modified by SUMO-I. Additionally, SUMO-! conjugation of PML has been 
demonstrated to be essential for the recruitment of Daxx into ND 1 0 and for efficient 
inhibition of Daxx-mediated transcriptional repression (Li et al., 2000), and to play an 
important part in transactivation of pS3 (Gostissa et al., 1999). This implies that the 
modification of PML by SUMO-l plays an essential part in its function. Information on 
SUMO-l and SUMO-l modification is discussed in greater detail in a later section. 
1E.2.2 Sp100 
1E.2.2.1 Introduction 
SplOO was the first NDIO constituent to be characterised biochemically (Ascoli & 
Maul, 1991, Szostecki et al., 1990). Among the currently known NDIO constituents, 
Sp 1 00 and PML are the best characterised at present. Although very different in primary 
structure, SplOO and PML share many properties: IFN-induced gene expression, 
alternative splicing and SUMO-l modification. 
The Sp 1 00 promoter region consists of ISRE and GAS elements that mediate 
transcriptional induction in response to IFNs (Grotzinger et al., 1996). SplOO is an acidic, 
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phosphorylated protein with a calculated molecular weight of 54 kDa, but it shows an 
aberrant electrophoretic mobility in SDS-PAGE corresponding to approximately 100 kDa 
(Szostecki et al., 1990). In addition, a number of transcripts, alternatively spliced at their 
C-termini and encoding several SplOO isoforms have been identified (reviewed by 
Sternsdorf et al., 1997) (see below). As with PML, Spl00 is post-translationally modified 
by SUMO-I. It has been shown that Spl00, together with its SUMO-I-modification 
isoforms, was degraded in cells infected with HSV-l (Chelbi-Alix & de The, 1999, 
Parkinson & Everett, 2000). Little is known about the functions ofSplOO, however it has 
been found to interact with a cellular protein, HPl, suggesting a connection between Spl00 
and the chromatin compartment (see below). 
lE.2.2.2 The structures of Spl00 and its splicing variants 
Analysis of a number of the Agtll cDNA expression library clones revealed that the 
primary SplOO transcript was alternatively spliced (Szostecki et al., 1990). Immunoblot 
analysis with extracts from HeLa S3 cells treated with IFNs revealed additional proteins, 
immunoreacted with antibodies for SplOO (Grotzinger et al., 1996). Additionally, 
comparison of the expression pattern with that of proteins synthesised in vitro provides 
strong evidence that alternative splicing or post-translational modification occurs during 
expression of Sp 1 00. Several groups have revealed a number of alternatively spliced 
Sp 1 00 variants containing homologies to high mobility group 1 (HMG 1) and a human 
nuclear phosphoprotein-box (HNPP) motif as a C-terminal domain (Guidner et al., 1999, 
Lehming et.al., 1998, Seeler et al., 1998). To date, at least four Spl00 splicing variants 
have been identified including SpAlt-C, SpAlt-212 (SplOO-B), SpAlt-HMO (SpIOO-HMO) 
and SplOOC (Seeler et al., 2001, reviewed by Stemsdorf et al., 1997). An illustration of 
the structure ofSpl00 and its splicing variants is shown in Fig. 1.9. 
• SplOO A (480 a.a.) 
This isoform, usually referred to as simply Sp 1 00, is the protein commonly studied 
and used for NDIO analysis. In its N-terminal region, SplOO harbours significant sequence 
homology to the peptide-binding groove of MHC class 1, termed the MHC-like motif, 
followed by a domain that is conserved in its murine homologue, designated 
Homogeneously Staining Region (HSR) (Stemsdorf et aJ., 1997). The C-terminus of 
69 
Chapter J introduction 
Amino Acids 
I 
100 
I 
MHC-like 
200 
I 
300 
I 
400 
I 
HP1 interaction region 
500 
I 
600 
I 
T ansactivating Domain 
Sp100 
(480 a.a.) 
~~~---r~--"~-' 
SpAlt-C 
(472 a.a.) 
basic region (24 aa) 
SpAlt-212 rr-.... PIP.!I5- -T-r---r-..-r"l---..... ""'1!!IIl 
(688 a.a.) 
700 
I 
800 
I 
SpAlt-HMGrr--... ~.---~~-----. ... n--~----.IM!....,I----;::::::-----n (879 a.a.) HMG 
Sp100C 
(885 a.a.) 
900 
I 
Fig. 1.9 Schematic representation of the Sp 100 and pI 00 alternative splicing variants and 
their corresponding motifs. 
SplOO contains an MHC-like motif followed by a HSR domain near the N-terminus and a 
transactivating domain, which is overlapped by a Nef-Iike region near the C-terminus. Sp 1 00 
and all the splicing variants share most of the N-terminal 476 amino acids (the yell ow region 
indicated), except SpAlt-C in which a basic region (24 a.a.) replaces the acid region (32 a.a.) 
at the C-terminus of plOO. SplOO and all the all the splicing variants contain a HPl 
interaction region (residues 287-334) and one UMO-l modification site (K297) . 
SpAlt-212 contains the entire SpiOO sequence except for the last 4 amino acids, as indicated. 
An extra HNPP region is located in the C-terminal end. 
pAlt-HMG is identical to pAIt-212 up to amino acid 684 and has a HMG domain in the N-
terminus. 
pl OOC contains 700 N-terrninal residue of th pAlt-HMG and two additional regions, 
PHD and Bromodomain in its C-terminus. The details for each domain are discussed in text 
in section l E2.2. 
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Sp 1 00 contains a transactivating domain involved in the transactivation ability of Sp 1 00 in 
transfection assays when Sp 1 00 was tethered to DNA (Lehming et 01., 1998), and a Nef-
like motif, a region overlapping the transactivating domain that shows similarity to the 
HIV-l regulatory protein Nef (Adachi & Oshima, 1999). The C-terminus of SplOO is 
acidic and contains a putative phosphorylation site for casein kinase II. 
• SpAlt-l12 (688 a.a.) 
In immunoblot analyses, at least two high molecular weight Sp I 00 proteins were 
observed in cells treated with IFN (Orotzinger et 01., 1996). Sequence analysis of the 
cDNAs of two IFN-inducible isoforms (SpAlt-212 and SpAlt-HMO) identified an 
additional domain in their C-termini termed an 'HNPP' box with high sequence similarity 
to an IFN-inducible human nuclear phosphoprotein (Ouldner et 01., 1999). Earlier studies 
identified a variant named SplOOB (Bloch et 01., 1996) that is virtually identical to SpAlt-
212 described here. 
• SpAit-HMG (879 a.a.) 
The SpAlt-HMO variant, with the highest molecular mass, contains a domain (the 
HMO box) that represents an almost complete and highly conserved copy of the HMO-l 
protein, after the HNPP box (Ouldner et 01., 1999). Various proteins, including many 
transcription factors and coactivator proteins, belong to the HMO-superfamily and are 
involved in processes as diverse as rRNA transcription and sex determination in mammals 
(Affara et 01., 1993, Yang-Yen & Rothblum, 1988). Therefore, it is conceivable that 
Sp 1 00 variants also have regulatory functions. 
• SpAlt-C (472 a.a.) 
In contrast to the other two variants, the SpAlt-C variant has no additional domains. 
The C-terminus contains a basic region (24 amino acids) of several lysine residues that 
replace the acid region (32 amino acids) at the C-terminus of SplOOA, resulting in loss of 
the consensus casein kinase II phosphorylation site. 
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lE.2.2.3 Functional domains of Spl00 
Stemsdorf et 01. (1999) used a series of truncated version ofSplOO and specific point 
mutation constructs to characterise domains necessary for dimerisation, nuclear 
localisation, NO I 0 targeting and SUMO-I conjugation. The initial work suggested that the 
C-terminal region (residues 334-480) might contain a NLS. Sequence analysis of this 
region revealed a putative NLS sequence (pSRKRRF) mapping to residues 444-450, and 
SplOO expressed from a substitution mutation (K447E) construct was found mainly in the 
cytoplasm indicating that Lys447 is required for nuclear localisation. In addition, 
immunofluorescence analysis of Sp 100 transfected cells co-stained with PML 
demonstrated that SplOO residues 33-149 are the minimal region for targeting SplOO to 
NOlO. Consistently, Negorev et 01. (2001) also reported that the region between residues 
29 and 152 was the shortest SplOO polypeptide to be deposited at NDlO. Results from 
immunoprecipitation experiments concluded that Sp 1 00 can form homodimers and 
subsequent analysis of Sp I 00 homomeric interactions using the mammalian two-hybrid 
assay defined the region between residues 33-149 (that responsible for NOlO targeting) is 
also essential for SplOO homodimerisation (Sternsdorf et 01., 1999). Since SUMO-l only 
modifies lysine residues of a target protein, analysis of three constructs in which lysine 
residues K297, K298 and K300 were changed to arginine, showed that K297 is the SUMO-
I modification site (Negorev et 01., 200 1, Stemsdorf et 01., 1999). 
lE.2.2.4 Proteins that interact with Spl00 
Recently, it has been shown that Spl00 binds to members of the heterochromatin 
binding protein (HP!) family both in vitro and in vivo (Lehming et 01., 1998, Seeler et 01., 
1998). HP 1, a member of the family of non-histone chromosomal proteins, bears a chromo 
shadow domain (CSD) that is required for the form of gene repression termed position 
effect variegation (Eissenberg et 01., 1990). Lehming et al. (1998) demonstrated that in a 
yeast two-hybrid system using the Sp 1 OOB variant as bait, two proteins (human HP 1 a, 
HPly) interact with Spl00B. By means of yeast two-hybrid screening and GST-pull down 
assays, findings consistent with these were obtained by Seeler et 01. (1998). Further 
analyses revealed that HP 1 residues 113-191 are sufficient for Sp I 00 binding and Sp 1 00 
residues between 287-334 are required for interaction with full length HPI (Seeler et al., 
1998). Moreover, immunofluorescence assays demonstrated that Sp I 00 colocalised with 
HP 1 in NO 1 0 structures and the enhancement of Sp I 00 expression by transient 
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transfection promoted HPI accumulation in NOlO. Finally, it has been shown that both 
SplOO and HPI act as transcriptional repressors when tethered to DNA in transient 
transfection assays. 
As HP I has been implicated in the proper functioning of centromeres during mitosis 
(Kellum et 01., 1995), these findings raise the interesting possibility that the NO 1 0 may be 
involved with the control and maintenance of chromatin or heterochromatin architecture. 
lE.l.3 SUMO-l 
tE.2.3.t Discovery ofSUMO-l and its related proteins 
A novel IOI-residue protein designated PIC-l (PML-interacting clone 1, now 
commonly called SUMO-l) was discovered to have a strong and specific interaction with 
PML, using yeast two-hybrid screening from a human B-cell cDNA library (Boddy et 01., 
1996). This protein is 18% identical to ubiquitin, a highly conserved 76-residue protein, 
and as with ubiquitin, SUMO-I has been shown to be covalently conjugated to a number of 
proteins, therefore it has been named as SUMO-I (for Small Ubiquitin-related Modifier I) 
(Mahajan et 01., 1997, Saitoh et 01., 1997). Intriguingly, cDNAs identical to that encoding 
vertebrate SUMO-l were discovered almost simultaneously by several research groups and 
given other names, including Sentrin (Okura et 01., 1996), UBL 1 (ubiquitin-like protein 1) 
(Shen et 01., 1996), and GMP-I (GAP modifying protein-I) (Matunis et 01., 1996). 
Recently, two cDNAs encoding proteins related to SUMO-I have been identified in 
humans and mice, designated SUMO-2/SMT3A (Lapenta et 01., 1997) and SUMO-
3/SMT3B (Chen et 01., 1998) respectively. Sequence analyses have shown that SUMO-! 
displays a relatively high identity to SUMO-2 (48%) and SUMO-3 (46%). However 
amino acid sequence identity between SUMO-2 and -3 is 95%, suggesting that SUMO-2 
and SUMO-3 should group into a subfamily distinct from SUMO-I. Saitoh and Hinchey 
have revealed that SUMO-2 and -3 are more abundant than SUMO-I in COS-7 cells using 
semiquantitative immunoblot assays. In addition, over 70% of SUMO-2 and -3 was found 
as a free or non-conjugated forms in vivo, whereas SUMO-l existed mainly (over 90%) in 
the conjugated form (Saitoh & Hinchey, 2000). 
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lE.2.3.2 The pathway of SUMO-l conjugation 
Like ubiquitin, SUMO-1 is believed to form an isopeptide bond between the carboxy 
terminal glycine of SUMO-1 and the E-amino group of a lysine residue of a target protein 
(Kamitani et 01., 1997, Mahajan et 01., 1998). The pathway of SUMO-1 conjugation (Fig. 
1.10) is mechanically analogous to ubiquitination, but SUMO-1 modification requires a set 
of specific enzymes that are distinct from those involved in ubiquitination (reviewed by 
Seeler & Dejean, 2001). As illustrated in Fig. 1.10, the C-terminus of pre-SUMO-1 needs 
to be proteolytically processed to the mature form of the SUMO-1 molecule prior to its 
conjugation. SUMO-I is subsequently activated in an A TP-dependent reaction by the 
formation of a thioester bond with the SUMO-activating enzyme (E 1), followed by the 
transfer of the SUMO-1 molecule to the SUMO-l conjugating enzyme (E2). In 
ubiquitination, sometimes, a further enzyme, the E3 ligase, may be needed to transfer 
ubiquitin from the E2 to substrate. Whether SUMO-l conjugation requires an E3 ligase is 
still uncertain, although a number of proteins have recently been identified that may have 
SUMO-1 E3-like properties (reviewed by Hochstrasser, 2001, Jackson, 2001). In contrast 
to ubiquitination, SUMO-l conjugation does not appear to form SUMO-SUMO chains. 
Finally, SUMO-l conjugation is a reversible process by which the attached SUMO-l can 
be cleaved from target proteins by SUMO isopeptidases, which are thought to be the same 
type of enzyme for that is used for SUMO-1 maturation. 
• Maturation 
SUMO-1 is expressed as a precursor protein with 4 extra amino acids (His-Ser-Thr-
Val) following the C-terminal Gly-Gly residues of the mature SUMO-l molecule 
(Kamitani et 01., 1997). As with ubiquitination, the cleavage of these extra residues to 
expose the C-terminal glycine residue is essential for SUMO-1 ligation to target proteins 
(reviewed by Hochstrasser, 1996). To date, at least four SUMO-l specific hydro lases have 
been identified. Li and Hochstrasser (1999) first identified the 72-kDa Ulpl, which can 
specifically cleave Smt-3 (the yeast homologue of SUMO-I) and SUMO-l from their 
conjugates, but not ubiquitin (Li & Hochstrasser, 1999). In addition, a 30-kDa SUMO-l C-
terminal hydrolase has been isolated from bovine brain extracts (Suzuki et 0/., 1999). This 
enzyme cleaved the SUMO-1 precursor and also SUMO-1 conjugated RanGAPI, but not 
ubiquitin. Furthermore, two SUMO-! specific hydrolases, the 126-kDa SUSPI (Kim et 
01., 2000) and the 73-kDa SENPt (Gong et 01., 2000), were obtained through the basic 
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Fig. 1.10 The UMO-l pathway. SUMO-l is synthesised as a precursor molecule 
that is processed C-terminally by a hydrolase to expose a C-terminal Gly residue. 
The mature SUMO-l subsequently forms thioester intermediates with El enzyme 
(AosllUba2), E2 (Ubc9) and possibly an E3 enzyme before bing coupled to the 
substrates. The UMO-l modification pathway is a reversibl process. The 
conjugated SUMO-l can be cleaved from substrates by isopeptidases. 
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local alignment search tool program (BLAST) on the basis of homology to Ulp 1, from a 
human cDNA or EST library. Interestingly, these two enzymes have different intracellular 
localisations that correlate with their effects on preferential targets. SENP I has been shown 
to specifically cleave SUMO-! conjugates of PML in the nucleus, but not SUMO-
RanGAPl in the nuclear rim, indicating that SENPI preferentially removes SUMO-l from 
its conjugates in the nucleus (Gong et al., 2000). SUSP!, expressed in the cytoplasm, 
efficiently released SUMO-! from SUMO-! modified p-galactosidase, but was unable to 
process other ubiquitin-like protein conjugates, such as Smt-3 conjugated ~-galactosidase 
(Kim et 01., 2000). 
• Activation 
In the human SUMO-l conjugation pathway, the activation of mature SUMO-! is 
carried out by the SUMO El enzyme, a heterodimer consisting of the 38-kDa Aos-l and 
the 72-kDa Uba-2 proteins, also referred to as SAElISAE2 (Desterro et al., 1999, Gong et 
al., 1999, Okuma et al., 1999). In the presence of the E2 enzyme (hUbc9), the Aosl/Uba2 
complex has been shown to form thioester bonds with SUMO-I, -2, and -3 (Gong et al., 
1999), and to efficiently conjugate SUMO to the protein substrate hcBa. in vitro (Desterro 
et al., 1999). These conjugation proteins are also required for SUMO-I conjugation of p53 
(Rodriguez et al., 1999) and RanGAPI (Okuma et al., 1999). These observations also 
imply that SUMO-l conjugation in vitro does not require an E3 protein ligase activity. 
• Conjugation 
In the yeast two-hybrid system, using SUMO-I as a bait to screen a human placenta 
cDNA library, a ubiquitin-conjugating enzyme, Ubc9 was identified (Gong et 01., 1997). 
Although Ubc9 is homologous to E2 ubiquitin conjugating enzymes, it is unable to form a 
thioester with ubiquitin. Instead it forms a thioester with SUMO-l with high affinity, 
demonstrating that Ubc9 is a SUMO-l specific E2 enzyme. In addition, thioester linkage 
between SUMO-! and Ubc9 required the C-terminal Gly-Gly residues of SUMO-I. 
Furthermore, it has been shown that a conserved Cys residue (Cys93) of Ubc9 is required 
to form a thioester bond with SUMO-J prior to conjugation with the target protein 
(reviewed by Seeler & Dejean, 2001). 
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IE.2.3.2 SUMO-! targets 
SUMO-I was initially found to be covalently conjugated to the 90-kDa form of the 
Ran GTPase-activating protein, RanGAPI, a protein required for nuclear transport 
(Mahajan et al., 1997). SUMO-l modification of RanGAP 1 was thought to facilitate the 
association of cytosolic RanGAP with Ran binding protein 2 (RanBP2) at the nuclear pore 
complexes to form the functional nuclear import machinery (Mahajan et al., 1997, 
Mahajan et al., 1998, Matunis et al., 1998, Saitoh et al., 1998). Recently, SUMO-l has 
also been found to conjugate with a growing list of cellular proteins (Table 1.3) that are 
important cellular regulators, including ND I 0 proteins, transcription factors (p53, c-Jun, 
TIF -I a., etc.), and chromatin-associated proteins as well as some viral proteins ( see below). 
However, how SUMO-I modification influences the function of its target proteins is not 
well understood. 
IE.l.3.3 SUMO-! and NDIO 
Stemsdorf et al. (1997) initially proposed that a fraction of nuclear PML is covalently 
modified by SUMO-I. In addition, Muller et al. (1998) have shown that SUMO-l is 
covalently attached to a subset of PML isoforms in a reversible and phosphorylation-
dependent manner in non-APL cells. Unmodified PML is found in the soluble fraction of 
the nucleus, whereas SUMO-I-modified PML is compartmentalized in NDlO, indicating 
that SUMO-l modification of proteins plays a general role in the regulation of their 
subcellular localization (Muller et al., 1998a). Three lysine residues in PML (Lys65 in the 
RING finger domain, Lys160 in the Bl box, Lys490 in the NLS) have been found to be 
modification sites for SUMO-} (Kamitani el al., 1998). 
The second NDIO protein modified by SUMO-I is SpIOO. Mutagenesis of SplOO 
revealed a single lysine residue (Lys297) that serves as the SUMO-l acceptor site 
(Stemsdorf et al., 1999). In contrast to PML, mutation of Lys297 completely abolished 
SUMO-I modification of SpIOO, but did not affect the localisation of SplOO to NDIO. 
Furthermore, Sp 1 OO(K447E), a nuclear localisation mutant construct that encodes 
cytoplasmic unmodified Sp 1 00, when expressed with a functional NLS, was efficiently 
modified by SUMO-I, suggesting that modification of Sp I 00 by SUMO-l is strongly 
correlated to nuclear localisation. More recently, studies from Seeler et al. demonstrated 
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Table 1.3 SUMO substrates and the potential functions of SUMO modification 
Proteins 
N D I 0 proleills: 
PML and PML-RARa 
SplOO 
Cyfoplm.mic proteins: 
RanGAPl 
IKBa 
GLUTl, GLUT4 
Yeast septins: 
Suggested/unction or observed effect 
ND I 0 integrity, potentiation of arsenic- induced degradation 
Stabilisation of Sp I OO-HP I interaction in vitro 
Targeting to RanBP2 at nuclear pore complex 
Antagonise ubiquitylation 
Unknown; weak SUMOylation but di ffe rentially regulated by Ubc9 
Cdc3p 
Cddlp 
Sep7p 
Regulation of septin ring dynamics during budding yeast cytokinesis 
Viral protein,\': 
CMV-IEl 
CMV-IE2 
BPV-El 
EBV-BZLFI 
Unknown 
Reduction in transactivation 
Nuclear translocation/ local isation 
ND I 0 disruption, subnuclear targeting 
Transcriptioll factors amI eh rol1latill-a. sociated proteins: 
p53 Modest increase in transactivation and apoptotic response; no effect 
on p53 stability 
p73a Potentiation of proteasomal degradation; relocalisation to detergent-
insoluble fraction 
c-Jun 
HSF2 
Dorsal (Drosophila) 
Tkt69 (Drosophila) 
Androgen Receptor 
TEL 
TOP! 
TOP2 
TIFla 
Otlter: 
Mdm2 
HIPK2 (kinase) 
CaMKII (Drosophila) 
Modest reduction of transcriptional activation 
increases DNA binding 
Enhancement of nuclear translocation and transcriptional activation 
Unknown 
Slight enhancement of transcriptional activation 
Subnuclear targeting to TEL bodies 
Unknown 
Unknown 
Unknown 
Antagonise ubiquity lat ion 
Subnuclear loca li ation to speckle 
Unknown 
Adaptedfrom Seeler & Dejean, 2001 
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that SUMO-l conjugated SplOO enhanced the interaction of SplOO with HPl, suggesting 
that SUMO-l modification might directly mediate this interaction (Seeler et al., 200 I). 
As mentioned in section lE.2.1.4, SUMO-l modification of PML appears to be 
important for certain proteins (e.g. Oaxx and p53) to be targeted to NOlO and subsequently 
modulating their transcriptional activity. However, it is unknown how SUMO-I regulates 
transcriptional processes mechanistically. 
IE.2.3.4 SUMO-! modification and viral infection 
During infection, the IE proteins of many certain viruses localise to and then trigger 
disruption ofNDlO which correlates with the disruption ofNDlO components (PML and 
SpIOO) as well as their SUMO-! modified isoforms (see section 10.4.1, reviewed by 
Maul, 1998, Everett, 2001, Seeler & Oejean, 2001). Intriguingly, some viral IE proteins 
including lEI and IE2 (HCMV), BZFLl (EBV), and El (bovine papillomavirus and 
human papillomavirus) are themselves conjugated by SUMO-I. Recently, studies from 
Hayward and coworkers have discovered more direct evidence for the interaction of IE 
proteins with SUMO-I during HCMV infection. Xu el al. (2001) reported that SUMO.-I 
modification of IEI can be enhanced either by overexpression of PML or SUMO-I. In 
addition, they have identified that Lys(450) in lEI is the SUMO-l conjugation site, but the 
lEI mutant (K450R) in which Lys (450) was changed to arginine still efficiently localised 
to NDI0, indicating that SUMO-l modification is not required for targeting of lEI to 
ND 10 (Xu el al., 200 l). Furthermore, SUMO-l conjugated IE 1 is not required for 
efficient IE' inhibition of PML-mediated transcriptional repression whereas IEI mutants, 
defective in displacing PML from NO 1 0, failed to inhibit the repression function of PML. 
IE2 ofHCMV has been shown to physically interact with, and to be modified by, SUMO-l 
(Ahn el al., 2001). Further work demonstrated that an increase in SUMO-l modification 
enhanced IE2-mediated transcription. These observations highlight the potential 
significance of SUMO-l modification and NO lOin viral gene expression. 
lE.2.4 Daxx 
lE.2.4.1 Identification of hDaxx as a NDIO protein 
Human Daxx (hDaxx) was initially isolated using a yeast-one hybrid screen to detect 
transcription factors regulating a steroidogenic factor I (SF-I)-like DNA element 
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(Kiriakidou et al., 1997). It was later found to be an NO 1 0 component, since it appeared to 
colocalise with PML at NO 1 0 (Everett et al., 1999b, Ishov et al., 1999). Further work 
showed that hDaxx physically interacted with PML, but not Sp 1 00, in yeast two-hybrid 
assays suggesting that the spatial colocalisation of PML and hDaxx in NO 1 0 reflects an 
interaction between these two proteins (Ishov et al., 1999). 
lE.2.4.2 The potential function of Dan: 
• A potent transcription repressor 
The hDaxx protein has been demonstrated to potently repress transcription from the 
HCMV promoter (27-fold decrease) and its C-terminal domain (residues 625-740) has 
been found to be both necessary and sufficient for transcriptional repression (Torii et al., 
1999). This finding was later supported by Li et al. (2000). In addition, studies using a 
number of mutants with various deletions in the C- or N-termini of hDaxx revealed that 
multiple regions of hDaxx are involved in transcriptional repression in a cell-type-
dependent manner. Several lines of evidence have shown that hDaxx interacts with certain 
proteins (e.g. Pax3, PML, histone deacetylases) and that the interaction subsequently 
influences Daxx-mediated transcriptional repression (Hollenbach et al., 1999, Ishov et al., 
1999, Li et al., 2000). For instance, through interaction with Pax3, Daxx repressed the 
transcriptional activity of Pax3 by up to 80% (Hollenbach et al., 1999). The potential 
effect of the interaction between Daxx and PML has been intensively studied, as described 
in previous sections (lE2.1.4, lE2.3.4) as well as in Ishov et al. (1999) and Li et al. 
(2000). In transient transfection assays, co-expression with wild type PML significantly 
reversed Daxx-mediated transcriptional repression (4-fold increase), while a PMLASUMO 
mutant lacking all three SUMO-l modification sites was less effective in reversing the 
repressor function of Daxx. These observations indicate that SUMO-l modified PML is 
required not only for localisation of Daxx to ND 1 0 but also for Daxx-mediated 
transcriptional repression. 
• A role in apoptosis 
Murine Daxx (mDaxx) was identified as a novel Fas-binding protein that showed a 
strong interaction with the Fas death domain in yeast two-hybrid screens (Yang et al., 
1997). Overexpression of mDaxx alone greatly enhanced the activation of the Jun N-
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terminal kinase (JNK.) to a level similar to that ofFas and was able to enhance Fas-induced 
apoptosis, indicating that mDaxx acts as an activator of the JNK pathway. Consistently, 
hDaxx was shown to mediate enhancement of Fas-induced apoptosis, but this effect was 
through activation of the caspase pathway instead of with JNK. (Torii et at., 1999). It was 
shown that hDaxx did not appear to interact with Fas, but showed a strong interaction with 
PML in yeast two-hybrid assays and colocalised with PML in ND 1 0 structures (lshov et 
at., 1999, Torii et 01., 1999). Intriguingly, the truncated mutant lacking the residues (625-
740) required for transcriptional repression also failed to localise to NDlO, implying that 
hDaxx possibly enhances Fas- induced apoptosis and regulates transcription of genes by a 
mechanism that requires it to be able to localise to NDI0 structures (Torii et al., 1999). A 
consistent result was shown in PML knockout mice (PML-I-) (Zhong et at., 2000). In 
PML+I+ splenocytes (particularly in B-cells), mitogen Con A enhanced the expression of 
Daxx and localisation of Daxx to ND 1 0, which is correlated with B cell apoptosis. 
However, the absence of PML (in PML -1- splenocytes) resulted in a dispersed nuclear 
pattern of Daxx and in impaired apoptosis of splenocytes upon Con A treatment. 
Similarly, activation of apoptosis only occurred in PML+I+ primary keratinocytes 
transfected with Daxx, but not in PML-I- cells whether or not they were transfected with 
Daxx. These findings indicate that interaction of PML with Daxx might be involved in a 
novel nuclear pathway for apoptosis (Zhong et al., 2000). 
lE.2.4.3 The interaction with centromere proteins 
In addition to Fas, PML, and Pax3, Pluta et at. (1998) reported that hDaxx physically 
interacted with CENP-C, an intrinsic protein of the human centromere, and further 
determined that the C-terminal 104 amino acids of hDaxx and the N-terminal 315 amino 
acids of CENP-C were required for this interaction (pluta et at., 1998). Moreover, 
immunostaining of HeLa cells with hACA (human autoimmune serum recognising CENP-
A, -B, -C) antibodies revealed that many hDaxx foci were colocalised with centromeres in 
interphase nuclei. The association of hDaxx with chromatin structures has also been 
reported by other research groups. Ishov et at. (1999) demonstrated that in the absence of 
PML (in PML-I- mouse embryo fibroblast cells), hDaxx redistributed from NDI0 to foci 
associated with condensed heterochromatin. Li et al. (2000) reported that in NT2 cells, 
expressing low levels of PML and with fewer ND 1 0 foci, a subset of hDaxx is found to 
accumulate at condensed chromatin and to be preferentially associated with centromeres 
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(more details are shown in the Results and Discussion, Chapter 4, of this thesis). These 
findings suggest that with low PML expression or in the absence of SUMO-I modified 
PML, condensed chromatin provides an alternative site for hDaxx accumulation. 
lE.3 Factors involved in the integrity ofNDlO structures 
ND 1 0 are highly dynamic structures that can be modified by a number of factors, 
including the cell cycle, cellular stress (heat shock, heavy metals, chemicals), and 
interferon treatment. These factors result in changes in size, number and cellular 
distribution of the ND 1 0 structures, or sometimes cause complete loss of the punctate 
staining pattern. In addition, the integrity of ND 10 structures, in terms of assembly and 
disassembly, is affected by several other factors including viral infection, progression of 
cell cycle and interaction with other cellular proteins. 
tE.3.t Effect of cellular stress: heat shock 
Time course experiments using various temperatures revealed that in Hep-2 cells a 
short, mild heat shock treatment (42°C, 10 min) was sufficient for induction of NDlO 
redistribution. Treatment with such a heat shock led to dispersion of ND 1 0 into hundreds 
of tiny dots, forming a microspeckled pattern (Maul et al., 1995). Whilst subsequent 
incubation at 37°C restored normal NDIO structures. The number of PML foci were 
increased significantly after lO-min heat treatment followed by a lO-min recovery at 37°C 
and the "microspeckled" pattern caused by 1 h heat treatment was restored to normal 
completely after 8 h recovery at 37°C. The effect of heat shock on Sp 1 00 was similar to 
that on PML, but microdots were smaller and less intensely stained after a 1 h heat shock. 
In contrast, the staining ofNPD55 was enhanced after heat treatment for 1 hour, suggesting 
that the effect of heat shock is not universal for all components of ND 1 0 proteins and 
might differ between cell types. 
A similar effect was observed in cells treated with CdS04 (Cd++ ions) (Maul et al., 
1995). A significant redistribution, similar to the pattern of 20-min heat shock, was 
observed after a 60-min treatment ofCdS04. 
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IE.3.2 Effect of interferon (lFN) treatment 
Immunofluorescence assays revealed that the staining of NDI0 was increased, their 
number increased and their size was more homogeneous upon treatment with IFN-P and 
IFN-y (lOOOU/ml) for 18 hours (Maul et al., 1995). However, subtle differences in the 
staining of NDIO proteins in the nucleoplasm were observed. After IFN treatment, the 
nucleoplasmic staining of PML was increased, whereas there was no change in that of 
SplOO. In contrast to PML and SplOO, the staining ofNDP55 was diminished throughout 
the nucleus as compared to untreated cells. Additionally, no significant difference of the 
effects of treatment with IFN-P or IFN-y was found. 
Analysis of promoter regions ofNDl0-associated proteins indicated that a number of 
them contain the IFN-stimulated responses element and/or IFN-y activation sites 
(Grotzinger et al., 1996, Stadler et al., 1995). To date, at least six NDIO-associated 
proteins, PML, Sp 1 00, Sp 140, Sp 11 0, ISG20 and P A28, have been found to be up-
regulated by IFN treatment (reviewed by Regad & Chelbi-Alix, 2001). 
IE.3.3 Effect of chemicals: AS103, and all-trans retinoic acid 
As described in section IE.2.1.1, the "microspeckled" distribution ofNDIO has also 
been found in APL affected cells which were characterised as resulting from the specific 
chromosomal translocation resulting in the expression of the PML-RARa. oncoprotein (de 
The et al., 1991, Goddard et al., 1991). This leukemia is caused by a differentiation block 
of myeloid precursors at the promyelocyte stage and is sensitive to therapy using all-trans 
retinoic acid (ATRA) and AS203 (reviewed by Zhang et al., 2001). 
After treatment with 1 J.1M A TRA, the PML-RARa. fusion protein in APL-derived 
NB4 cells was selectively degraded through the proteasome pathway, resulting in the 
release of wild-type PML and leading to differentiation of the transformed cells within 24 
h (Dyck et al., 1994, Muller et al., 1998b). Muller et al. reported that AS20) treatment 
induced the degradation of PML-RARa. and restoration of ND lOin NB4 cells more 
efficiently than ATRA: after 2 h AS20J (1 J.1M) treatment, the amount of PML-RARa. 
fusion protein was decreased dramatically, and it was under the detectable level after 6 h 
treatment (Muller et al., 1998b). Over the past several years, AS20 3 has been an effective 
treatment for primary and relapsed APL patients. Although the exact mechanism of action 
of AS203 on APL is not fully understood, it was proposed that a low dose of AS20) (0.1-0.5 
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J.l.Mlkglday) induces slow degradation of the oncoprotein resulting in nonnal 
differentiation and high-dose treatment (1-2 J.l.Mlkglday) induces apoptosis (Zhang et al., 
2001). 
lE.3.4 PML and its SUMO~l modified isoforms 
Ishov et 01. (1999) noted that in PML -/- MPEF (mouse primary embryonic fibroblast) 
cells, the distribution of many ND 1 O-associated proteins (Sp 1 00, Daxx, ISG20, BLM, and 
CBP) was seen as a nuclear diffuse pattern that was re-Iocated into NO 10 when wild type 
PML was later transfected into the cells, suggesting that PML is essential for the assembly 
ofNDlO. 
As mentioned, NO 1 0 structures can be restored from the microsparkled pattern 
following treatment with AS203 in APL derived NB4 cells (Muller et al., 1998b). In about 
30% of AS203 treated NB4 cells, the size of PML dots greatly enlarges after a 4 h 
treatment, which correlates with an increase in SUMO-l modified PML isofonns (Muller 
et 01., 1998b). These observations imply that post-translational modification by SUMO-l 
might be involved in NO 1 0 dynamics. 
IE.3.S Cell cycle 
Koken et 01. (1995) proposed that the average number and size of NOlO change 
during progression through the cell cycle. When cell growth was arrested at Go phase, the 
lowest number of NOW was observed (Koken et 01., 1995). As the cell progressed 
through G) phase, the number of NO 1 0 increases gradually and the highest number of 
ND} 0 is in S phase. ND} 0 are disrupted and the components are redistributed during 
mitosis and then are quickly re-fonned in G. phase (Ascoli & Maul, 1991). In M phase, 
PML is though to be the most persistent NO 1 0 protein, and can be found between 
chromosomes at metaphase and anaphase, forming large aggregations at the periphery of 
the mitotic cell in telophase (reviewed by Maul et al., 2000). More recently it has been 
found that the disruption of NO 10 that occurs during mitosis can be attributed to the 
complete loss of SUMO-} modification from both PML and Sp 1 00. In addition, a mitosis-
specific hyperphosphorylated form of PML appears (Everett et al., 1999b). Previous work 
had suggested that phosphorylation of PML might induce the loss of SUMO-l 
modification (Muller et al., 1998a). 
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lE.3.6 Effects of viral infections on NDIO 
Viral infection has been considered a factor affecting the integrity of ND 1 0 structures 
since Maul and co-workers demonstrated disruption of ND lOin the course of herpesvirus 
infection (Maul et al., 1993). In the past few years, the interaction with viruses and ND 1 0 
has been extensively studied, in particular the effects of DNA viruses: herpesviruses, 
adenoviruses, papilloma viruses and some RNA viruses: hepatitis delta viruses, 
retroviruses, and influenza viruses. A recent report from the Wilcox's group demonstrated 
that IFN co-ordinately inhibits the disruption ofNDlO and viral IE gene expression during 
HSV-l infection. The results showed that pre-treatment of cells with IFNs induced a 
specific and almost complete inhibition of expression from the IE-3 promoter, concomitant 
with enlargement and stabilisation of the NO 1 0 structures in HSV -1 infected cells (Taylor 
et al., 2000). 
lE.3.6.1 Herpesviruses 
Infection by several herpesviruses including HSV-l, HCMV, and EBV results in the 
disruption ofNDI0 (Maul et al., 1993). Further investigations have demonstrated that IE 
gene products of these viruses are required for this effect. For example, as described 
previously (sectionl0.2.2, ID.4.2), studies using a number ofHSV-l mutants revealed that 
ICPO alone is sufficient for such disruption and its RING finger region is required for this 
effect. 
As with HSV-l, HCMV (Town strain) infection has been reported to disrupt NDlO 
structures (Kelly et aJ., 1995). Subsequent studies from the Hayward's group showed that 
at early times of infection (2 hpi), two IE products; IE 1 (lE72) and IE2 (IE86), colocalised 
with PML in ND 1 O. Observations from infection and trlJnsfection assays revealed that the 
IE2 protein localised within or adjacent to NDlO continuously, whereas lEI transiently 
colocalised to and subsequently induced the redistribution of NO I 0 proteins into a nuclear 
diffuse pattern (Ahn & Hayward, 1997). These results were supported by the observations 
by Ishov et al. (1997). In addition, a potential zinc finger region of the IE 1 protein has 
been shown to be essential for ND 1 0 disruption and this process appears to be required for 
efficient viral gene expression and replication (lshov et al., 1997). 
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For y-herpesviruses, EBV encoded nuclear antigen 5 (EBNA-5) has· been 
demonstrated to associate with NDIO in EBV-infected B cells and cells of EBV-
transformed lymphoblast cell lines (LCL), although EBNA-5 does not cause the 
redistribution of ND 1 0 structures (Szekely et al., 1996). In addition, heat treatment has 
been reported to cause dissociation of EBNA-5 from NDIO structures (Szekely et al., 
1996). Most recently, BZLFI (Zta), one of the earliest viral proteins expressed, was 
reported to disrupt PML in transient transfection experiments, but only when BZLF 1 was 
highly expressed (Adamson & Kenney, 2001). Infection by another y-herpesvirus, HHV-8, 
has also been shown to involve interactions with ND 1 0 (Katano et al., 2001, Wu et al., 
200la). Wu et al. (2001) demonstrated that the HHV8 K8 protein, shares significant 
homology to the BZLFI protein of EBV and colocalised to but did not disrupt NDlO in 
both transient transfection and during viral infection experiments. The results of Katano et 
al. (2001) confirmed this observation and also defined the functional domain for K8 
protein NDlO localisation to be its leucine zipper motif. In addition, it was observed that 
PML was highly expressed in HHV-8 and also in EBV-infected cells when compared to 
non-infected B cell lines. Intriguingly, transient expression of the K8 protein with the 
leucine zipper domain facilitated the recruitment ofp53 to NDIO. Taken with the finding 
that K8 represses the transcriptional activity of p53, this implies that colocalisation of K8 
to ND 1 0 might be associated with its interaction with cellular factors. 
lE.3.6.2 Adenoviruses 
Ishov and Maul (1996) reported that the peripheries of ND 1 0 were the preferential 
sites for the early stages of transcription and replication of SV 40, adenovirus S. (AdS) and 
HSV-l. However, as with HSV-I, infection of Ad5 has been demonstrated to disrupt 
ND 10 before replication. Cells infected with adenovirus mutants with a deletion in the 
E40rf3 region retained intact ND 1 0, indicating that E40rf3 is sufficient to disrupt ND 1 0 
structures (Carvalho et al., 1995, Ishov & Maul, 1996). Moreover, a special track-like 
redistribution of ND 10 proteins was observed at 8 h after infection (Ishov & Maul, 1996). 
Immunostaining for NDIO associated proteins such as PML, SplOO, NDP55 and NDP52 
revealed that all proteins tested redistributed to the tracks before DNA replication began. 
After replication progression, only PML still remained in the tracks throughout the 
replication cycle, but other ND 1 0 proteins segregated from the tracks to replication 
domains (detected by staining for the major viral DNA binding protein). The mechanism 
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of disruption of NO 1 0 by E40rf3 remains unknown, but it has been observed that infection 
with adenovirus leads to progressive apparent phosphorylation of PML and loss of its 
SUMO-l modified isoforms in an E4orfJ-dependent manner (Leppard & Everett, 1999). 
lE.3.6.3 Hepatitis delta viruses 
The hepatitis delta virus (HDY) genome consists of a single coding region encoding 
the hepatitis delta antigen (HDAg) in two isoforms: large (L-HDAg) and small (S-HDAg) 
(Kuo et al., 1989). S-HDAg is required for HDV replication whereas L-HDAg inhibits 
viral replication. Bell et al. (2000) described that L-HDAg was located in hollow sphere-
like aggregates in the nucleus of Hep-2 cells transfected with HDV vectors at 4 days post-
transfection. Double-staining with antibodies for L-HDAg and NDIO proteins (SUMO-I, 
PML, SplOO and NDP55) revealed that approximately 55% of L-HDAg aggregates were 
often located adjacent to NOW. Furthermore, at later times, the distribution of NOlO 
constituents diverged visibly, with PML in the rims of the spheres, and others (Sp I 00, 
hDaxx and NDP55) in the centers of the spheres (Bell et al., 2000). The observation that 
relocalisation of NOlO proteins into L-HDAg spheres differs to the phenotypes previously 
observed using other DNA viruses raises new possibilities for the regulation of both viral 
replication and NO I 0 function. 
lE.3.6.4 Retroviruses 
Infection with two retroviruses, human T cell leukemia virus (HTL V) and murine 
mammary tumour virus (MMTV), have been demonstrated to be associated with ND 1 0 
dynamics or proteins (Desbois et al., 1996, Marchetti et 01., 1995). During MMTV 
infection, integration of the viral genome into the Int-6 gene locus (one of the proteins 
transiently associated with NO 1 0) resulted in disruption of the gene and generation of a 
truncated form of the Int-6 protein (Marchetti et 01., 1995). HTL V interacts with NO 10 by 
a different mechanism to MMTV, but it targets the same ND 1 0 protein, Int-6. It has been 
found that the Tax protein of HTL V, which plays an important part in provoking 
transformation of infected cells, directly bound to Int-6 and diverted this protein into the 
cytoplasm from the nucleus (Desbois et al., 1996). 
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lE.3.6.5 Arenavirus 
It has been shown that during infection by the arenavirus lymphocytic 
choriomeningitis virus (LCMV), the viral Z protein interacted with PML resulting in the 
redistribution of PML into the cytoplasm (Borden et al., 1998). Studies using a number of 
PML mutant constructs discovered that the Z protein, which consists of a RING finger 
domain, bound to the N-tenninal region of PML. More recently, Djavani et a/. reported 
that stable expression of PML in fibroblasts diminished LCMV virus replication, resulting 
from a decrease in transcription and translation levels of viral genes (Djavani et al., 2001). 
Details of this aspect are described in section lE.5 and reviewed by Regad & Chelbi-Alix 
(2001). 
IE.4 Various NDIO patterns in certain cell types 
Little is known about ND lOin cells from species other than humans since most ND 1 0 
studies have been conducted using antibodies recognising only human forms of the ND 1 0 
proteins. However, it has been found that the presence or distribution of ND 1 0 proteins 
can vary in a cell type-specific manner. A set of immunofluorescence and immuno-
precipitation experiments using monoclonal antibodies 1150 and 138, which recognise 
SplOO and NDP55 respectively, were employed to investigate the distribution ofNDlO in 
various cell types including nonnal and neoplastic human tissues (Cho et al., 1998). The 
results showed that NDlO size was increased in some sex-hormone dependent neoplastic 
cell types including breast ducal epithelium, endometrium, myometrial cells and testicular 
Leydig cells, compared with other cell types tested. Besides this, tumour cells with 
estrogen receptors have been found to have large NDlO. Moreover, the number and size of 
ND 1 0 were strongly increased in malignant tumours compared to benign tumours. These 
observations indicate that the distribution patterns of ND 10 are closely associated with 
external factors such as hormonal stimulation and oncogenesis. 
A number of studies revealed that some peripheral lymphoid tissues such as the 
germinal centre of spleen, lymph nodes and Peyer's patches lacked NDlO (Daniel et a/., 
1993, Flenghi et a/., 1995, Gambacorta et a/., 1996, Lam et al., 1995). In certain cells, loss 
of some but not all NDIO proteins was observed. For instances, no SplOO was detected in 
Sertoli cells, whereas PML was expressed at a high level, and NDP55 was missing from 
hepatocytes whereas PML and SplOO were detectable (reviewed by Negorev & Maul, 
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2001). Another example is that NT2 cells, an embryocarcinoma cell line, have no 
detectable expression of Sp I 00 and although other NO I 0 components are present, the 
expression pattern was different from other fibroblast cell lines tested (Hsu & Everett, 
2001, Ishov et al., 1999, Negorev et al., 2001). As regards this last aspect, more details 
will be presented in this thesis. 
IE.5 Potential roles ofNDIO on viral infections 
As described in section lE.3.2, the promoters of two major NOlO components, Spl00 
and PML, contains both ISRE and GAS elements (Grotzinger et aI., 1996); (Stadler et al., 
1995), which mediate primary transcriptional induction in response to IFN-alf3 and IPN-y, 
respectively (Darnell et al., 1994). It has been noted that SplOO and PML expression, both 
at the RNA and protein level, were strongly enhanced by IFNs (Chelbi-Alix et al., 1995, 
Grotzinger et al., 1996, Stadler et al., 1995). Together with the findings that viral infection 
causes NOlO disruption or reorganisation, this strongly implies that NOlO might playa 
role in host antiviral defence. 
Chelbi-Alix et al. first demonstrated that the viral yields of VSV and influenza A 
viruses in CHO (Chinese hamster ovary) cells stably expressing PML, were decreased by 
up to 125- and 100-fo1d respectively, compared to control eHO cells (Chelbi-Alix et al., 
1998). Subsequent studies revealed that the function of PML in inhibition of viral 
replication was through interference with viral mRNA and protein syntheses and in an 
MOl dependent manner. However, resistance to viral infection is not a global effect shown 
by all NOlO proteins, since stable expression of SplOO in CHO cells appeared to have no 
effect on the multiplication ofVSV and influenza virus. 
Recent work by Ahn and Hayward (2000) showed that disruption of NOlO correlates 
with efficient viral gene expression and replication in HCMV infection. Their previous 
reports initially demonstrate the association of HCMV infection with NO 10 structures. At 
the early stages of HCMV infection, the major IE proteins IE 1 and IE2 initially targeted to 
NO 1 O. Within 3 hours, both IE 1 and PML are redistributed into a nuclear diffuse pattern 
(Ahn & Hayward, 1997) whereas IE2 was stably remained adjacent to NOlO but later 
associated with viral DNA replication compartments (Ahn et al., 1999). Later studies 
found that disruption of NOlO by HCMV was significantly delayed in U373-PML cells 
that express high levels of PML(560) (isoform VI) compared to the control U373 cell line 
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(Ahn & Hayward, 2000). Additionally, at 48 h after HCMV (Towne) infection, the 
formation of replication compartments (RC) in U373-PML cells was 5-fold lower than that 
in U373 cells. Notably, the delay of RC formation in cells expressing high levels of PML 
that had been infected with lEI deletion mutants was lO-fold lower than in the control 
cells. Furthermore, western blot analysis revealed that in U373-PML cells, expression of 
E (Pol) and L (Pp28) genes was repressed by 5- and 22-fold respectively, compared to that 
in U373 cells. These findings imply that at very early times after infection, disruption of 
ND 1 0 resulting from interaction of IE 1 with PML might play an important part for the 
progression of HCMV infection. 
Recently, PML has been reported to mediate the interferon-induced antiviral state 
against two RNA viruses (Djavani et al., 2001, Regad et al., 2001). Djavani et al (2001) 
described that 48 hpi with LCMV at which time the highest virus yield is found, 4- to 5-
fold decreases in PML +1+ MEF cells expressing PML compared to PML-/- cells. In 
addition, the decrease of viral replication in PML expressing cells was exacerbated by IFN-
Y pre-treatment, up-regUlating PML expression, suggesting that PML contributes to the 
antiviral effect of IFN. Consistent with this, Regad et al. (2001) proposed that infection 
with HFV (a retrovirus) was diminished in U373 MG cells stably expressing PML, but not 
that expressing Mx 1 or MxA proteins. Further investigations found that IFN treatment 
inhibits HFV infection only in wild type cells but not in PML-I- cells. These two 
individual studies provide evidence that PML might play an important part in mediating an 
IFN-induced antiviral state. 
As described in this section, during HSV -1 infection ICPO induces disruption of 
NDI0. However the effect of redistribution of NDlO proteins on the progress of HSV-I 
infection is poorly understood. Studies investigating the effect of over-expression of 
NDlO proteins on HSV-l infection have been carried out and are included in Chapter 3 of 
this thesis. 
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The aims of this study 
As illustrated in the Introduction, several lines of evidence led me to investigate the 
role of ND 10 in viral infection. Firstly, the expression of several ND 10 proteins is up-
regulated by IFNs. Secondly, in the course of viral infection some DNA viruses 
preferentially deposit their parental genomes close to NOlO structures. Thirdly, many viral 
IE gene products colocalise with NO 1 0 proteins at early times of infection and 
subsequently trigger the degradation of these proteins resulting in the disruption of NO 1 0 
structures. Finally, it has been demonstrated that the formation of HSV-I replication 
compartments is correlated with the disruption of NOlO structures. The lPN-inducible 
character, the spatial relationships, and the effect of viral proteins on NO 1 0 during 
infection indicate that these events might not be a simple accident, but imply a role for 
NO lOin an antiviral effect. 
The aim of this study is to investigate the potential role of ND 1 0 proteins in HSV-l 
infection in different cultured fibroblast cells. To address this question, I initially 
compared the infectivity of HSV -1 under various conditions such as stress or transient 
transfections by which the integrity of NO 1 0 was disrupted or the expression of NO I 0 
proteins was induced, respectively (Chapter 3 and Chapter 5). Secondly, I characterised a 
human neuronal committed cell line (NT2) that contains abnormal NDIO expression 
pattern and further investigated its susceptibility to HSV-I infection (Chapter 4). Finally, a 
series of mutant constructs of SUMO-I, which had a potential antiviral effect (based on the 
observations of the earlier work in this thesis), were made to study the effect of this NO I 0 
component on viral infection in the NT2 cell line (Chapter 5). 
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2.1 Materials 
2.1.1 Plasmids 
Chapter 2 Materials and Methods 
• The following plasmids were provided by the acknowledged investigators: 
• pPML (F) (also known as pPML-ER(F)/pTL2) (Kastner et ai., 1992) expresses PML 
isoform IV (633aa) with a C-terminal tag derived from the estrogen receptor. It was a 
gift from Pierre Chambon. 
• pcDNA3/PML-RH (Kamitani et ai., 1998) expresses PML coding sequences (isoform 
undefined by originators) as a fusion protein with a polyhistidine tag at the C-terminus 
under the control of the HCMV promoter. It was generated by inserting a 2.03-kb full-
length PML cDNA into pcDNA31RH-C between the Hind III and Kpn I sites. It was 
kindly proved by Tetsu Kamitani (University of Texas). 
• pcDNA3/UbcH9 was a gift from Dr. Joanna Desterro. The cDNA of UbcH9 was cloned 
with a C-terminal SV5 tag into pcDNA3 using its BamH I and Xho I sites (Desterro ef 
ai., 1997). 
• pcDNA3-HPl was kindly provided by Dr. Alexander Ishov. The HPI was expressed 
as a fusion protein with N-terminal FLAG tag (unpublished). 
• pEGFP-NLS-hDaxx was a gift from Dr. Alexander Ishov. The hDaxx protein was 
expressed as a fusion protein with N-terminal EGFP and the nuclear localisation signal 
from SV 40 large T-antigen (Ishov et al., 1999). 
• pCIQEUb52 (Everett et ai., 1997) expresses the polyhistidine tagged Ub52 ubiquitin 
precursor gene under the control of the HCMV promoter. 
• pClmycSp 100 expresses Sp 1 00 (isoform A) with an N-terminal myc tag driven by the 
HCMV promoter. 
• pCIPIC-l (Everett et ai., 1998) was used to express SUMO-l and contains the SUMO-l 
coding region with an N-terminal c-myc epitope tag sequence inserted downstream of 
the HCMV promoter in vector pCIneo. 
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• pSS80 contains the CAT gene under the control of the ICP6 promoter (Everett et al., 
1995). 
• pCI-rtag-cICPO: This plasmid expresses ICPO from its cDNA with an N-terminal tag 
derived from HSV-l UL30 protein that is recognised by rabbit serum rI13. It is the 
cDNA version of a related plasmid described by Parkinson and Everett, 200 I. 
• pl75 contains the ICP4-coding region under the control of the SV40 early promoter 
(Everett, 1988). 
• pTK.I contains the HSV-I BamHI P fragment including the HSV-l TK gene (Wilkie et 
al., 1979). 
2.1.2 Bacteria (E. coli strains): 
Escherichia coli (E. coli) strain DH5a (F'/endAI hsdRl7 (rk-mk+) supE44 thi} recAI 
gyrA (NaIj relAl /:i(lacZYA-argF) UI69 (cj)80dlac/:i(lacZ) MIS) was used for propagation 
and maintenance of plasmid DNA. 
2.1.3 Bacterial culture media 
DHSa bacteria were grown in Lauria-Bertani medium (LB) (lOg NaCI, 109 
Bactopeptone, Sg yeast extract in IL water, pH7.5). Agar plates were made with 1.5% 
(w/v) agar in LB. Where necessary, media and agar plates were supplemented with 
antibiotics: 100 J.l.g/ml ampicillin for bacteria harbouring plasmids containing the ampicillin 
resistance gene and 30 J.l.glml kanamycin for EGFP plasmids. 
2.1.4 Cells and tissue culture media 
All cell culture media were obtained from Life Technologies (Gibco BRL). 
• Hep2 cells (obtained from the cytology department of the Institute of Virology), an 
epithelial cell line, were grown in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% foetal calf serum (FCS), 100 unitslml penicillin and 100 J.l.g/ml 
streptomycin. 
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• Baby hamster kidney-21 el3 (BHK-21 e13) fibroblast cells were derived from baby 
hamster kidney and were cultured in Glasgow-modified Eagle's medium (GMEM) 
supplemented with 10% (v/v) tryptose phosphate broth, 10% newborn calf serum and 
100 units/ml penicillin and 100 J.1g/ml streptomycin. 
• Vero cells, derived from African green monkey kidney, were grown in DMEM 
supplemented with 10% FCS, 100 units/ml penicillin and 100 J.1g1ml streptomycin. 
• Human foetal lung (HFL) diploid fibroblast cells (Imperial Laboratories) and 
osteosarcoma U20S cells were propagated in DMEM supplemented with 5% FCS, 5% 
NBCS, 1 % non-essential amino acids, 100 units/ml penicillin and 100 J.1g1ml 
streptomycin. 
• The Ntera 21D1 (NT2) cell line was obtained from Stratagene and was grown in 
DMEM with nutrient mixture F12, supplemented with 4 mM glutamine, 10% FCS, 100 
units/ml penicillin and 100 J.1g/ml streptomycin. 
2.1.5 Viruses 
• HSV-l strain 17+, the wild type virus (Brown et al., 1973), was the parental strain used 
for the construction of all mutant derivatives. 
• Virus FXE has an in-frame deletion ofICPO residues 106-150, which removes the zinc 
binding RING finger domain of the protein (Everett, 1989). 
• Viruses vEG-llOwt and vEG-FXE express derivatives of wild type and FXE mutant 
ICPO with EGFP linked to their N-terminal ends (Lomonte & Everett, 1999). 
• d11403 is a ICPO null mutant virus, from which the majority of ICPO coding region 
(from residue 106 onwards) has been deleted (Stow & Stow, 1986). 
• Virus Ml contains double amino acid substitutions (R623L, K624I) in the USP7 
binding region of ICPO, such that the mutant MI ICPO protein does not bind to USP7 
(Everett et al., 1999c). 
• Virus tsK has a single amino acid substitution that inactivates the ICP4 transactivator 
protein at 38.S°C. As a result, there is a failure to activate early and late gene expression 
and high level expression of the other IE proteins at the nonpermissive temperature of 
38.SoC (Preston, 1979). 
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• Virus in1330 carries an HCMV lac Z gene cassette inserted into UL43, the ICP4 t8K 
mutation, and a deletion in the ICPO coding region inducing a frameshift in codon 105 
(Homer et al., 1999). 
2.1.6 Antisera and monoclonal antibodies (Table 2.1) 
2.1.7 Oligonucleotides 
Oligonucleotides used in PCR and generation of the c-myc tag were supplied by 
MWG. They were used without further purification. 
2.1.8 Enzymes 
Restriction enzymes were purchased from Roche Biochemicals and New England 
BioLabs. T4 DNA ligase and E. coli DNA polymerase I Klenow fragment were purchased 
from Life Technologies. Lysozyme and RNase A were purchased from Sigma. T4 
polynucleotide kinase, calf intestinal phosphatase, proteinase K, and Taq DNA polymerase 
were obtained from Roche Biochemicals. 
2.1.9 Sequencing 
All sequences in this thesis were kindly carried out by Mrs. L. Taylor at the Institute 
of Virology and performed on an ABI Prism 377 DNA sequencer. 
2.1.10 Phosphor-imaging 
The results of CAT assays were analysed on a BioRad Molecularlmager FX machine 
using a Biorad Pentium computer with QuantityOne Phospho and Multi-imager software 
(4.0.3). Instruction was generously provided by Mr. Colin Loney. 
95 
..c 
0-. 
Table 2.1 Antibodies used 
Prl"",,,, antibodies Dilution used Reference 
Antibodv Antibodv a2ainst Tvoe IFA W. blot 
11060 ICPO mouse 1:10,000 1:10,000 (Everett et al., 1993b) 
10176 ICP4 mouse 1:5,000 1:5,000 (Everett et al., 1993aJ 
rl90 ICPO rabbit 1:200 NO (Everett et al., 1998) 
r76 UL39 rabbit NO 1:10,000 (Conner et af. 1995) 
r515 UL29 rabbit 1:200 NO (Marsden et al., 1996) 
ZIFll UIA2 mouse NO 1:5,000 (Schenk el aI., 1988) 
rI2714112 6-galactosidase rabbit 1:1,000 NO NP 
SpGH Spl00 rabbit 1:1,000 NO (Stemsdorf et al., 1995) 
5EI0 PML mouse 1:20 NO (Stuurman et al., 1992) 
r8 PML rabbit 1:1000 NO OBod_~etaf., 1996) 
r554 CENP-C rabbit 1:300 NO . (Saitoh el al., 1992) 
r1866 hDaxx rabbit 1:2,000 NO (pluta el al., 199tn 
ACA-GS centromeres human 1:20LOOO NO (Earnshaw, 1988) 
9EI0 c-myc mouse 1:1,000 NO 
A14 c-myc rabbit 1:1,000 NO 
F3 Ftag mouse 1:1,000 NO (Ali el al., 199:,rr 
MRGS-His MRGS-His mouse 1:1,000 NO 
pp65 pp65(HCMV) mouse 1:1,000 NO 
SV5 SV5-P-K mouse 1:500 NO (Dunn et al., 1999) 
IFA W. blot 
1:100 NO 
1:100 NO 
Anti Mouse 1:5,000 NO Amersham 
Anti Rabbit Cy3 Con· 1:5,000 NO Amersham 
Anti Rabbit Cy5 Con· 1:200 NO Amersham 
Anti Human TRITC Con· 1:100 NO Si 
Anti Mouse HRP Con· ate NO 1:1,000 Si 
Anti Rabbit HRP Conjugate NO 1:5~000 _Sigma 
Abbreviations: NO, not done; NP, not published; IF A, immunofluorescence assay; W. Blot, western blot. 
Source 
R. D. Everett,MRC Virology Unit, Glas_gow 
R. D. Everett, MRC Virology Unit, GlasAow 
R. D. Everett, MRC Virology Unit, Glas_gow 
H. Marsden, MRC Virolo~ Unit, GlasAow 
H. Marsden. MRC Virolo~ Unit, Glasgow 
H. Marsden, MRC Virolo~ Unit, Glasgow 
H. Marsden. MRC Virology Unit, GlasgOW 
T. Stemsdorf, University of Hamburg 
Roel van Oriel, University of Amsterdam 
P. Freemont, Imperial Cancer Research Fund 
w. Earnshaw, University of Edinburgh 
A. Pluta, University ofMaIYland 
W. Earnshaw University of Edinburgh 
Santa Cruz Biotechnology 
Santa Cruz Biotechnology 
Chambon, (IGBMC), College de France, France 
Qiagen 
Capricorn Products Inc. 
R. E. Randall, UIli"y~ity_ of St. Andrews 
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2.1.11 Common solutions 
Recipes of general solutions have been listed below and the details of all other 
solutions have been included either in the text or at the end of the relevant section. 
DNA gel solutions: 
Blue juice 
(lOx Loading buffer) 
20x TBE 
SOx TAE 
lxTE 
STET 
Cell culture solutions: 
PBS(A) 
Versene 
Trypsin 
Water 
1 x TBE, 1 % SDS, SO% glycerol, 
bromophenol blue 
2.S M Tris, 0.8 M boric acid, 54 mM EDTA (PH 8.0) 
0.2 M Tris, 50 mM EDT A, pH to 7.6 with acetic acid 
10 mM Tris-HCI, 1 mM EDT A (PH 8) 
8% sucrose, 5% Triton-XlOO, 50 mM EDTA, 50 mM 
Tris-HCI (PH 8) 
170 mM NaCI, 3.4 mM KCI, 10 mM Na2HP04, 1.8 
mM KH2P04, pH 7.2 
0.6 mM EDT A in PBS(A), 0.02% phenol red 
0.25% (w/v) trypsin in Tris-saline containing phenol 
red, adjusted to pH 7.5 with NaHC03 
Sterile deionised water obtained from a "Milli-Ro 60 
plus" deioniser (Millipore, USA) and sterilised by 
autoclaving. 
Solutions for immunofluorescence: 
Fix solution 2% (w/v) sucrose, 5% (v/v) formaldehyde (37.5%) in 
PBS (A) 
Permeabilisation solution 10% (w/v) sucrose, 0.5% NP40 in PBS (A) 
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Cell lysis buffer 
(total DNA extraction) 
20x SSC 
denaturing solution 
Neutralising solution 
Prehybridisation buffer 
Wash solution 
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0.6% SDS, 10 mM EDTA, 10 mM Tris-HCI (PH 7.4), 
0.5 mg/ml Proteinase K 
0.3 M Na3Citrate, 3 M NaCl 
0.5 M NaOH, 1.5 M NaCI 
0.5 M Tris-HCI (PH 7.2), 1.5 M NaCI, 1 rnM EDTA 
5x SSC, 0.5% SOS, 0.1 % (w/v) Ficol (type 400), 0.1 % 
(w/v) polyvinylpyrrolidone, 0.1% (w/v) bovine serum 
albumin, salmon sperm DNA (20 ~glml) 
2x SSC, 0.1 % SDS 
Solutions for SDS-polyacrylamide gel electrophoresis: 
3x boiling mixture 6% SOS, 30% glycerol, 30% SGB, 0.3% bromophenol 
(protein loading buffer) blue, 2 M p-mercaptoethanol 
SGB (stacking gel buffer) 0.5 M Tris-HCI, 0.4% SDS, pH 6.7 
RGB(resolving gel buffer) 1.5 M Tris-HCI, 0.4% SDS, pH 8.9 
Running buffer 0.05 M Tris, 0.05 M glycine, 0.1 % SDS 
Towbin (blotting buffer) 25 mM Tris base, 192 rnM glycine, 20% (v/v) 
Stripping buffer 
PBS-T 
CAT assays: 
TNE buffer 
TLC running buffer 
methanol 
100 rnM p-mercaptoethanol, 2% SDS, 62.5 mM Tris-
HCl,pH6.7 
PBS(A), 0.2% TWEEN-20 
50 mM Tris-HCl, 1 mM BOTA, 0.15 M NaCI, 
adjusted to pH 7.2 
95% Chloroform, 5% Methanol 
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2.1.12 Chemicals and reagents 
All chemicals and reagents were purchased from BDH Chemicals UK or Sigma 
Chemical Company, unless otherwise stated below or in the relevant sections: 
compound Supplier 
30% acrylamide (37.5:1) National Diagnostics 
agar Difco 
ampicillin Beecham Research Laboratories Ltd 
APS (ammonium persulphate ) Bio-Rad 
bactotryptone Difco 
boric acid Prolabo 
butanol Prolabo 
chlorofonn Prolabo 
Citifluor Citifluor Ltd 
coomassie brilliant blue Bio-Rad 
caesium chloride Melford Laboratories Ltd 
dNTPs Phannacia 
DMSO (dimethyl sulphoxide) Koch-Light Laboratory Ltd 
dried skimmed milk Marvel 
Ethanol (ultra pure) Prolabo 
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glacial acetic acid Prolabo 
Glycerol Prolabo 
hydrochloric acid Prolabo 
isopropanol Prolabo 
Methanol Prolabo 
Nitro-cellulose membranes Hybond 
Rainbow markersTM Amersham Life Science 
TEMED (N,N,N',N'-
tetramethylethylenediamine) 
Bio-Rad 
TLC plates (polygram SIL G) Machery-Nagel 
yeast extract Difco 
2.1.13 Radiochemicals 
Compound Specific activity (concentration) 
[a,32p] dCTP 3000 Ci/mmol (10 mCi/ml) 
[C I4] chloramphenicol 58.5 mCi/mmol (0.1 mCilml) 
2.1.14 Autoclaving and glassware sterilisation 
Supplier 
Amersham 
Amersham 
Equipment and solutions were sterilised by autoclaving at 15 psi for 20 min by the 
staff in the wash room, Institute of Virology, Glasgow. Glassware was sterilised by baking 
in an oven at 180°C for at least 12 h. Heat labile solutions were sterilised by filtration 
through a Whatman syringe filter (0.2 f.lm pore size) into a sterile tube. 
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2.2 METHODS 
2.2.1 Nucleic acid manipulation 
2.2.1A Restriction en1J1me digestion of DNA 
Restriction enzyme digestion of DNA was carried out according to the manufacturer's 
instructions for the relevant enzyme. Usually, 0.5 J.1g DNA was digested for diagnostic 
analysis and 5-20 J.1g for isolation of specific restriction fragments. 
2.2.1B PhenoVChloroform extraction and alcohol precipitation 
When the enzyme buffers were incompatible for double enzyme digestions or further 
enzyme reactions, the DNA was purified by a method involving several stages. The first 
stage was the heat inactivation of enzymes for 10 min at 65 0 C. A Leder phenol (phenol: 
chloroform: isoamyl alcohol = 25:24:1) extraction was performed on the sample. An equal 
volume of TE-saturated Leder phenol was added to the sample and mixed by inversion, 
followed by centrifugation at 13,000 rpm for 5 min at room temperature CRT). The upper 
aqueous phase containing the DNA was transferred to a fresh tube and precipitated using 
an ethanol precipitation method. This involved the addition of 2.5 volumes of absolute 
ethanol and 1/1Oth the sample volume of 3 M NaOAC (PH 5.2) to the sample, which was 
then left at _20 0 C for 30 min. The DNA was pelleted by centrifugation at 13,000 rpm for 
10 min at RT and the DNA pellets were washed with 70% ethanol and resuspended in 
water before use or storage at _20 0 C. 
2.2.1C Production o/blunted ends on DNA fragments 
Fragments generated by enzymes, which produce 5' overhangs sometimes required 
modification (i.e. "blunt ending") to enable ligation. DNA was blunt-ended by incubation 
of the digestion mixture with dNTPs (at 50 J.1M per dNTP) and 2 units of DNA polymerase 
I large Klenow fragment for 30 min at 37°C. 
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2.2.1D Dephosphorylation ofS' ends of DNA (Phosphate removal/rom 5' ends) 
The removal of phosphate residues at the 5' ends of vector fragments with 
complementary ends produced by digestion with a single restriction enzyme was performed 
to prevent re-circularisation of the vector fragment upon ligation. This was achieved with 
the incubation of the digestion mixture with 1 unit of calf intestinal alkaline phosphatase 
(CIP) in the appropriate buffer for 20 - 30 min at 37 0 C. 
2.2.1E Electrophoretic separation and purification of DNA fragments 
DNA fragments produced by restriction enzyme digestion or PCR were resolved by 
agarose gel electrophoresis. Horizontal slab gels approximately 0.5 cm thick were utilised 
and samples were loaded following addition of the relevant amount of agarose gel loading 
buffer. Appropriate size markers were always run on the gels. Agarose gels of between 
0.7% and 1.5%, depending on the size of the fragments to be analysed, were made up in Ix 
TAE and run at 12 Vlcm in Ix TAB buffer. Following electrophoresis, the gels were 
stained in 1 ~g1ml EtBr (ethidium bromide) solution followed by rinsing the gel three times 
with water. DNA was visualised under V.V. light (normally short wave, but long wave 
was used for preparative gels). Photography was carried out using The Imager 
(Appligene). 
2.2.1 F Preparation of annealed oligonucleotide DNA fragments by polyacrylamide gel 
electrophoresis (PAGE) 
The oligonucleotide pellet supplied by MWG was resuspended in water at a 
coricentration of 100 pmoV~l. The oligonucleotide DNA fragments (O.5~g) were mixed 
with O.1M NaC) in a total volume of 50 ",I and denatured at 90°C. The heat- denatured 
DNA fragments were then annealed at room temperature and purified using PAGE when it 
was cooled to 30°C. 8% vertical non-denaturing polyacrylamide (acrylamide: N,N'-
methylene-bisacrylamide 19:1) gels containing Ix TBE were used to resolve DNA 
fragments of between 50-200 bp. Polymerisation was initiated by adding 0.01 volumes 
10% APS and 0.001 volumes TEMED. Samples were mixed with a gel loading buffer 
containing glycerol, bromophenol blue and xylene cyanol ("blue juice") were loaded on the 
gels in a kit manufactured in-house and run in Ix TBE running buffer at up to 16 V/cm. 
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DNA fragments were visualised using the EtBr staining method described in Section 
(2.2. IE) 
2.2.2 Isolation of DNA fragments from agarose gels 
Agarose blocks containing appropriate DNA fragments were excised from gels under 
long-wave U. V. using a U. V. Products Inc. transilluminator and the DNA recovered using 
a commercial kit, GENECLEANII (BIOI01) Inc., La Jolla, CA. The kit contains a silica 
matrix, which binds DNA in the presence of high concentrations of sodium iodide 
(Vogel stein & Gillespie, 1979). 
The gel slice was weighed to estimate its volume and cut into small pieces to facilitate 
gel dissolution in 3 volumes of NaI solution. This sample was incubated at 55 0 C for 5 
min, or until the gel slices were dissolved. The silica matrix was then added (5 J.lI for up to 
5 Ilg DNA) and the mixture vortexed and left on ice for 5-10 min. Following a 10 sec full-
speed (13,000 rpm) centrifugation, the silica matrix pellet was washed twice in 700 III 
'NEW' wash. The DNA was eluted into water by mixing the washed pellet with 20 III 
water and incubating the sample at 55 0 C for 5 min. The matrix was pelleted and the 
supernatant containing the DNA transferred to a fresh tube and stored at _20 0 C. 
2.2.3 Ligation of DNA fragments 
Before ligation, extraction of linearised DNA from a previous enzyme reaction was 
done by using the Leder phenol method followed by alcohol precipitation described in 
section (2.2.18). 
Ligation of appropriately ended insert and vector DNA fragments was done by 
incubation ofa 3:1 respective ratio ofinsertlvector DNA in a reaction volume of20 J.ll with 
Ix ligation buffer and 1 unit ofT4 DNA ligase at RT overnight. 
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2.2.4 Transformation of E. coli 
1.1.4A Preparation offrozen transformation-competent bacterial cells 
Frozen transfonnation-competent E. coli DH5a. cells were prepared using the calcium 
chloride method. A fresh single colony from a LB plate was inoculated into 5 ml of LB 
broth and grown at 37°C overnight. The next day, 1 ml of the overnight bacteria culture 
was added to 100 ml fresh LB broth and cultured at 37°C to an optical density (00) 550 of 
0.3 - 0.5. Cells were chilled on ice for 15 min, pelleted by centrifugation at 3000 rpm for 
10 min at 4°C in a Sorvall GS3 rotor, drained, and resuspended by pipetting up and down 
in 10 ml of 0.1 M MgCh. The cells were then washed in 10 ml of 0.1 M CaCh in the same 
way and incubated on ice for 45 min. The cells were re-pelleted, drained, resuspended in 5 
ml of the competent cell storage buffer (20% Glycerol, 50 mM CaCh, 0.1 M Na salt 
MOPS) and then the competent cells used immediately for plasmid transfonnation or flash 
frozen in 100 III aliquots using a dry-ice/ethanol bath and stored at -70°C. 
1.2.4B Transformation of competent cells 
Frozen competent cells were thawed slowly on ice. A half volume (10 J-ll) of ligation 
mixture (for plasmid DNA subcloning) or 10 ng of intact plasmid (for DNA amplification) 
was added to 100 J-li of competent cells, gently mixed, and incubated on ice for 30 min. 
The cells were heat shocked at 42°C for 90 sec, chilled on ice for 1 min, and 400 J-li of LB 
broth without any antibiotics added, before incubation at 37°C for 1.5 h with agitation. 100 
j..ll of the culture was plated onto pre-dried nutrient agar plates, supplemented with 
appropriate antibiotics, for example 100 ug/ml ampicillin for selection for ampicillin 
resistant colonies. Plates were incubated inverted at 37°C overnight. 
2.2.5 Preparation of plasmid DNA 
1.2.5A Small scale crude plasmid preparation 
The boiling method was used to produce plasmid DNA for diagnostic purposes. A 
single fresh colony was inoculated into 3 ml LB broth with appropriate antibiotics (for 
example 50 Ilg/ml ampicillin) and cultured in a 37°C incubator with shaking for 5 h. The 
bacterial culture (1.5 ml) was pelleted using a bench top centrifuge (Micro Centaur, 
SANYO) at full speed for 2 min, the supernatant was discarded and the pellet was 
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resuspended in 200 IJI of STET buffer. A 5 IJI aliquot of a lysozyme solution (10 mg/ml) 
was added to the bacterial suspension, which was then transferred to a boiling water bath 
for 50 sec, followed by full-speed centrifugation for 10 min. The supernatant was 
transferred into a new eppendorf tube and precipitated with 0.9 volumes of iso-propanol 
and centrifuged for another 10 min. The plasmid pellet (containing RNA) was dissolved in 
20 IJI of either Ix TE buffer or water and 4 IJI of the DNA was analysed by restriction 
enzyme digestion. 
2.2.SB Large scale plasmid preparation 
E.coli containing the desired plasmids were streaked from an older culture onto a LB 
agar plate containing the appropriate antibiotics and incubated at 37°C overnight. Plasmid 
DNA was prepared from bacteria according to the 'maxi-boiling' method (Holmes & 
Quigley, 1981) and the supercoiled DNA was purified on a caesium chloride gradient. A 
single colony was picked from a fresh plate and used to inoculate 350 ml LB broth 
containing antibiotics as appropriate, which was incubated in a shaking incubator at 37°C 
overnight. Bacterial cultures were centrifuged at 5,000 rpm for 10 min at RT in a Sorvall 
GS3 rotor, then the pellets were resuspended in 20 ml STET and 2.5 ml of a freshly 
prepared 10 mg/ml lysozyme solution was added to the bacteria culture for I minute. The 
mixture was brought to the boil over a bunsen flame and placed in a boiling water bath for 
45 sec, before pelleting the cell debris by centrifugation in a Sorvall SS34 rotor at 18,000 
rpm for 50 min at RT. Nucleic acids were precipitated from the supernatant by the addition 
of 0.9 volumes of isopropanol, and pelleted by centrifugation in a Beckman GPR 
centrifuge at 3,000 rpm for 5 min at RT. The pellet was resuspended in 5.5 ml Ix TE (to 
give a volume of around 6.3 ml), then 7 g caesium chloride and 0.2 mIlO mg/ml EtBr were 
added. The samples were incubated on ice for 20 min prior to centrifugation at 3,000 rpm 
for 10 min at 4°C. The supernatant was transferred to a Dupont 03945 crimp-seal 
centrifuge tube using a syringe and centrifuged at 45,000 rpm for 16-18 hr, at 15°C in a 
Sorvall TV865 vertical rotor. The lower fluorescing DNA band containing supercoiled 
plasmid DNA was removed using a syringe, taking care to avoid contamination with 
bacterial chromosomal DNA from the upper band. The EtBr was removed from the 
plasmid solution by 2-3 extractions with butanol saturated with Ix TE, and the caesium 
chloride was removed by dialysing against Ix TE at RT for 2 hr. Following this, the 
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solution was treated with 100 J.tg/ml RNase A at 65°C for 1 hr, and 100 J.tglml proteinase K 
plus 0.1 % SDS at 37°C for another I hr. The plasmid DNA was cleaned by phenol 
followed by chloroform extraction, and concentrated by ethanol precipitation at -20°C 
overnight. The DNA was pelleted by centrifugation at 3,000 rpm for 15min at 4°C, 
resuspended in 400J.lI IX TE transferred in a new eppendorf tube and ethanol precipitated 
again. The final pellet was washed in 70% ethanol and resuspended in an appropriate 
volume of lxTE before storage at 4°C. The plasmid DNA concentration was determined 
by measuring the absorbance at 260 run on a Beckman DU-62 spectrophotometer, 
assuming 10D A260 = SO J..lglml. 
2.2.6 Amplification of DNA by polymerase chain reaction (peR) 
2.2.6A Oligonucleotide primers 
The oligonucleotide primers were supplied by MWG, and prepared for use by 
dissolving in distilled H20. 
2.2.6B peR 
peR was used to generate wild type and mutant forms of the SUMO-l cDNA. PCR 
reactions were performed in sterile 0.5 ml Eppendorftubes using a tbermocycler (Techne) 
and Taq DNA polymerase (Roche). 
Two units of Taq DNA polymerase were added to I ng of Sal I - Not I fragment from 
plasmid DNA (pCIPICl) in 100 J..lI of Ix Taq PCR buffer (supplied with the enzyme), 
containing 0.2 mM dNTPs and 2.5 mg/ml oligonucleotide primers and the reaction was 
overlaid with a drop of molecular biology grade mineral oil (Sigma). DNA was denatured 
at 95°C for 5 min and amplified by 25 cycles of denaturation at 95°C for 1 min, annealing 
for 3 min at the lowest calculated annealing temperature for the primers used, where: 
Annealing temperature = n (G+C) x 3 + n(A+T) x 2 °C 
and elongation at 72°C for 3 min, and then finally elongated for 5 min at noc. The 
Amplified DNA was clarified by Leder phenol extraction and alcohol precipitation 
followed by appropriate restriction enzyme digestion to produce the appropriate ends for 
cloning. 
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2.2.7 Southern blot analysis of DNA 
2.2.7 A Preparation of labeled probes by random priming 
50 ng of plasmid DNA was denatured at 95°C for 10 min, cooled on ice, and 
radioactively labeled with 50 JjCi of [a32PldCTP (Amersham) using a Megaprime DNA 
labelled kit (Amersham), according to the manufacturer's protocol. The reaction was 
stopped with 0.2 M EDTA (PH 8) and unincorporated nucleotides removed by column 
chromatography (section 2.2.7.B). 
2.2.7B Column chromatography purification of radiolabelled probes 
"Nick" columns (Pharmacia) containing a size exclusion resin were washed three 
times with 2 ml Ix TE, 0.1% SDS before use. The Megaprime (Amersham) reaction mix 
was applied to the column with 100 Jjl Ix TE, 0.1 % SDS and 1 ml Ix TE, 0.1 % SDS were 
further added to wash the radiolabelled mix through the column. Fractions (5 drops) were 
collected and monitored using the Geiger counter. The initial peak (within the first 10 
fractions) contained the probe while the unincorporated radioactivity was eluted later. 
2.2.7C Southern blot hybridisation (Southern, 1975) 
i. Southern transfer 
DNA fragments were resolved by agarose gel electrophoresis (Section 2.2.1.E). The 
gel was washed in water and submerged in 200 ml denaturing solution on a shaker for 60 
min to denature the double stranded DNA. After a brief rinsing of the gel in deionised 
water, the gel was incubated in 200 ml neutralising solution on a shaker for 30 min and in 
fresh neutralising buffer for another 60 min. The gel was rinsed in 2X SSC for 2. min and 
the DNA was transferred to a Hybond-nitrocellulose membrane, which had been pre-
soaked in water and 2X sse for 5 min, by capillary action for 12-15 h overnight at RT. 
Subsequent hybridisations and washes were performed with rotation in an oven (Hybaid). 
ii. Hybridisation with probes 
The membrane was soaked for 2 min in 6X sse and incubated at 65°C for 3 h in 5 ml 
of prehybridisation buffer. 32P-Iabeled probes were denatured by boiling for 5 min, rapidly 
107 
Chapter 2 Materials and Methods 
chilled on ice, added to the prehybridisation buffer, and hybridised to the membrane at 
65°C overnight. The nitrocellulose was washed twice in 2X SSC, 0.1 % SDS at RT for 10 
min, followed by washing three times in 2X SSC, 0.1 % SDS at 65°C for 30 min, dried, 
wrapped in cling-film, and exposed to X-ray film or a phosphor-imager screen. 
2.2.8 Tissue culture 
2.2.8.4 Maintenance and subculture of cell stocks 
Mammalian cells were passaged in sterile disposable 75cm2 plastic flasks in 
appropriate media (Section 2.1.4) and grown at 37°C in a humidified incubator containing 
5% C02. Confluent layers were trypsinised by washing the monolayer once with 10 ml of 
versene and once with versene/trypsin (4:1, supplied by Institute of Virology Media 
services) respectively. Rounded cells were resuspended in 10 ml of fresh medium. For 
continual passage, BHK cells were split 1: 10 every 4 days, HFL 1:3 every 4 days, Vero 
cells and Hep-2 cells 1:6 every 4 days. For the NT2 cell line, a seeding density of 4 x 104 
cells per 25 cm2 flask area was used to avoid spontaneous differentiation. 
2.2.8B Differentiation of NT2 cells 
NT2 cells were harvested from flasks as described above by trypsinising and 
resuspending in 10 ml of medium. 1 x 106 NT2 cells were seeded into 25cm2 flasks with 5 
ml of medium containing 10 J.1M all-trans-retinoic acid (ATRA). The culture medium was 
changed 3 times per week for 6 weeks. The 6-week differentiated hNT cells were 
transferred to a 75 cm2 flask in media without ATRA and cultured for an additional 2 days. 
The loosely adherent hNT cells were recovered in the culture medium by striking the flask 
sharply, resulting in a population of cells with more than 30% having a significant neuronal 
morphology. 
2.2.8C Frozen stocks of NT2 and hNT cells 
Confluent cell mono layers of NT2 or hNT cells were harvested from 175 cm2 flasks 
by trypsinising and resuspending as described above in 15 ml of media followed by 
centrifuged at 1000 rpm at 4°C for 5 min. Cell pellets were resuspended in NT2 cell 
storage buffer (95% Foetal calf serum, 5% DMSO) at a density of 2 x 106 cells/ml. 
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Aliquots of 1 ml were added to 1.5 ml cryo-vials, kept at 4°C overnight followed by an 
overnight period at -70°C, then transferred to a liquid nitrogen freezer for long term 
storage. 
2.2.9 Protein expression and analysis (transient expression in mammalian 
cells) 
2.2.9A Electroporation 
Hep2 cells from a 17Scm2 flask were trypsinized as described previously, then washed 
with serum- and antibiotic-free DMEM twice. After the final wash, cells were resuspended 
in an appropriate volume, such that the concentration of cells was 5 x 106 cells/ml. For 
each electroporation, 4 x 106 cells and 20 Jlg of DNA were used. DNA was put in a 4 mm 
cuvette and incubated with the cells on ice for 10 min. After pipetting gently to resuspend 
settle~ cells, the cells were electroporated at 400 V (Hybaid cell shock electroporator), and 
incubated on ice again for 10 min. Electroporated cells were added to 10 ml complete 
medium to give a final cell density of 4 x lOS cells/ml and cells distributed into Linbro 
wells as required. For immunofluorescence, a density of 2 x lOS cells per Linbro well was 
required. 
2.2.9B Lipofection 
The Lipofectamine PLUS kit (Life techonologies) was employed for all the 
lipofection experiments. According to the manufacturer's protocol, cells were seeded in a 
Linbro well with a coverslip at a density of 1 x lOs cells per well one day prior to 
transfection to reach 60-80% confluent next day. For each well, 100 ng of DNA and 2 JlI 
of PLUS reagent were mixed in 100 JlI of plain DMEM (without serum and antibiotics) and 
the mixture incubated at RT for 15 min. Pre-mixed lipofectamine solution (1 ul of 
Lipofectamine with 100 JlI of plain DMEM for each well) was added to the DNA-PLUS 
reagent solution and kept at RT for another 15 min. In the meantime, cell monolayers were 
washed with plain DMEM twice (the conditioned medium was kept for further use), and 
200 JlI of DMEM was added after this wash. The 2S0JlI sample of DNA-PLUS-
Lipofectamine mixture was poured over the celJ monolayer and incubated at 37°C for 3 h 
followed by the addition of an equal volume of complete medium with 20% of FCS for a 
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further 2 hr. At this time, the transfection mixture was removed and the conditioned 
medium retained from the original growth of the cells was added, and the cells were left in 
the 37°e incubator overnight. 
2.2.10 Resolution of proteins by SDS-polyacrylamide gel electrophoresis 
Proteins were resolved by electrophoresis through SDS polyacrylamide minigels 
(Laemmli, 1970) using the Bio-Rad miniprotein II apparatus. The resolving gel mixes 
were prepared first and poured into glass plate sandwiches in the BioRad gel former 
apparatus, overlaid with butanol and left to set. Once 'the gel had set, the butanol was 
washed away with water. The set gel was then overlaid with stacking gel mixture and a 
comb inserted. Details of how the resolving and stacking gel mixes were prepared are 
given in Table 2.2. Protein samples were mixed with the relevant gel loading buffer and 
placed in a boiling water bath for 2 min prior to loading. Gels were run in tank buffer at 
200 V until the tracking dye reached the bottom. 
Table 2.2 Solutions used to make SDS-polyacrylamide gels 
Solution 7.5% 10% 12.5% Stacking gel 
30% acrylamide 2.5 ml 3.33 ml 2.5 ml 0.4 ml 
RGB 2.5 ml 2.5 ml 2.5 ml NA 
SGB NA NA NA 0.6 ml 
Water 5 ml 4.17 ml 3.33 ml 1.4 ml 
Note: Amounts of 30% acrylamide (2.5% cross linker) and water were adjusted 
accordingly for preparation of7.5%, 10% or 12.5% resolving gel mixes. To each resolving 
gel mix 80 J.11 10% APS and 8 J.11 of TEMED were added and 20 J.11 10% APS and 3 J.11 
TEMED were added to stacking gel mixes, in order to catalyse setting of the gels. 
110 
2.2.11 Western blot analysis of proteins 
2.2.11A Electroblotting to a nitrocellulosejilter 
Chapter 2 Materials and Methods 
Proteins resolved on SDS-PAGE minigels were transferred to a nitrocellulose filter by 
the method in (Towbin et al., 1979) in a BioRad mini transblot cell. A blotting sandwich 
was set up such that the gel was in contact with a sheet of nitrocellulose (Schleicher and 
Schuell Inc.) and both were sandwiched between Whatman 3mm paper of the appropriate 
size. This was in turn sandwiched between sponges provided by BioRad and blotting 
carried out in Towbin buffer at 250 rnA for 3 hr. 
2.2.11B Immunodetection o/proteins 
Following transfer the nitrocellulose membranes were removed from the tank. and 
immersed in 5% Marvel (made in PBS-T) overnight at 4°C to prevent non-specific binding 
of antibodies, or for at least an hour at RT. The blots were washed once for 5 min at RT in 
PBS-T, and then incubated with a primary antibody (made up to the appropriate dilution in 
20 ml of 5% Marvel in PBS-T for each blot) and left shaking for 2-4 hr at RT. Following 
this the blots were washed 6 times, for 5 min each time, in PBS-T at RT and then incubated 
with the relevant secondary antibody for 60 min at RT followed by 6 final 5 min washes as 
previously. The secondary antibodies were all diluted in 20 ml of 2% Marvel in PBS-T: 
anti-mouse IgG whole molecule peroxidase conjugates were used at a 111,000 dilution and 
goat anti-rabbit IgG whole molecule peroxidase was used at a 1150,000 dilution. 
2.2.11C Protein detection by enhanced chemiluminescence (EeL) 
Bound antibodies were detected using the NEN enhanced chemiluminescence (EeL) 
system. The two reagents provided in the kit were mixed in equal volumes and a total of 
I.S ml poured on to the filter, which was then agitated for 1 min. The filters were wrapped 
in cling film and exposed to Kodak X-OMAT S film for variable lengths of time. 
2.2. lID Stripping and re-pl'obing membranes 
The complete removal of primary and secondary antibodies from membranes was 
sometimes required in order to re-probe a membrane. This involved submerging the 
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membrane, after immunodetection, in stripping buffer (100 mM p-mercapto-ethanol, 2% 
SDS, 62.5 mM Tris-Hel, pH 6.7) and incubating it at 55°C for 60 min with occasional 
agitation. The membrane was then washed twice with PBS-T for 10 min at RT. The 
membrane was then re-probed using one of the blocking protocols, followed by the 
detection of proteins by ECL as described above. 
2.2.12 Immunoflurorescence assay 
Samples for analysis by immunoflurorescence assay using a confocal microscope 
were prepared on 13 mm glass covers lips in 24-well plates. Cells were washed twice with 
PBS(A), and incubated with 0.5 ml fix solution (section 2.1.11) for 10 min at RT. Fixed 
cells were washed with PBS(A) twice and kept in 0.5 ml of permeabilisation solution for 
10 min at RT. Cells were washed twice with PBS(A)-1 % FCS, and incubated with 20 /-11 of 
appropriate diluted first antibody (Table 2.1) for I h at RT. Unbound antibody was 
removed by six washes with PBS(A)-l % FCS over a 15 min period. 20 I.d of secondary 
antibody was added, and after 1 hat RT in the dark, the cells were washed as before. The 
labelled samples on coverslips were mounted on microscope glass slides with a drop of 
Citiflour anti-fade reagent, sealed with nail varnish, and stored at 4°C in the dark, or 
viewed immediately. 
2.2.13 Confocal microscopy 
Confocal analysis was performed using a Zeiss LSM 510 Laser Scanning Microscope 
system, with three lasers giving excitation lines at 488 nm (for fluorescein isothiocyanate 
and EGFP), 543 nm (for Cy3) and 633 nm (for Cy5), and using a 63x oil immersion 
objective lens, NA 1.4. Data collection was performed under conditions of no detectable 
channel overlap. Images were exported as .tif files for presentation using Photoshop or 
Powerpoint. 
2.2.14 CAT assays 
The CAT enzyme assay system is an adaptation of that described by Gorman et al. 
(1982) and Cullen (1 987)(Gorman et al., 1982; Cullen, 1987). Cells were scraped into 400 
/-11 TEN buffer (section 2.1.11) and pelleted by centrifugation at 13,000 rpm for 30 sec in a 
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bench top centrifuge. The pellet was resuspended in 30 J.11 0.25 M Tris-HCI, pH 7.5 and 
cells lysed by freeze-thawing three times on dry ice and in a 37°C water bath. Cell debris 
was pelleted by centrifugation at 13,000 rpm for 10 min and the cell extract was incubated 
with I J.11 50 mM acetyl Co-A, 1 J.11 14C-radiolabelled chloramphenicol and 13 J.11 0.25 M 
Tris, pH 7.5 at 37°C for 1 hr. 200 J.11 of ethyl acetate was added to terminate the reaction, 
mixed by vortexing for 10 sec and centrifugation for 5 min to separate the aqueous and 
organic phases. The upper organic phase was lyophilised and then resuspended in 25 J.11 
ethyl acetate before being applied to a TLC plate (Polygram SIL G; Machery-Nagel) which 
was placed in a tank containing 95 ml chloroform and 5 methanol in a fume hood. When 
the chloroform/methanol mix had reached the top of the TLC plate, the plate was removed, 
air-dried and subjected to autoradiography for 16 h. 
2.2.15 Fluorescence-Activated Cell sorting (FACS) 
2.2.1SA Preparation olcellslor FACS 
Cells were grown in a 35 mm petri-dish. Infected and transfected cells were harvested 
at specific times. Cell mono layers were washed once with versene followed by 
trpsinlversene once and incubated in 0.5 ml of trypsinlversene for 5 min or until the 
mono layers became loose and the cell were no longer in large clumps. The dissociated 
cells were transferred to a 15 ml Falcon tube, washed in PBS (complete) twice, and 
centrifuged at 1,000 rpm at 4°C for 2 min. The mono-dispersed cells were then transferred 
to an eppendorf tube for further immuno-staining. 
2.2.1SB lmmuno-staining 
The medium was aspirated from the pellet, and the cells from each Petri-dish were 
thoroughly resuspended in 0.5 ml fix solution (section 2.1.11) and incubated for 10 
minutes. Fixed cells were washed with PBS(A)-I % FCS once and incubated in 0.5 ml of 
permeabilisation solution (section 2.1.11) for another 10 minutes and the washing repeated. 
Cells were resuspended in 200 J.11 and labeled with primary antibody for 60 minutes at RT 
and were then washed once and resuspended in PBS(A)-l % FCS as previously described. 
The fluorescent labeling of cells was achieved by addition of I J.11 of anti-IgG-PE (Sigma) 
resulting in a I: 100 dilution of the secondary antibody. The cells were incubated in 
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secondary antibody for 50 min at RT and were washed once and resuspended in a final 
volume of 0.5 ml. 
2.2.ISC FACS 
Fluorescence quantitation and analysis was achieved by passing the cells through a 
Becton Dickson F ACScan using Cell Quest software. 
2.2.16 Production ofTK-IEGFP mutant virus 
2.2.16A Recombination ofTK deleted EGFP plasmid with HSV-I DNA in mammalian 
cells 
The pTK-IEGPF plasmid, in which the TK open reading frame had been replaced by 
that of EGFP, was co-transfected with 1 J.!g of HSV-l DNA into BRK cells using the 
lipofection method (see section 2.2.9B). Three days after transfection, when CPE was 
observed, the transfected cells were harvested by scraping into the medium and sonicated 
for 15 sec three times using a soni-bath (Kerry). 
2.2.16B Selection and plaque purification of HSV-I virus recombinants 
Petri dishes (35 mm2) of 80% confluent BHK cells were infected with 0.5 ml of the 
initial viral supernatant from the above transfection at dilutions of 10-1 to 10-3, and overlaid 
with 3 ml of 0.5% agar overlay containing 0.1 ug/ml of ACG to select for propagation of 
viruses with the TK negative phenotype conferred by insertion of the EGFP open reading 
frame. The plates were incubated for 2-3 days at 37°C for plaques to develop. Viral 
plaques with EGFP fluorescence, visualised by phase contrast and fluorescence 
microscopy, were picked using a plastic pipette tip, added to 1 ml of BHK medium and 
sonicated for 20 sec twice. One tenth of the stock of positive plaques were further 
amplified in BHK cells in 24-well plates for one day and the infected cells and medium 
were harvested and purified as above, by infecting cells with 10-3 to 10-s dilutions of the 
amplified virus stocks. Plaque purification was repeated three times until a pure 
recombinant viral DNA pattern was obtained from Southern blotting assay (section 2.2.7). 
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2.2.16C Preparation o/working stocks o/virus 
Three 175cm2 flasks of 70% confluent of BRK cells were infected with virus at a 
multiplicity of 0.01 pfu/cell, and incubated at 37°C until compete CPE occurred. Cells 
were dislodged into the medium by sharply hitting the edges of the flask and recovered by 
centrifugation at 3000 rpm for 10 min. The supernatants containing CRY (cell released 
virus) and the pellets containing CAY (cell associated virus) were processed separately . 
• CRV: 
The supernatant was transferred into SORV AL OS3 tubes and centrifuged at 12000 
rpm for 2 h at 4°C. The viral pellet was resuspended in BRK medium, sonicated for 30 sec 
three times on ice, aliquoted to cryo-vials, and stored at -70°C . 
• CAV: 
The cell pellet was resuspended in BHK medium, sonicated for 30 sec three times on 
ice, and re-pelleted at 3000 rpm for 10 min to remove cell debris. The supernatant was 
transferred into a new tube and stored at -70°C.D. 
2.2.16D Titration o/virus 
Ten-fold serial dilutions were prepared from virus stocks and 100 J.l.1 of dilutions from 
10-4 to 10-9 were used to infect BHK cells in 6-well plates in duplicate. After absorption of 
the virus for 1-2 hr at 37°C, the cells were overlaid with 500 J.l.1 of Eagle's medium (140 ml 
of Eagle's A, 20 ml of Eagle's B, 5% of human serum). After the required incubation at 
37°C, plaques were visible and the cells were stained with 0.5 ml of Giemsa reagent prior 
to quantitation. 
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Chapter 3 A study of ND1 0 proteins and their effects on 
HSV·1 infection 
Nuclear domain 10 (NDI0) aresubnuclear structures, containing a number of proteins 
including PML, Sp 1 00 NDPS2 and Oaxx. Several other proteins have been found in at 
least a proportion ofNDI0 in a variety of studies. Among these proteins, PML and Spl00 
are the most well studied (reviewed by Negorev & Maul, 2001). It has been reported that 
NO 10 domains are dynamic structures that are highly sensitive to environmental stimuli 
such as stress, heat shock, interferons (IFNs), and metal ions, as well as viral infections 
(reviewed by Maul, 1998). The number and size of NOlO foci and the distribution of 
NO 1 0 associated proteins can be dramatically altered by these stress factors. 
It has been reported that the promoter regions of both SpiOO and PML contain cis-
acting interferon response elements and the expression of these two ND I 0 associated 
proteins has been shown to be enhanced by IFNs (an integral part of the innate immune 
response against viral infection) on the mRNA and protein levels (Chelbi-Alix et ai., 1995, 
Grotzinger et ai., 1996, Guldner et 01., 1999, reviewed by Regad & Chelbi-Alix,). As 
described in the Introduction, the regions of ICPO that are required for NOlO localisation 
and disruption closely correlate with those required for its ability to stimulate viral 
infection. These findings indicate that NO 1 0 may play a crucial role in virus-host 
interactions. 
The aim of the experiments described in this chapter was to study the distribution of 
NO 1 0 associated proteins under environmental stress, including heat shock and IFN 
treatment in different cell lines and to investigate whether the alteration or up-regulation of 
expression of NOlO associated proteins affects HSV-l infection. 
3.1 Heat shock 
3.1.1 The effect of heat shock on NDIO 
Hep-2 and HFL cell lines were used to characterise the heat shock effect at a 
temperature of 42°C for 15, 30, and 60 min followed by immunofluorescent double-
staining for Sp I 00 and PML. In Hep-2 cells, after a IS-min heat shock, some of the Sp 1 00 
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Fig. 3.1 The effect of heat shock on ND 10 proteins in Hep-2 cells. 
Hep-2 cells were incubated at 42°C (heat shock) for 15, 30, and 60 min. 
The cells were then fIxed and stained for PML (5 E 10) and Sp 100 
(SpGH). The labeled proteins are indicated in the uppermost row, and are 
the same in each panel. The merged view of PML and Sp 100 indicates 
the localisation of these two proteins. PML and Sp 100 were largely 
separated after a 60 min heat shock, as indicated by the increase in the 
number of dots that were either red or green, rather than yellow. 
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dispersed into microdots throughout the nucleus (Fig. 3.IB). By 60 min, distribution of 
PML and Sp 1 00 was chaotic in most Hep-2 cells, and only few cells still retained intact 
NDIO domains (Fig. 3.10). 
In HFL cells, the effect of heat shock on ND I 0 was slower compared with Hep-2 
cells, but with a similar effect (Fig. 3.2). An obvious response was observed after a 30-
min heat shock, and the staining and number of Sp I 00 and PML foci were decreased in 
HFL cells after a heat shock of 60 min. In addition, the heat shock response of Sp 1 00 was 
more rapid than that of PML, since with a 15-min heat shock treatment, most Sp 100 foci 
were dispersed into tiny microdots, but many PML foci were still located in apparently 
normal NOlO. This effect was more obvious after a 30-min heat shock (Fig. 3.3). 
3.1.2 The effects of prior heat shock on HSV-l infection 
During the course of HSV-I infection, expression of ICPO leads to disruption of 
ND 1 O. Since the ability of ICPO to bring about this disruption correlates with its 
stimulation of viral infection, it was thought possible that prior disruption of NOlO by heat 
shock might increase the efficiency of HSV- I infection in the absence of functional ICPO. 
To explore whether the alteration of NOlO by heat shock affected the efficiency and 
progress of viral infection, HFL cells were infected by the ICPO mutant virus FXE, diluted 
in 37°C pre-warmed medium, at an MOl of 1 after a 60-min heat shock. The initiation and 
progression ofHSV-1 infection were monitored by staining the cells for ICPO (an IE gene) 
and UL29 (an Early gene) respectively, at 2 and 6 h post-absorption (hpa) at 37°C. The 
images were collected with a LSM 510 confocal microscope, using a 20x objective lens, to 
quantify the viral infection after heat shock in HFL cells. 
At an early time of infection (2 hpa), 56% of heat shocked HFL cells were infected 
and expressed ICPO and 5% of cells had progressed to Early gene expression (Table 3.1). 
At 6 hpa, 65% of cells were infected and up to 24% of cells expressed UL29. However, 
there were no significant differences between these results and those of cells that had been 
incubated at 37°C prior to infection (Table 3.1). Therefore prior disruption of NDIO by 
heat shock had no significant effect on the expression of selected IE and Early gene 
products in the absence of functional ICPO. 
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Fig. 3.2 The effect of heat shock on ND 10 proteins in HFL cells. 
HFL cells were incubated at 42°C (heat shock) for 15, 30, and 60 min. 
The cells were then fixed and stained for PML (5E 1 0) and Sp 100 (SpGH). 
The labeled proteins are indicated in the uppermost row, and are the same 
in each panel. The merged view of PML and SplOO indicates the 
localisation of these two proteins. PML and SplOO were partially 
separated when cells were incubated at 42°C. However the effect of heat 
shock was less marked in HFL cells compared with Hep-2 cells (not very 
clear at 60 min-better at 30 min). 
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A 
B 
Fig. 3.3 The effect of heat shock on ND 10 proteins in HFL cells. 
HFL cells were incubated at 42°C (heat shock) for 15 and 30 min 
as labeled in the lower right-hand corner in each image . The cells 
were then fixed and stained for Sp 1 00 (SpGH, panel A) and PML 
(5ElO, panel B). In HFL cells, dispersion ofSplOO was faster than 
PML. The white arrow-heads indicate that most Sp 1 00 foci were 
dispersed into microdots, whereas most PML foci were still intact 
and located in ND 10. 
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Table 3.1 The effect of heat shock on HSV -1 infection 
3 'rCa 42°C" 
% ICPOc %UL29d % ICPO %UL29 
2hpa 54 5 S6 5 
6hpa 62 22 65 24 
a Cells were incubated at 37°C before infection without treatment with heat shock. 
b Cells were incubated at 42°C for 1 hour prior to infection. 
c The proportion of HFL cells expressing ICPO. 
d The proportion of HFL cells expressing UL29. 
121 
Results and Discussions Chapter 3 The effect ojNDJO proteins on HSV-J infection 
3.2IFN-(1 
3.2.1 The effect ofIFN-a on NDIO 
The expression patterns of ND 1 0 associated proteins were determined using a rabbit 
serum (SpGH) specific for SplOO after IFN-a. (lOOOU/ml) treatment for 24 h. After 
treatment ofIFN-a., the number of NOlO foci was increased and their sizes were enlarged 
and more homogeneous than in untreated Hep-2 cells (Fig. 3.4). 
3.2.2 The effect of IFN-a on HSV -1 infection 
As previous results had shown that the expression ofNDIO proteins was up-regulated 
by IFN-a., I then asked whether this increase in NDIO protein expression affects HSV-l 
infection. Hep-2 cells were pre-treated with IFN-a. for 24 hours then infected by 17+ at an 
MOl of5 for various times. The efficiency of infection in IFN-a. treated cells was detected 
by immunostaining at 2, 8, and 12 hour postinfection, followed by confocal microscopy 
and compared to that in untreated cells. As illustrated in Table 3.2, pre-treatment of IFN-a. 
moderately inhibited initiation of HSV-l infection, since generally, expression of ICPO 
was reduced around 2 to 3 fold at all infection times tested, compared to those in IFN-a. 
untreated cells. Similarly, progression of infection was slightly affected by IFN-a.. 
3.2.3 The effect ofIFN-a on HSV-1 infection at various MOl 
Another experiment was designed to examine further whether the effect of IFN-a. was 
dependent on virus input. HFL cells, pre-treated with or without IFN-a., were infected 
with 17+ at MOl 5, 2, and 0.5 for 2 hours and then processed for the detection of infection 
efficiency. The fold reduction of infection in IFN-a. treated cells is shown in Table 3.3. 
As described previously, infection of HSV-l was affected by IFN-a., however the 
replication ofHSV-l was even worse when less virus was added (Table 3.3). This implies 
that IFN-a. has slightly greater effect on cells infected with HSV-l at lower MOIs. 
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Fig. 3.4 The effect ofIFN-a. on SpiOO structures. 
Hep-2 cells treated with lOOOU/ml IFN-a.. The expression of 
SpiOO was up-regulated and more SpiOO foci were observed 
in IFN treated cells (right-hand panel) compared to that in 
untreated cells (left-hand panel). 
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Table 3.2 The effect of IFN on HSV -1 infection 
- IFN-aQ - IFN-a + IFN-ab + IFN-a 
% ICPOc %UL29" % ICPO %UL29 
2hpa 42 1 18 0 
Shpa 56 14 19 3 
12hpa 59 11 24 5 
Q Cells were infected with HSV-lat an MOl of 5 without pre-treatment ofIFN-a. 
b Cells were treated with IFN-a for 24 hours prior to infection. 
C The proportion of Hep-2 cells expressing ICPO. 
d The proportion ofHep-2 cells expressing UL29. 
Table 3.3 The effect oflFN on HSV -1 infection at various MOl 
+ IFN-a" - IFN-a b Fold reduction 
%ICPOC %ICPO 
MOl 5 60 90 1.5 
MOl 2 30 60 2.0 
MOl 0.5 15 35 2.3 
Q Cells were infected with HSV -1 without pre-treatment of IFN-a. 
b Cells were treated with IFN-a for 24 hours prior to infection. 
C The proportion of HFL cells expressing ICPO. 
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3.2.4 Association ofNDI0 proteins with centromeres 
It has been shown that in the presence of the proteasome inhibitor MGl32 cells have a 
greater number of NDIO. In a proportion of these cells the NOlO can be found in 
association with CENP-C, a centromere component protein, particularly on progression of 
the cell cycle into G2 phase (Everett et al., 1999a). To explore whether the up-regulation 
of NOlO proteins by IFN-a has the same effect as MG132 on the localisation ofSpl00 and 
CENP-C, IFN-pretreated Hep-2 cells were examined by double-staining with antibodies 
Sp26 (a rat serum for Spl00) and r554 (a rabbit serum for CENP-C), followed by 
microscopy. Three fields of cells were selected randomly from each coverslip for 
statistical analysis. The total number of ND 10 foci was counted in a separate laser channel 
for Spl00 (red colour), then the colocalisation of Spl00 with CENP-C was determined in 
the Sp 1 OO-CENP-C merged channel. 
After treatment with IFN-a, it was observed that although the number of Spl00 foci 
was increased, the proportion of Spl00 foci associated with CENP-C in individual cells 
was not increased in IFN-a treated cells (data not shown). Therefore the increase in this 
association seen in MG132 treated cells is in some way specific to proteasome inhibition, 
and not simply due to the increase in NDIO number. 
3.3 The effect of over-expressJon of ND10 proteins by transient 
transfection on HSV-1 Infection 
3.3.1 Electroporation 
3.3.lA The strategy ojthis study 
To examine the potential effects of NDI0 associated proteins on viral replication,· 
transient transfection was employed to highly express NO 1 0 associated proteins in 
mammalian cells (Fig. 3.5). As illustrated in Fig. 3.5, plasmids encoding epitope tagged 
NO I 0 associated proteins, in particular PML, Sp 1 00, and two proteins involved in post-
translational modification of NO 10 proteins, SUMO-I and Ubc9, were introduced by 
electroporation into Hep-2 cells, followed by infection with virus vEG 11 Owt in which 
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• seed into Linbro-wells with coverslips 
OVernight 
infected with vEG-11 Owt virus 
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•
ShPa 
IFA 
(double-staining with the Abs against ND10 protein, and UL29) 
• Confocal microscopy 
• 
{ 
ICPO(GFP) 
UL29(cyS) 
ND10 (cy3) 
Statistical analysis: 
proportion of untransfected cells expressing ICPO, UL29 
proportion of transfected cells expressing ICPO, UL29 
Fig. 3.5 Analysis of the effect ofND lOon H V-I infection in Hep-2 cells. 
The ND 1 0 associated proteins were highly expressed in Hep-2 cells via electroporation. The 
electroporated cells were seeded on 13mm coverslips in Linbro-wells and were infected by 
vEG-IIOwt virus for 2 or 8 hr followed by immuno-staining for UL29 and ND 10 proteins. 
The proportion of cells expressing two viral proteins, ICPO and UL29 were determined to 
indicate viral immediate-early and early gene expression. 
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ICPO is expressed as a ICPO-EOFP fusion protein (Lomonte & Everett, 1999). The 
infected cells were fixed and double-stained with antibodies directly against the relevant 
tagged ND 1 O-associated protein and also the viral DNA replication protein UL29 to 
monitor the initiation of viral infection and its progression to the Early phase in transfected 
cells compared with untransfected cells. The images were collected from 10 fields of each 
coverslip and the proportion of cells expressing these two viral proteins was determined by 
simple statistical analysis. The following is an example calculation: 
Total cells (with background colour) = 566 
Cells expressing ICPO (with green fluorescence) = 108 
Cells expressing UL29 (with blue fluorescence) = 16 
Transfected cells over-expressing the NDIO protein (with red fluorescence) = 133 
Transfected cells expressing ICPO (with green and red fluorescence) = 37 
Transfected cells expressing UL29 (with blue and red fluorescence) = 3 
Therefore: 
The infection proportion in untransfected cells is 16% (108-37/566-133); 
The proportion ofuntransfected cells expressing UL29 is 3% (16-3/566-133); 
The proportion of trans fee ted cells expressing ICPO is 28% (37/133); 
The proportion of trans fee ted cells expressing UL29 is 2.3% (3/133). 
Therefore in this example, the initiation of infection and progression to UL29 
expression in transfected cells expressing high levels of an exogenous ND 1 0 protein, are 
not significantly different from the results in untransfected cells (Fig. 3.6). 
3.3.1B Over-expression of PML 
To test a possible antiviral effect of PML, plasmid pPML-RH was transfected into 
Hep-2 cells followed by infection of vEO-110wt virus at an MOl of 1 for 2 and 8 hr. 
Through statistical analysis of the immunofluorescent images collected from confocal 
microscopy, a representative result is shown in Fig. 3.7A. Due to the relatively slow 
progression of infection by HSV -1 in Hep-2 cells, with only a few cells expressing ICPO 
and even fewer expressing UL29, Fig. 3.7 only includes the data from the late time point of 
infection (8 hpa). Expression of ICPO was assessed to determine whether the initiation of 
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Fig. 3.6 A histogram of the effect of overexpression of ND 1 0 
proteins on HSV -1 infection . 
The results obtained from microscopy were analysed and 
converted into a histogram. The proportion of transfected cells 
expressing ICPO is slightly higher than that of untransfected 
cells. The expression ofUL29 in transfected cells was similar 
to that in untransfected cells. 
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HSV -I infection is reduced in cells over-expressing PML. At 8 hpa, around 40% of 
untransfected cells were detected expressing ICPO and about 45% of transfected cells 
expressed ICPO. Progression to the productive middle stage of infection was defmed by 
the expression of the UL29 gene encoding the single strand DNA binding protein ICP8. 
At the late time point of infection, 8% of untransfected cells expressed UL29 and around 
10% of transfected cells expressed UL29, thus illustrating that high level expression of 
PML did not affect the initiation and progression of HSV -I infection. 
3.3.1C Over-expression ofSplOO 
SpIOO, another NDIO associated protein, is also induced by IFNs. Although over-
expression of PML did not confer antiviral resistance (Fig. 3.7A), there is still the 
possibility that NO 10 are involved in an antiviral mechanism via Sp 100, instead of PML. 
To generate a plasmid expressing tagged Sploo protein, two fragments containing the full-
length SplOO ORF were subcloned from plasmid pCMVSplOO (digested with Nco I·Xho I 
andXho I-Hinc III) into pp65-ICPO plasmid (Parkinson & Everett, 2000). Since the pp65-
ICPO plasmid contains a HCMV pp65 epitope tag up stream of its ICPO coding region, 
insertion of the SplOO fragments between the Nco I and Hinc III sites of pp65-ICPO 
replaced the ICPO ORF but the pp65 tag was retained at the 51 end ofSplOO. The strategy 
described in section 3.3.1B was used to address the effect of SplOO on HSV-I infection. 
The proportion of transfected cells expressing epitope tagged pp65-Sp I 00 and expressing 
ICPO after infection (46%) was slightly lower than in untransfected cells (65%) and the 
proportion ofSplOO over-expressing cells progressing to the early gene stage was two-fold 
lower than in untransfected cells (Fig. 3.7B). 
3.3.lD Over-expression of SUMO-lor Ubc9 
It has been found that the NOlO associated proteins PML and Spl00 are modified by 
covalent linkage with the ubiquitin-like protein, SUMO-I and this modification may 
promote the assembly of these structures (Muller et 01., 1998a, reviewed in Sternsdorf et 
ai., 1997). In addition, during the course of HSV-I infection, PML and SplOO together 
with their SUMO-I modified isoforms are degraded by the proteosome in response to ICPO 
expression (Everett et al., 1998a, Parkinson & Everett, 2000). These findings imply that 
the SUMO-I modification pathway may play an important role in antiviral resistance. To 
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Fig. 3.7 The effect ofND 1 a proteins on viral infection in Hep-2 cells. 
The transfected Hep-2 cells, infected by EO 11 a for 8 hr, were examined by confocal 
microscopy followed by statistical analysis. The proportion of cells expressing TCpa and 
UL 29 in untransfected cells are shown as • , and the proportion of transfected cells 
expressing ICpa and UL29 are shown as . These results were obtained from a single 
experiment, but were reproduced on at least two individual experiments. 
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address this question, SUMO-l and its E2 conjugating enzyme Ubc9 were overexpressed 
in Hep-2 cells and infected transfected cells were analysed by the same method as 
described in section 3.3.1A. The proportion of pCIPIC-l transfected and untransfected 
cells expressing ICPO were 30% and 31% respectively (Fig. 3.7C). The proportion of 
transfected cells expressing UL29 was up to 10%, which is not a significant difference 
from that of untransfected cells (8%). In the case of pUBC9 plasmid transfection, 
similarly to SUMO-I, Hep-2 cells highly expressing Ubc9 had a slightly higher percentage 
of infection, however, in these experiments the progression of viral infection to UL29 
expression was too low to be detected. 
3.3.2 Lipofection 
Transient transfection via electroporation offered an efficient and representative way 
to study the effect ofNDIO proteins in Hep-2 cells. However, since viral gene expression 
and the progression of HSV-l infection were relatively slower in Hep-2 cells, the 
population of cells expressing UL29 was too small to give a reliable statistical analysis, 
even at input virus of 1 pfu (Plaque forming unit) per cell. BHK cell line is an efficient host 
cell for HSV -1, but they were found unsuitable for the electroporation method. Therefore 
a lipofection method was employed with BRK cells to explore in more detail the effects of 
exogenous NDIO protein expression on the progress of HSV-l infection. As with the 
electroporation method, a plasmid expressing PML, SplOO, SUMO-I, or Ubc9 was 
transfected into BHK cells seeded in a 35 mm petri-dish with 4 coverslips. Transfected 
cells were infected by 17+ at an MOl of 0.5 for 2 and 6 hr, followed by 
immunofluorescence staining to detect the expression of viral immediate-early and Early 
proteins in transfected cells compared with untransfected cells (Fig. 3.8). 
3.3.lA Single-plasmid trans/ections 
• 3.3.lA.] Results/rom IFA 
Among those plasmids used for expressing ND I 0 proteins, the average transfection 
efficiency via lipofection of BHK cells was up to 40% (Fig. 3.9A). Due to the efficient 
infection progression of 17+ infection in BHK cells, the infected transfected cells were 
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Plasmid 
OVernight! 
2hpa 
• IFA 
infected with 17+ virus 
/at MOl 0.5, for 2, or 6 hr 
1+ 2 
6hpa 
coverslip 1 stained with Abs for ND10 protein and ICPO 
coverslip 2 stained with Abs for ND1 0 protein and UL29 
C f I~ { Viral protein (FITC) on oca microscopy 
• ND10 (cy3) 
Statistical analysis: 
proportion of untransfected cells expressing ICPO, UL29 
proportion of transfected cells expressing ICPO, UL29 
Fig. 3.8 Analysis of the effect of D 10 on H V-I infection in BHK cells. 
The ND10 as ociated proteins were highly expre ed in BHK cell via lipofection. 
BHK cells were seeded on 13mm coverslips in 35mm Petri-dish and wer tran fected 
with 010 plasmids and then infected by 17+ wild type virus for 2 or 6 hr followed 
by immuno-staining for fCPO, UL29 and NOlO protein . Th images collected from 
confocal microscopy were statistically analy d to compare viral gene expr s ion and 
progression of infection in transfected c lis with untran rected c lis. 
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Fig. 3.9 The effect ofND 1 0 proteins on viral infection in BHK cells. 
• untransfected cells 
o transfected cells 
A. Immuno-staining of infected and transfected BHK cells with SUMO-l (SElO) and IepO (r190). 
In the merge (right) panel, the white arrows show that the SUMO-l transfected cells were infected 
by HSV-l. 
B.- D. The transfected BHK cells, infected by 17+ for 2 and 6 hr, were examined by confocal 
microscopy followed by statistical analysis. The proportion of un trans fected cells expressing ICPO 
are shown as . , and the proportion of ND 10 protein transfected cells expre sing ICPO are shown 
as . Counts of over 1000 cells were made to determine the proportion of cells expressing JCPO. 
Each experiment was repeated 3 times. The results shown for each length of infection are those 
from a single experiment, but are representative of all three repetitions. 
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fixed at 2 and 6 hpa. In transfected cells expressing exogenous PML, the expression of 
ICPO was decreased to 36% and 40% of that of untransfected cells at 2 hpa and 6 hpa 
respectively (Fig. 3.9B). As with PML transfection, many of the cells highly expressing 
SUMO-l conferred slight resistance to HSV-l infection (Fig. 3.9A), and the expression of 
ICPO in SUMO-l transfected cells was 27% and 30% lower than that in untransfected cells 
at 2 and 6 hpa, respectively (Fig. 3.90). In SplOO or Ubc9 transfected cells, expression of 
ICPO was not affected compared with untransfected cells (Fig. 3.9C, 3.9E). Despite the 
apparent small reduction in the efficiency of viral ICPO expression in cells transfected with 
PML and SUMO-l plasmids,_ this was not reflected in reductions in the progression to 
Early viral gene expression. In all transfections, the proportions of transfected cells 
expressing UL29 show no significant differences compared to untransfected cells (Fig. 
3.10). 
• 3.3.2A.2 Results from western blot analysis 
These findings were further confirmed by western blot analysis using an antibody 
mixture against several viral proteins. As described above, BHK cells were transfected 
with plasmids expressing high levels of NOW proteins, then infected with HSV-l at 
multiplicities of 0.5 and 5 pfu per cell. As a control, BHK cells transfected with an empty 
vector plasmid, pCIneo, were similarly infected. Cells were directly harvested in SOS-
PAGE boiling mixture (3 x 106 cells/ml) and 1 x lOs cells were used for SOS-PAGE 
followed by western blot analysis. Due to the different molecular weights of the proteins, 
samples from the PML and SplOO transfections were analysed on 7.5% gels and the 
smaller molecules (SUMO-l and Ubc9) on 12.5% gels. Firstly, blots were probed using 
antibodies against the ND 1 0 proteins to determine the expression level, then the previously 
bound antibodies were stripped from the membranes and another antibody mixture against 
viral proteins including immediate-early and early gene products was added. PML, Sp 1 00, 
and their SUMO-l modified isoforms were highly expressed in transfected BHK cells, but 
as expected no tagged ND 1 0 proteins was detected in the pCIneo transfected cell extract 
(Fig.3.1IA). However, compared with control cells, neither PML nor SplOO transfected 
cells had reduced levels of viral protein expression (Fig. 3.11B). Similar to the PML and 
Spl00 transfections, overexpression of SUMO-l and Ubc9 also showed no effect on viral 
gene expression (Fig. 3.12). It should be remembered that a limitation of this experiment 
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Fig. 3.10 The effect of NOlO protein on viral infection in BHK cells. 
A. Immuno-staining of infected and tran fected BHK cells with UMO-1 (5 10) and 
UL29 (r515). In the merg (right) panel, the white arrow how that the UMO-l 
transfected cells were infected with H V-I and viral infection had uccessfully 
progressed to the early gene tage. 
B. The transfected BHK cells, infect d by 17+ for 8 hr, were xamin d by confocal 
microscopy followed by tatistical analy is. The proportion of untran fected cell 
expres ing UL29 are hown as. , and th prop rtion oftransti t d cell expressing 
UL29 are shown a I . ount of over 1000 c lis were made to detemlin th 
proportion of cells expressing ICPO. Each exp rim nt wa r p at d 3 times. The 
results shown ar from in a single exp rim nt, but ar repre ntative of all thr 
repetitions. 
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Fig.3.11 Western blot analysis of the viral gene expression in transfected cells. 
Western blot analysis of the extracts of cells transfected with either PML-RH, 
pp65-Sp 100 plasmid, or the empty vector, pCIneo (as labelled on top of the 
panels), followed by infection with 17+ at MOl 0 (as mock infection), 0.5, and 5 
for 6 hr. 
A. Blotted with pp65 Ab for tagged-SplOO and monoclonal Ab MRGS-His for 
tagged-PML. The arrow-heads indicate the overexpressed NOlO proteins and the 
black dots show SUMO-I modified ND I 0 proteins. 
B. The membrane from panel A was reused for blotting with a mixture of 
antibodies recognising viral IE proteins, ICPO and ICP4, and also the E genes 
UL8, UL39, UL29, and UL42 as indicated on the left-hand side. 
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Fig. 3.12 Western blot analysis of the viral gene expression in transfected cells. 
Western blot analysis of the extracts of cells transfected with either pCIPIC-I , 
pUbc9 plasmid, or the empty vector, pClneo (as labelled on top of blots), and 
followed by infection with 17+ at MOlD (as mock), 0.5, and 5 for 6 hr. 
A. Blotted with 9E1O Ab for c-myc tagged-SUMO-l and monoclonal antibody 
PK5 for SV5 tagged-Ubc9. 
B. The membrane from panel A was reused for blotting with a mixture of 
antibodies recognising viral IE proteins, ICPO and ICP4, and also the E genes 
UL8, UL39, UL29, and UL42 as indicated on the left-hand side. 
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is that the potential maximum reduction in viral gene expression is limited by the 
transfection efficiency. For example, if the transfection efficiency was 50%, even if viral 
protein expression was reduced to background levels, the reduction in total viral protein 
expression in the culture as a whole would be only 50%. Despite this limitation, these 
experiments illustrate that the plasmids are expressing high levels of full-length NDIO 
proteins. 
• 3.3.lA.3 Detection of progeny viralyieldfrom transfected cells 
Since all antibodies used in immunofluorescent staining and western blot analysis are 
for detecting the immediate-early and early gene products, there is a possibility that ND 10 
proteins may interfere with viral late gene expression or virion packaging. To analyse this, 
the yields of progeny virus from transfected cells, which were infected with 17+ at a 
multiplicity of 0.1 for 24 h, were titrated on BHK cells. The titers from two individual 
experiments showed that overexpression of PML, Sp 1 00, SUMO-I, and Ubc9 had no 
protective effect against HSV-l infection at an MOl of 0.1 (Fig. 3.13). The same limitation 
of trans feet ion efficiency as described in the previous section applies to this experiment. 
3.3.2B Co-transfection of plasm ids expressing PML, SpJOO, and Ubc9 
The expression level of ND 1 0 proteins was drastically augmented by transient 
transfection, however most of those exogenous proteins were observed to be improperly 
located in the nucleoplasmic fraction, rather than sequestered in NDIO domains. SUMO-l 
modification has been implicated in the recruitment of proteins to NDW domains (Li e/ al., 
2000, Muller e/ al., I 998a). To investigate this observation, firstly, co-transfection of 
plasmids expressing various combinations of ND I 0 proteins, such as PML-Sp 1 00, PML-
SUMO-I, and PML-Ubc9, was used to determine the distribution of overexpressed NDIO 
proteins when expressed in combination with another ND 1 0 protein. The size and number 
of ND 10 foci were increased in many transfected cells expressing two ND 10 associated 
proteins compared with single transfected cells, and most of the exogenous proteins 
localised to ND 1 0 domains (Fig. 3.14). To test whether this more appropriate localisation 
of highly expressed exogenous ND 1 0 proteins could affect viral infection, cells co-
transfected with three plasmids expressing PML, SplOO and Ubc9, were infected by 17+ at 
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pClneo PML Sp100 SUMO-1 Ubc9 
Fig. 3.13 The titres of progeny viruses from transfected cells. 
BHK cells were transfected either plasm ids expressing PML, 
SpIOO, SUMO-! or Ubc9 and then were infected by HSV-I on 
next day. The progeny viruses were titrated on BHK at 24 hpa. 
The titers of progeny viruses were similar among cells 
transfected with different plasmids. 
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Fig. 3.14 Co-expression ofNDIO protein in Hep-2 cells. 
Hep-2 cells were co-transfected with PML/SpIOO, PML/SUMO-I , or PMLlUb 9 
plasm ids, fixed and immuno-stained 24 hour after transfection. The imag from 
each transfection are shown in panel A, S , and re pectively. The diffi r nt 
components probed for are indicated with their respective colours in the upp r left 
comers. The size of NDl 0 domains was increa ed in cells co-expr ing NO I 0 
proteins compared with single transfected cell indicating in white arrow. 
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an MOl of 0.5. At early times of infection, the proportion of transfected cells expressing 
ICPO was found to be two-fold less than inuntransfected cells (the histogram in Fig. 3.15). 
As shown in Fig. 3.15, most of the transfected cells, with green fluorescence, were not 
infected. However when viral infection progressed to middle stages, there was no 
resistance to infection of the transfected cells (Fig. 3.15). 
3.3.2C Co-trans/ection o/piasmids expressing PML, SpJOO, Ubc9, and SUMO-J 
As an extension of the above experiment, the plasmid expressing SUMO-l was also 
introduced into BHK cells in a quadruple plasmid transfection. After infection of the 
transfected cell population with 17+, at 2 hpa the proportion of trans fee ted cells infected by 
virus and expressing ICPO was found to be around 30% lower than that of untransfected 
cells (Fig. 3.16). Similar to the effect of three-plasmid transfection, at later infection, the 
proportion of transfected cells expressing ICPO and UL29 was not significantly different 
from that ofuntransfected cells (Fig. 3.16). 
3.4 The effects ofNDlO associated proteins on transactivation function of 
ICPO 
3.4.J HPJ 
It has been reported that Spl00 interacts in vitro and in vivo with members of the HPI 
(heterochromatin protein I) family of non-histone chromosomal proteins and that HPI can 
significantly repress transcription when fused to a heterologous DBD (DNA binding 
domain) in transiently transfected mammalian cells (Lehming et al., 1998, Seeler et al., 
1998). Since the region ofHPI required for interaction with Spl00 is also essential for its 
repression activity (Lehming et al., 1998), it is an interesting question whether the HPI 
protein could regulate ICPO function in terms of transactivation of early genes. A CAT 
assay was used to address this question. The reporter cassette used for these experiments 
was pSS80, which contains the promoter of the ICP6 gene that has been shown previously 
to be efficiently activated by ICPO in transfected cells. The amount of pSS80 used in the 
transfection was first optimised to give a detectable but low level of background 
expression. Next, to assess whether HPI represses the transactivation activity ofICPO, the 
amount ofICPO expression plasmid (pCI-rtag-cICPO), which can induce a relative high 
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Fig. 3.15 Co-expression of DIO proteins in BHK cells. 
4hpa 4hpa 
ICPO UL29 
BHK cells were co-transfected with plasmids expr ssing PML, pI 00, and Ubc9 
followed by infection with H V-I the next day. The transfected, infected BHK 
cells were then fixed and irnmuno-stained 2 and 4 hr after infection and examined 
by confocal microscopy followed by statistical analysis. Three plasm ids were 
transfected, but only PML was assayed to identify the cells that were transfected. 
The proportion of cells expressing either I PO or UL29 in untransfected cells ar 
shown as . , and the proportion of NDl 0 protein transfected cells expre ing 
UL29 are shown as 0 . 
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Fig. 3.16 Co-expression of D10 protein in BHK c Us. 
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ICPO 
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UL29 
The BHK cells were co-transfected with pia mids expre sing PML, pI 00, UMO-l , 
and Ubc9 followed by infection with H V -1 the n xt day. The transfected , infected 
BHK cells were then fixed and immuno-stained 2 and 4 hpa and examined by confocal 
microscopy followed by statistical analysis. Four pia mids wer transfected but only 
PML was assayed to identify the cells that were tran fected. The proportion of cells 
expressing either ICPO or UL29 in untran fected cells ar hown as . ' and the 
proportion ofNOl a protein transfected cells expressing UL29 are shown as D . 
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CAT activity (up to 70%), was detennined by cotransfection of the CAT reporter plasmid 
with a series of dilutions of the plasmid expressing ICPO. To investigate the function of 
HPl, Vero cells (seeded in Linbro-well) were transfected with various amounts of HPI 
expression plasmid (pcDNA3-HPl) together with 3ng ofpCI-rtag-cICPO expressing ICPO 
and lOng ofpSS80. The total amount of DNA was equalised using plasmid pUC9. Each 
transfection was done in duplicate, one for the CAT assay and the another for western blot 
to monitor the expression of the proteins from the transfected plasmids. Transfected cells 
were harvested on the next day, and one fifth of the crude cell extract was processed for a 
CAT assay, followed by thin layer chromatography (TLC). When cells were transfected 
with ICPO alone, without HPI plasmid, the ICP6 promoter was highly activated by ICPO, 
resulting in a high CAT activity (up to 90% conversion of substrate to product) (Fig. 
3.17 A). Significantly, when cells were co-transfected with ICPO and HP 1 expression 
plasmids, the activation of the CAT reporter by ICPO was greatly inhibited by HPI protein 
in a dose-dependent manner (Fig. 3.l7A). Western blotting using anti-ICPO antibodies 
revealed that ICPO was expressed equally in each transfection sample and increased HPI 
levels did not affect ICPO expression. These results suggest that the transcription 
activation of the early gene promoter via ICPO was inhibited by HPl, but that HPI has no 
significant effect on the expression ofICPO (Fig. 3.17B). 
3.4.2 hDaxx 
In addition to HPl, the Fas-binding protein hDaxx was recently identified as a PML-
interacting protein in a yeast two-hybrid screen (Li et al., 2000). The study also reported 
that hDaxx colocalised with PML in NDIO and had transcriptional repressor activity. 
Based on the same localisation of hDaxx with the viral protein ICPO and being a 
transcriptional repressor, it is possible that hDaxx might regulate viral gene transcription. 
Following the system already described for HPI study, the activation of the ICP6 promoter 
via ICPO was drastically inhibited by OFP-hDaxx fusion proteins in a dose-dependent 
manner. Notably, the transcription of CAT was decreased by 70% when cells were 
transfected with lOng ofpEOFP-NLS-hDaxx plasmid and was completely repressed when 
cells were transfected with sOOng of the hDaxx expression plasmids (Fig. 3.l8A). 
Furthermore, western blotting using antibodies against ICPO and OFP proteins 
demonstrated that expression of ICPO, driven by HCMV promoter, was also repressed by 
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Fig. 3.17 Effect of HP I on transactivation of an ICP6 expre sion cassette by lCPO in 
Vero cells . 
Cells were co-transfected with reporter plasmid pSS80 (TCP6 promoter linked to the 
CAT gene), ICPO expression plasmid pCI-rtag-cICPO and the indicated amounts of 
plasmid express ing HP I fo llowed by CAT assay (see Materials and Methods section). 
A. The TLC result of CAT assay (upper panel) was ana lysed by using the 
Phosphorimager ana lysis system and the data were analysed to ca lcu late the 
percentage conversion of substrate to product (midd le panel). The decrea e of CAT 
activ ity was more significant when more HP 1 protein was expre ed. 
B. The western blot ana lysis of total ce ll proteins in samples transfected in paralle l 
with the same amount of plasmid and probed for ICPO are shown below. Repre or 
HP 1 did not affect the expression of ICPO, since ICPO was equall y expressed among 
samples. The results of this single experiment were reproduced on severa l independent 
occasions. 
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Fig. 3.18 Effect of GFP-hDaxx on transactivation of an lCP6 expression cassette by 
ICPO in Vero cell s. 
Cell s were co-transfected with reporter plasmid pSS80 (lCP6 promoter linked to the 
CAT gene), ICPO expression plasmid pCI-rtag-c1CPO and the indicated amounts of 
pEGFP-nls-hDaxx plasmid followed by CAT assay ( ee Materials and Method section). 
A. The TLC result of CAT assay (upper panel) was ana lysed by using the 
Pho phorimager analys is system and the data were analysed to ca lcu late the percentage 
conversion of substrate to product (lower panel). The decrease of CAT activity was 
more significant when more hDaxx protein was expre sed. 
B. The western blot analysis of total cell protein in samples tran fee led in parallel with 
the same amounts of plasmid and probed for GFP-hDaxx and I PO are shown below. 
Expression of ICPO was repressed by hDaxx. The result of thi single experiment were 
reproduced on several independent occasions. 
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OFP-hDaxx in a dose-dependent manner (Fig. 3.l8B). This raises the question as to 
whether the inhibition of CAT activity seen in the sample expressing a high level of OFP-
hDaxx is simply due to the reduction in ICPO expression or whether OFP-Daxx causes a 
global effect on both HCMV and ICP6 promoters? The CAT activity in sample 3, 
expressing a high level of OFP-Daxx, was one third of that in sample 2 (hDaxx mock 
transfection), whereas ICPO was equivalently expressed in those two samples (Fig. 3.18). 
In addition, although ICPO was expressed at a lower level in sample 6, the CAT activity 
was under the basal transcription level obtained from sample 1, which is an ICPO mock 
transfection control. This suggests that OFP-hDaxx strongly represses transcription from 
the ICP6 promoter induced by ICPO. 
Similar experiments were performed to confirm that the inhibition of transcription is 
resulting from expression of hDaxx but not OFP. To generate a plasmid expressing the 
entire hDaxx protein without OFP, firstly, two fragments (BamH I-Hind III and Hind 111-
Xba I) containing full-length ofhDaxx ORF, were subcloned from the pEOFP-NLS-hDaxx 
plasmid into pCDNA3.1+ vector digested with BamH I-Xba I. Following the same 
strategies, a consistent result was obtained. As shown in Fig. 3.19, without hDaxx 
transfection, ICPO strongly induced ICP6 promoter activity, resulting in nearly 100% 
conversion of substrate to product, while the CAT activity was repressed by more than 
50% when cells were cotransfected with lOng of plasmid pcDNA 3.1IhDaxx. Notably, the 
CAT activity was lower than the basal level when 500ng of hDaxx expression plasmid was 
introduced into cells, indicating that hDaxx possessed a strong transcription repression 
activity. 
3.4.3 SUMO-l 
Results from 3.3.2A.l demonstrated that transfected cells over-expressing SUMO-I 
had a lower infectivity compared with untransfected cells. Furthermore, recently, Li et al. 
(2000) reported that in transient transfection assays, the transcriptional repression mediated 
by hDaxx was reversed by co-expression of wild type PML, while a PML mutant lacking 
SUMO-! modification sites was less effective. To examine whether SUMO-l itself affects 
the transactivation function of ICPO or whether SUMO-I is involved in the function of 
hDaxx in transcriptional repression, a multiple plasmid transfection was performed. As 
illustrated in Fig. 3.20, compared with the CAT activity of samples transfected with hDaxx 
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Fig. 3.19 Effect of hDaxx on transactivation of an ICP6 expression cassette 
by ICPO in Vero cells. 
Cells were co-transfected with reporter plasmid pSS80 (ICP6 promoter linked 
to the CAT gene), ICPO expression plasmid pCI-rtag-cICPO and the indicated 
amounts of pcDNA3-hDaxx plasmid fo llowed by CAT assay. 
The TLC result of CAT assay (panel A) was analysed by usmg the 
Phosphorimager analysis system and the data were analysed to calcu late the 
percentage conversion of substrate to product (panel 8). The decrease of 
CA T activity was more significant when more hDaxx protein was expressed. 
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Fig. 3.20 Effect of SUMO-1 on repression function of hDaxx on transactivation 
of an ICP6 expression cassette by ICPO in Vero cells. 
Cells were co-transfected with reporter plasmid pSS80, the indicated amounts of 
ICPO expression plasmid pCI-rtag-cICPO, pEGFP-n ls-Daxx and SUMO-l 
plasmids followed by CAT assay (see Materials and Methods section). 
The TLC result of the CAT assay (upper panel) was analysed by using the 
Phosphorimager analysis system and the data were analysed to calculate the 
percentage conversion of substrate to product (lower panel). Addition of 
SUMO-l had a slight effect on the activation of the ICP6 promoter (group A). 
However the CAT activities in group 0 had no significant differences from the 
CA T activities in groups Band C which were transfected with various amounts 
of the SUMO-I expression plasmid. 
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(group D), expression of SUMO-l triggered a very moderate repression of transcription 
even at high amounts of SUMO-l transfection (sample in group A). In addition, results 
from cells cotransfected with various amounts of SUMO-I (group B: 25 ng, group C, 
lOOng, and group D mock) demonstrated that the increase in SUMO-I concentration did 
not alter levels of the transcriptional repression mediated by hDaxx. These observations 
suggest that expression of exogenous SUMO-I appeared to have no direct effect on 
transcription regulation function of hDaxx. 
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3.5 Discussion 
The antiviral cytokine interferon increases the expression of ND 1 0 proteins PML and 
SplOO, leading to an increase in the size and number of NDI 0 foci (Grotzinger et ai., 
1996). Since many DNA viruses express proteins that cause redistribution of ND I 0 
proteins such as PML and SplOO, it is possible that ND10 associated proteins may playa 
part in an antiviral mechanism in host cells. Ifso, the increase in expression level ofNDlO 
proteins or their SUMO-l modified forms may promote resistance to viral infection. 
Transient transfection using electroporation and lipofection with a 40-50% 
transfection efficiency greatly increased the expression of ND 1 0 associated proteins (Fig. 
3.9- 3.12). However progression of viral infection was not affected by the raised NDlO 
protein levels. It was observed that in singly transfected cells, only a very low proportion 
of PML and Sp 1 00 was covalently modified by SUMO-I, and most overexpressed PML 
was in the unmodified form (Fig. 3.11A), and located throughout the nucleoplasm (data 
not shown). This implies that transiently overexpressed proteins may not produce their 
proper biological activity. In addition, since SUMO-l has been found to be a factor 
promoting the recruitment ofPML into NDIO structures (Muller et al., 1998), this finding 
suggests a possibility that the amount of endogenous SUMO-l may be not sufficient to 
modify all the overexpressed NDIO proteins. To improve the SUMO-l modification level, 
plasmids expressing SUMO-l and Ubc9 were cotransfected into BHK cells. The results 
from 3-plasmid and 4-plasmid cotransfections showed that at an early time of infection, the 
initiation of HSV-l infection in transfected cells were decreased by two-fold compared to 
untransfected cells, but no significant effect on the progression of viral infection at 6 hpa 
was observed (Fig. 3.15, 3.16). Taken together, this study indicates that transfected cells 
expressing high levels of NDIO proteins conferred a marginal resistance to infection by 
HSV-l at an early time of infection, 2 hpa, but did not appear to compromise the overall 
efficiency of HSV -1 infection in Hep-2 and BHK cells. 
It has been reported that some DNA viruses, such as HSV-I and HCMV, disperse 
ND 10 structures at early times of infection by the action of their immediate early gene 
products, ICPO and lEn respectively' (Everett & Maul, 1994, Korioth et al., 1996). It is 
not clear whether dispersion ofNDlO is advantageous to the viral infection, but in the case 
of ICPO and lEn, loss of these proteins reduces productive infectivity at low multiplicities 
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of infection. These findings imply that if ND lOis a crucial factor for the establishment of 
productive virus infection, then this structure must be the premier target for viral proteins 
(for example ICPO) early in infection. However, HFL cells pre-treated with heat shock 
lose the integrity of the NO I 0 structure, but this did not affect or increase the susceptibility 
for HSV-I infection (Table 3.1). This suggests that while the interaction between NDIO 
and ICPO may playa role in the initiation of viral infection, it can not be a simple case of 
disruption of the cellular structure of itself. It is clear from the results of many other 
studies that the mechanism by which ICPO disrupts NOlO is an essential factor in its ability 
to stimulate viral infection and increase gene expression. 
The limitation of the transfection study is that an ideal cell line to study the function 
of ICPO, in terms of viral-host cell interactions, is HFL (human foetal lung) cells in which 
the virus has a high requirement for ICPO. However, HFL cells are poorly transfectable 
and therefore not amenable for this type of analysis. Apart from this, infection with lower 
input virus « 0.1 MOl) or at early times of infection «2 hpa), the fluorescence of ICPO 
and UL29 were too faint to be detected. Due to the dynamic property of NOlO structure 
and the function of ICPO in an MOl-dependent manner, a suitable cell line, virus inputs, 
and infection times are important factors that should be considered in the study of ICPO-
NO 10 proteins interaction by these methods. A further 1imitation of these methods is that 
the scoring of both transfected and infected cells was simply by presence or absence of 
signal above background, and not by the intensity of signal. This means that if relatively 
reduced levels of viral proteins occurred in cells expressing. high levels of exogenous 
NO 1 0 proteins, such inhibition would not be detected by this analysis. Indeed, the method 
could only detect high levels of inhibition as any more moderate effects would be less 
likely to reduce the number of vi rally infected cells scored as positive. 
Although results from transient transfection in this chapter shown that overexpression 
of NOlO proteins does not significantly compromise HSV-I infection, two NOlO 
associated proteins, hDaxx and HP 1 strongly repressed the activation of transcription 
induced by ICPO as detected by CAT assay. SUMO-I modification of PML has been 
shown to efficiently inhibit the hDaxx-mediated repression (Li et al., 2000). However 
exogenous expression of SUMO-I did not increase the repression activity of hDaxx in 
CAT assay (Fig. 3.20). These observations implicate a possible role of NO I 0 constituents 
involved in the function of viral proteins. 
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Chapter 4 Characterisation of human neuronal committed 
teratocarcinoma NT2 cells and their infection by HSV-1 
After primary infection, HSV -1 remains in a latent state in nervous tissue for the 
lifespan of the host. This latent infection may be reactivated by various stimuli, including 
stress. As described in some detail in the Introduction, the mechanism controlling 
reactivation from latency is not fully understood, since no single animal or cultured cell 
model has been established to mimic the situation in the natural human host exactly. Many 
in vitro studies have used rat or mouse cultured explanted foetal neurons or neuronal-like 
cell lines, since there are difficulties in using primary human neurons. Rodent cells do not 
readily lend themselves to examination of their NO 1 0 structures since most antibodies 
available recognise only human forms of the major constituent proteins. Therefore we 
sought to use a human neuronal cell line to study the interaction of viral proteins with 
cellular factors during lytic or latent infection in cultured cells with at least some 
resemblance to human neurons. 
The NT2 cell line, derived from a hwnan teratocarcimona, represents a committed 
neuronal precursor stage of differentiation (Pleasure & Lee, 1993, Pleasure et al., 1992). 
NT2 cells can be induced by retinoic acid to differentiate in vitro into a mixture of 
postmitotic cells that resemble central nervous system (CNS) neurons since they express 
many well-defined neuronal markers and elaborate axonal and dendritic processes (hNT 
neurons) (Pleasure et al., 1992). Furthermore, NT2 cells can be transfected, allowing for 
the study of genes of interest in a neuronal precursor environment. 
The aims of this study were to investigate the characteristics ofNDIO and HSV-l gene 
expression and replication in both NTI and the differentiated hNT cells. I also aimed to 
assess the role of ICPO in the interaction with NDIO proteins and in viral infection in these 
cell lines. 
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4.1 The expression status of ND10 proteins in NT2 cells 
The expression pattern of ND 10 proteins in NT2 cells, prior to retinoic acid induced 
differentiation, was determined and compared with fibroblast HFL cells by staining these 
cells with antibodies recognising constituents ofNDIO, such as PML (rS), SplOO (SpOH), 
and hDaxx (r1866) as well as a centromere protein, CENP-C (r554). On average, there 
were less than 10 foci of PML in each NT2 cell (Fig. 4.1A) and in many NT2 cells, the 
distribution of PML was commonly seen to be as short rods or strings of small PML foci 
throughout the nucleoplasm (see the inset in Fig. 4.lA). Surprisingly, expression of SplOO 
in NT2 cells was not detectable by immWlofluorescence (Fig. 4.1 B). The staining of hDaxx 
was present throughout the nucleus of NT2 cells with a high background of diffuse 
material, within which many large and small clumps ofhDaxx were observed (Fig. 4.1C). 
In HFL cells, as with many other cultured human cell lines, the major NDIO 
components Sp 1 00, PML, and hDaxx were observed in distinct foci with an average 
number of around 20 to 30 per nucleus (right-hand panel in Fig. 4.1). In NT2 cells, as 
compared with HFL cells, there were fewer PML and hDaxx foci of various sizes and 
Sp 1 00 was absent in NT2 cells. In contrast to the unusual staining profile of ND 1 0 
proteins, staining of CENP-C was quite similar in both NT2 and HFL cells (Fig. 4.1 D). 
Double staining for PML and hDaxx revealed that the majority of hDaxx foci were 
perfectly colocalised with PML in the nucleus of HFL cells, whilst in NT2 cells, many 
hDaxx foci were separate from PML (Fig. 4.2A). As reported, hDaxx accumulates at both 
ND 1 0 and centromeres, although the association of hDaxx with these two structures varies 
between cells, and represents a dynamic distribution dependent on cell status (Everett et al., 
1999b). To explore the association of hDaxx in NT2 cells, double labeling with antibodies 
for hDaxx (rlS66) and centromeres (human serum OS) showed that hDaxx proteins were 
preferentially associated with centromere structures (Fig. 4.2B). In HFL cells, however, 
only a small proportion ofhDaxx was localised in the vicinity of centromeres (Fig. 4.2B). . 
154 
Results and Diseu sions haraeterisation of T "ells and their injection hy /I. 'V- I 
NT2 HFL 
Fig. 4.1 ompari on of the appcaran II 
NT2 (left-hand panel) and HFL (right-hand pan I) II w r tain d 10 
and centromere protein as lab I d in th right-t p in a h imag " Th 
statu of ND I 0 proteins in NT2 c II wa d i tin t rr m that in II . L 
was no detectable pi 00, and few r PML and hOa ~ i in N 2 II 
pr SI n 
II " Th r' 
155 
Fig. 4.2 Distinct expression pattern ofNDlO and centromere proteins in HFL, NT2, and 
hNT cells. 
Confocal micrographs of the three cell lines are presented, as indicated by white lettering. 
(A) The labeled proteins are indicated in the top row and are the same in each vertical 
row of panels. PML was stained with mouse MAb 5EIO (green), and the cells were also 
stained With SpGH (left-hand panels), rabbit serum r1866 (center panels), or rabbit serum 
r554 (right-hand panels) for SplOO, hDaxx, and CENP-C, respectively. There is no 
Sp 100 expression and less PML expression in NT2 cells, and PML does not colocalise 
efficiently with hDaxx. In HFL and hNT cells, PML extensively colocalises (yellow) 
with Sp 100 and hDaxx but not with CENP-C. 
(B) localisation of hDaxx (green) and centromere proteins (red). Cells were double 
labeled with rl866 and human serum ACA-GS which contains antibodies against several 
centromere proteins. In NT2 cells, a significant proportion of centromeres are associated 
with local accumulations ofhDaxx, but this occurs more rarely in HFL and hNT cells. 
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4.2 Differentiation of precursor NT2 cells to hNT neurons 
The methodology used for the differentiation of NT2 cells to hNT neurons was 
described in the Materials and Methods chapter (section 2.2.8B). A time course experiment 
was employed to monitor the development of ND 1 0 structures throughout the 6-week 
differentiation process. NT2 cells from the same flask were split and seeded into 35-mm 
Petri dishes with 4 coverslips in each plate and then cultured in medium containing 10IJM 
retinoic acid at 37°C. The cells were stained for NDIO proteins including PML, SpIOO, 
hDaxx, as well as a centromere protein, CENP-C, after a period of differentiation of 1 day, 
I week, 3 weeks, 5 weeks, and 6 weeks. During retinoic acid induction, the localisation 
patterns of ND I 0 changed gradually and displayed characteristics more similar to those of 
differentiated fibroblast HFL cells (Fig. 4.3). Intriguingly, after a 3-week treatment of 
retinoic acid, the expression level of SplOO was increased dramatically, with the novel 
SplOO foci colocalising with PML (Fig. 4.3). 
A 6-week induction of NT2 cells with retinoic acid followed by incomplete 
purification (as described in section 2.2.8B), resulted in a population of cells with more 
than 30% having a significant neuronal phenotype. The morphology of hNT cells observed 
by phase contrast microscopy showed that the average size of differentiated hNT neurons 
was larger than that of NT2, with typical multiple lengthy cell processes (Fig. 4.4). 
Staining of hNT neurons for PML and Sp 1 00 presented a similar expression profile of 
NO I 0 to that of HFL cells, except that the fluorescence intensity of both proteins was 
comparatively bright in the hNT cells. More than 20 foci of ND 1 0 were seen on average 
per cell, and these foci showed perfect co-localisation ofSplOO with PML (Fig. 4.2A). In 
addition, the string-like accumulations of PML were observed in some hNT neurons (Fig. 
4.2A). The clumps ofhDaxx accumulation observed in NT2 cells were no longer present in 
the differentiated hNT neurons and in contrast to NT2 cells, hDaxx was strongly associated 
with PML and much less associated with centromeres (Fig. 4.28). Therefore a significant 
alteration in NO I 0 composition and NO 1 0 protein localization has occurred during the 
differentiation process. 
The expression level of ND I 0 proteins in the three cell lines was also quantified by 
western blot analysis. An equal number of cells from HFL, NT2 and hNT neurons were 
simply lysed in a boiling mixture, and the proteins were separated by SDS-PAGE and 
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Fig. 4.4 A differentiated hNT neuron. 
NT2 cells differentiated to hNT neurons by 
induction of retinoic acid for 6 weeks. The 
typicaJ multipJe length celJ processes were 
observed in differentiated hNT neurons 
(shown in blue fluorescence). 
Note: the red fluorescence in the nucleus was 
labelled for centromer protein, CENP-C. 
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detected by antibodies against PML, SplOO as well as an antibody for actin as an internal 
control. In hNT neurons, long-term induction of retinoic acid resulted in an extreme 
increase in the unmodified and SUMO-I modified forms of both PML and Sp 1 00. 
Moreover, the expression of both NDIO proteins in hNT neurons was even higher than 
that in HFL cells (Fig. 4.5). SUMO-I modified PML was hardly detectable in NT2 cells 
(Fig. 4.5). Therefore the differences in NDIO morphology and composition between HFL, 
NT2 and hNT cells can be correlated in changes in the biochemical characteristics of the 
major ND 10 proteins. The abnormal appearance of ND lOin NT2 cells appears to be 
caused by lack of SplOO expression, low levels of PML expression, poor SUMO-I 
modification of PML and, probably in consequence, lesser amounts of associated hDaxx. 
4.3 The susceptibility of NT2 and hNT cells to HSV-1 infection 
4.3.1 The temporal progression ofHSV-l infection in NT2 cells 
At least three DNA viruses, including HSV-I, have a tendency to deposit their parental 
genomes adjacent to NDIO, from where viral replication begins (Ishov & Maul, 1996). It 
has been reported that rodent neuroblastoma cell lines were poorly infected by HSV -I due 
to the inefficient transcription of IE genes (Kemp et ai., 1990), however the ability of HSV-
1 to infect human neuroblastoma cell lines has not been rigorously studied. Together with 
the results described in sections 4.1 and 4.2 which illustrate that NT2 cells contain unusual 
NDIO with fewer PML foci and no detectable SpIOO, it was interesting to explore whether 
HSV -I replicates successfully in NT2 cells. To this end, the efficiency of HSV-I 
replication in NTI cells was compared with that in HFL cells. Both cell lines were infected 
by HSV -I at an MOl of 1 pfu per cell for 12, 24, 36, and 48 hours and the yields of the 
progeny viruses were determined in BRK cells. At early times of infection, the yields of 
HSV -1 from NT2 cells were around 10-fold lower than in HFL cells, but after 36 hpa, viral 
yields were just slightly reduced in NTI cells (Fig. 4.6). 
4.3.2 Infection of HSV-l in NT2 cells and hNT cells 
To study the susceptibility of both NT2 and hNT cell lines to HSV-I infection in more 
detail, cells were infected with various multiplicities ranging from 50 to 0.01 pfu per cell. 
Results from the time course of HSV -1 infection in NTI cells (Fig. 4.6) show that the 
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HFl NT2 hNT HFl NT2 hNT 
Fig. 4.5 Western blot analysis of the expression patterns of Sp I 00 and 
PML in HFL, NT2, and hNT cells. 
The left-hand three tracks show PML species detected by 5E 1 0, with actin 
detected simultaneously as the internal control. The right-hand three lanes 
show the same filter after stripping and re-probing for Sp 100 with SpGH. 
The arrows mark the presumed unmodified forms of PML or Sp 100, and 
the arrowheads indicate the high molecular mass isoforms of PML and 
Sp 1 00. NT2 cells do not express Sp 1 00, whereas in hNT cells, long-term 
induction of retinoic acid results in a drastic increase of both unmodified 
and modified forms of SplOO and PML. The extent of SUMO-J 
modification ofPML is reduced in NT2 cells. 
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Fig. 4.6 Growth curves of HSV -1 strain 17+ in HFL and NT2 cells. 
Cells were infected with the virus at 1 pfu per cell and both cells 
and medium were harvested at the indicated times after infection 
and progeny virus titers were determined on BHK cells. The data 
are the average of two independent experiments. 
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exponential stage of viral replication was between 12 to 36 hpa, and therefore progeny 
viruses were harvested and titrated in BRK. cells at 36 hours postinfection. In general, the 
yields of progeny viruses from NT2 cells were lower than from HFL cells, and this 
reduction was slightly more pronounced in hNT neurons (Table 4.1). While the yields of 
progeny virus in NT2 and hNT cells were only modestly reduced after high multiplicity 
infection, virus yields were extremely reduced when the virus input was less than 1 pfu per 
cell. For instance, compared with HFL cells, at an input multiplicity of 0.01, the fold 
reduction was 414 and 1,228 in NT2 and hNT neurons respectively (Table 4.1). No 
significant difference in viral yields was noticed in HFL cells among the various virus 
inputs at 36 hpa (Table 4.1). This effect might be due to the relatively efficient replication 
of wild type HSV-l in HFL cells, enabling multiple rounds of infection at this length of 
incubation. 
4.4 Viral gene expression in NT2 and hNT cells 
4.4.1 Results from western blot analysis 
To explore the efficiency of viral gene expression in NT2 and hNT2 cells, the cells 
were infected by HSV-I at various MOIs and were harvested at 1, 2, 3, 4 hours post 
infec~ion. Total cell extracts were probed for IE proteins ICPO and ICP4 as well as for 
products of typical E genes such as UL29, UL39 and UL42. At high multiplicity of 
infection (5 pfu per cell), viral gene expression was extremely inefficient in hNT neurons; 
even at 4 hours after infection only ICPO was observed (Fig. 4.7 A). In NT2 cells, 
expression of the two IE genes was slightly greater than in HFL cells, whereas all the early 
genes were less well expressed in NT2 cells (Fig. 4.7 A). This phenomenon was more 
significant when virus input was reduced to 1 pfu per cell (Fig. 4.7B). By 2 hpa in NT2 
cells, expression of ICPO was detected at a higher level than in HFL cells, but the two early 
genes UL39 and UL29 were observed only after 4 hours of infection. In contrast to 
infections in NT2 cells, the early genes UL39 and UL29 were highly expressed in HFL 
cells after infection for 3 hours and expression of UL29 was even higher than ICPO at 4 hpa 
(Fig. 4.7B). These effects of reduced viral gene expression in NT2 cells compared to HFL 
cells were more obvious at a multiplicity of 0.2 (Fig. 4.7C). In NT2 cells, the only viral 
gene expression detected was that of ICPO, even after 4 hours of infection (Fig. 4.7C). The 
relatively high levels of ICPO expression in NT2 cells in these experiments suggest 
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Table 4.1 Replication of HSV -1 strain 17+ in HFL, NT2, and hNT cellsa 
r Titer (pfu/ml) at 36 hr in cell type Fold reduction 1 
Input MOlb HFL NT2 hNT NT2 hNT 
50 9.4 X 107 7.4 X 107 1.2 X 107 1.3 7.8 
10 6.3 x 107 2.7 X 107 1.0 X 107 2.4 6.3 
1 6.2 x 107 1.9 x 107 5.6 x 106 3.0 11 
0.1 7.8 x 107 1.1 X 106 6.8 X 105 70 114 
0.01 7.3 x 107 1.8 x 105 5.9 x 104 414 1,228 
a The three cell types were infected with HSV -1 strain 17+ at the indicated 
multiplicities, and then the cells and medium were harvested after 36 hr and 
sonicated. The virus progeny was titrated on BHK cells. The fold reduction of 
virus titers in NT2 and hNT cells compared to hNT cells is shown. Note that 
the yields of virus in HFL cells do not decrease with multiplicity because rapid 
viral replication ensures all the cells become infected during the time course of 
the experiment. 
b MOl, multiplicity of infection. 
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Fig. 4.7 Comparison of the rates of viral gene expression in HFL, NT2 and differentiated hNT cells. 
Cells were infected with 5 (A) 1 (B) or 0.2 (C) pfu per cell of wi ld type HSV -1 strain 17+ and 
harvested at 0 (labeled as m), 1, 2, 3, and 4h after absorption (hpa), then processed by SDS-PAGE 
and western blot analysis. A mixture of antibodies recognising several viral proteins was employed 
to detect IE proteins ICPO and ICP4, and also E genes UL39, UL29, and UL42 (as indicated on the 
left). The expression levels ofICPO and ICP4 genes are relatively higher in NT2 cells compared to 
HFL cells, and the rate of appearance and relative amounts of the E proteins are reduced in NT2 cells. 
In hNT cells, little viral gene expression, apart from ICPO, is apparent. (B-C) At the lower MOl 
infection, expression of viral E genes is again much slower in NT2 than in HFL cell s. 
Note that the use of the western blot approach means that the absolute levels of the proteins are not 
being measured, but that the results clearly demonstrate differences between relative expression 
levels of the proteins in the different experimental conditions. 
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that the defect in the expression of other viral proteins is not due to failure of the virus to 
penetrate the cell. Instead, the cells appear to be blocked at a stage when ICPO is being 
expressed, but the infection fails to develop to the later stages. 
4.4.2 Immunofluorescence detection of viral proteins 
The results of the western blot analysis (Fig. 4.7) show the viral gene expression 
profiles in populations of infected cells in the three cell lines. However, the defect in viral 
gene expression in NT2 cells could be explained by a low proportion of infected NT2 cells 
expressing very high levels of ICPO while the other cells fail to be infected at all. To 
investigate this possibility, an immunofluorescence assay was employed to detect viral gene 
expression in infected HFL, NT2, and hNT neurons. At 2 hours after infection, with a 
multiplicity of 1, most HFL and NT2 cells were detectably infected as judged by the 
expression of ICPO, whereas only a few hNT neurons were infected (Fig. 4.8A). Although 
ICPO was expressed with an equivalent efficiency in NT2 and HFL cells, the expression of 
UL29 in NT2 cells was much less efficient than in HFL. cells and no infected hNT neurons 
progressed to the early gene expression stage (Fig. 4.8A). Similar results were obtained 
from a later time point, at 8 hpa (Fig. 4.8B). At this time, almost all the infected HFL cells 
had progressed to the expression of early proteins, but only 50% of infected NT2 and hNT 
neurons expressed UL29 (Fig. 4.9A). This effect was more significant at lower virus input 
multiplicities. On reduction of the multiplicity to 0.1 pfu per cell, at 2 hpa, one fourth of 
infected HFL cells expressed UL29, but none of the infected NT2 cells expressed UL29 
(Fig.4.9B). The deficiency in the progression of viral infection in NT2 cells and hNT cells 
was not overcome by elongation of the length ofinfection to 8 hours (Fig. 4.9B). 
4.5 Infection of NT2 and hNT cells with an tCPO·deficient virus 
The efficient expression of ICPO, but not other viral proteins, in NT2 and hNT neurons 
implies that the induction of gene expression by ICPO is not very effective. Two ICPO-
deficient mutant viruses were used to investigate the function of ICPO in viral infection of 
NT2 cells and hNT neurons. The mutants selected for this study included the ICPO null 
mutant d11403 and the USP7 -binding negative mutant MI. It had been reported that dl1403 
has a severe multiplicity-dependent growth defect in HFL cells and that this defect varied 
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ICPO UL29 
B.8hpa 
ICPO 
Fig. 4.8 Inefficient progression of viral infection in NT2 and hNT cells. 
UL29 
HFL (top panels), NT2 (middle panels), and hNT (bottom panels) cells were infected 
with wild-type stain 17+ at 1 pfu per cell. Infected cells were fixed 2 (A) and 8 (B) hr 
after absorption and prepared for immunofluorescence and simultaneous staining for 
ICPO (left-hand panels in each time point of infection) and UL29 (right-hand panels in 
each time point of infection), using MAb 11060 and serum r515 as markers of viral IE 
and E gene expression. At a early time of infection (2hpa) in hNT cells, the number of 
infected cells expressing ICPO and UL29 is much less than in HFL and NT2 cells. The 
number ofNT2 cells expressing ICPO is equivalent to the HFL infections, but relatively 
few T2 cells are expressing large amount of UL29. The deficiency in the progression 
of viral infection in NT2 and hNT cells was not overcome at 8hpa. 
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Fig. 4.9 Comparison of the rates of viral gene expression in HFL, NT2 and 
differentiated hNT cells. 
Cells were infected with 1 (A) or 0.1 (B) pfu per cell of wild type HSV-l 
strain 17+ and immuno-stained for ICPO and UL29 2 and 8 hours post 
infection (hpa) followed by statistical analysis of the efficiency of infection. 
168 
Results and discussions Chapter 4 Characterisation olNT2 cells and their infection by HSV-I 
defect varied between cell types (Stow & Stow, 1986). To compare the yields of these 
viruses in the various cell types, the titres of the viral stocks were first titrated in U20S 
cells in which ICPO function is not required, thus allowing efficient replication of wild type 
and ICPO mutant viruses (Yao & Schaffer, 1995). HFL and NT2 cells were infected by 
each virus at various MOIs, and the progeny virus was again titrated in U20S cells to 
remove any bias in the results that would result from titration in a cell line that was less 
permissive for the ICPO mutant viruses. The yields of d11403 progeny viruses were 
relatively lower in HFL cells compared to wild type virus, even at an MOl of 500 (Table 
4.2). However, the results presented show that replication of d11403 in NT2 cells was 
extremely poor, particularly at a low multiplicity of infection (Table 4.2). At a multiplicity 
of 5 this mutant virus replicated a further 69-fold less in NT2 cells than in HFL cells, and 
extension of the infection to 48 hours did not affect the results (Table 4.2). In NT2 cells, 
MI virus replicated less well than 17+, but relatively efficiently compared to d11403 (Table 
4.2). Interestingly, the ability of Iere to bind to USP7 appeared to be very important in 
NT2 cells. At 36 hpa with a multiplicity of 0.01, Ml virus had an approximate 2500-fold 
reduction of progeny viral yield in NT2 compared to HFL cells (Table 4.2). This finding of 
the poor growth of MI in NT2 cells was also supported by results using another USP7-
binding negative mutant virus, D12, in which ICPO residues from 494 to 633 had been 
deleted (Meredith et al., 1995). The results revealed that D 12 virus replicated very 
inefficiently in NT2 cells and the fold reduction was very similar to that seen with MI (data 
not shown). In hNT neurons, the fold reduction of progeny virus yields from dl1403 and 
MI viruses were similar to those in NT2 cells, although MI virus replicated slightly better 
in hNT neurons than in NT2 cells (Table 4.2). 
4.6 Characterisation of the function of ICPO in NT2 cells 
Results from western blot analysis revealed that ICPO was relatively highly expressed 
in NT2 cells but early proteins were not. This defect was particularly evident at low 
multiplicities of infection (Fig. 4.7B, 4.7C). In addition, at an equivalent efficiency of ICPO 
expression during infection, the progression of HSV -1 infection was much slower in NT2 
cells compared with HFL cells, since only a small portion of infected NT2 cells could 
successfully progress to the early stage of infection, even at 8 hpa (Fig. 4.9). Furthermore, 
the ICPO-null virus, d11403 had severe growth deficiency (Table 4.2) and another ICPO-
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Table 4.2 Efficiency of replication ofHSV-l strain 17+ and ICPO mutants d11403 and Ml in 
HFL, NT2, and hNT cellso 
Titer (pfu/ml) at 36 b Fold reduction 
Virus and input MOIb 
HFL NT2 HFLvs. NT2 HFLvs. NTl NTlvs. bNT 
at 36 b at 48 h at 36 b 
0.01 2.0 x 108 4.3 x lOS 465 244 3.0 
17+ 0.1 8.7 x 107 8.7 x 1()6 10 12 1.6 
7.1 x 107 2.8 X 107 3 3 3.7 
dl1403 5 3.8 x 10' S.S x 1()4 69 77 4.7 
50 8.2 x 10' 5.1 x lOS 16 10 1.2 
500 7.6 x 10' 5.1 x lOS IS 10 2.5 
0.01 1.5 x 107 5.7 x 1()3 2667 26000 0.3 
Ml 0.] 7.1 x 107 6.1 x 104 1164 562 0.46 
1 7.3 x ]07 ].4 x lOS 514 17 0.57 
° Virus 17+, d11403 , and Ml were used to infect the three cell types at the indicated 
multiplicities (calculated on the basis of titration in U20S cells). Cells and medium were 
harvested 36 and 48h later and sonicated, and the progeny was titrated on U20S cells. Actual 
titration figures are given for the 36-h sample. The fold reduction of the virus titers in NTI 
compared to HFL cells are shown at the two time points. Note that the yields of virus in HFL 
cells do not decrease with multiplicity because rapid viral replication ensures all the cells 
become infected during the time course of the experiment. The high figure for the reduction of 
Ml replication at the lowest multiplicity in NT2 cells was due to further replication of the virus 
between 36 and 48 h in HFL cells but not in NT2 cells. Comparative yields of the viruses in 
NTI and hNT cells from a separate are given in the last column. vs. , versus. 
b MOl, mUltiplicity of infection. 
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defect virus, MI, grew very poorly in NT2 cells as compared to HFL cells (Table 4.2). 
These data suggest that ICPO is important for infection in NT2 cells, but even the wild type 
protein might not function normally in these two neuronal cell lines. To address this 
question, further experiments were performed to investigate the function of ICPO in NT2 
cells and hNT neurons. 
4.6.1 The stability ofNDI0 proteins in NT2 and hNT cells during HSV-l 
infection 
A significant virus-host interaction during HSV-l infection is that ICPO firstly 
colocalises with and then degrades PML, SpIOO, and CENP-C resulting in disruption of 
both NDIO and centromere structures (reviewed by Everett, 2000). The function of ICPO 
was explored initially by investigating the localisation of NO 1 0 and centromere proteins in 
NT2 and hNT cells during HSV -1 infection. Cells were infected by 17+ at an MOl of 1 for 
2 and 4 hours and double-labeled for ICPO and PML, hDaxx, or CENP-C. The samples 
were examined by confocal microscopy to determine the efficiency of disruption of NO 1 0 
and centromeres by ICPO. Compared to HFL cells, overall, NO 1 0 and centromere proteins 
were relatively stable in NT2 and hNT cells during HSV -1 infection. In up to 96% of 
infected HFL cells expressing ICPO, staining of NOlO proteins was not visible, even at 
early times of infection (Fig. 4.10). In contrast to the rapid loss of discrete staining of 
NO 1 0 proteins in infected HFL cells, 56% of infected NT2 cells retained intact PML foci at 
2 hpa, and in these cells the PML was associated with ICPO (Fig. 4.10, Table 4.3). 
Intriguingly, results obtained when NT2 cells were co-stained for ICPO and CENP-C 
revealed that at 2 hours after infection, in 55% of infected cells, ICPO strongly associated 
with and did not disperse CENP-C (Table 4.3). This association of ICPO and CENP-C was 
to a greater degree than that observed in other cell lines (Fig. 4.10). However, this 
association was dynamic, since at 4 hours after infection most ICPO was separate from 
CENP-C, yet the punctate CENP-C foci remained (Fig. 4.10). Similar results were 
obtained from cells stained for hDaxx and CENP-C (Table 4.3). At 4 hpa, no infected HFL 
cells contained discrete foci of PML, hDaxx, or CENP-C (Table 4.3). However, at 4 hpa, 
around one third of infected cells still retained punctate hDaxx staining, and the dispersal or 
degradation of PML was not affected by an extension of incubation, since more than 50% 
of infected NT2 cells contained punctate PML foci even at this time after 
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2hpa 4hpa 2hpa 4hpa 
Fig. 4. ]0 Comparison of the stability ofND10 and centromer in H -L, t 2h 
and 4h after the start of infection . HFL (top panel), T2 (middl pan I ), m 
pan I ) cells were infected with wild-typ H V stain 17+ at I pfu p r II. n r rt us tim r 
infection, cells were fixed and tained for 1 PO (MAb 11060) and PML (r (I fl-hflnd p~ irs r 
panel) or J PO and CENP- (r554) (right-hand pair of pan I ). th 10 and nLr m I' " a ' 
judged by PML and CENP- staining, are mor table in in(l t d 2 and h than in Il rL lis. 
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Table 4.3 Proportion of infected cells retaining NOlO proteins and CENP·C in infected HFL 
and NT2 cellsa 
% of infected cells retaining: 
Cell type PMLat: CENP-C at: hDaxx at: 
2h 4b 2b 4h 2h 4h 
HFL 4 0 0 0 0 0 
NT2 56 54 55 35 49 32 
a Cells were infected with wild-type HSV -1 stain 17+ at 1 pfu per cell and then fixed and 
double-stained for ICPO and PML, CENP-C, or hDaxx separately. The proportion of 
infected cells retaining punctate staining for PML, CENP-C or hDaxx was calculated after 
counting 300 infected cells per coverslip at the indicated times after virus adsorption. 
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infection (Table 4.3). Furthermore, in hNT cells, the loss of punctate ND 1 0 protein staining 
induced by ICPO was even less efficient than in NT2 cells (Fig. 4.10). It was noticed that, 
unlike in NTI cells, the association of ICPO and CENP-C was not significantly greater in 
differentiated hNT neurons than in HFL cells, although the effect of ICPO on centromere 
structures was less efficient in hNT neurons compared to HFL cells (Fig. 4.10). These data 
imply, rather intriguingly, that the localization of ICPO in NT2 and hNT cells is affected by 
the alterations in ND 1 0 structure and composition, and to a certain extent mirrors that of 
hDaxx in uninfected examples of these cell types. 
4.6.2 The trans activation ability of ICPO in NT2 cells 
ICPO has long been known to be a promiscuous transactivator of gene expression in 
cells transfected with an ICPO expression plasmid and a gene reporter cassette. A 
chloramphenicol acetyltransferase (CAT) enzyme reporter system was used to detect the 
transactivation activity of ICPO in NT2 cells. Because HFL and hNT cells are refractory to 
transfection, the ability of ICPO to activate gene expression in NT2 cells was compared 
with that in Vero cells (a line frequently used in the past to study the ability of ICPO to 
activate gene expression). The reporter cassette used for these experiments was pSS80, 
which contains the promoter of the ICP6 gene that had been shown in previous studies to be 
efficiently activated by ICPO in transfected cells. The amount of pSS80 used in the 
transfection was first optimized to give a detectable but low level of background 
expression. Next, cells seeded in Linbro-wells were co-transfected with pSS80 and various 
amounts of the ICPO expression plasmid pCI-rtag-cICPO. Each transfection was done in 
duplicate, one for the CAT assay and the other one for western blot to monitor the 
expression of the proteins from the transfected plasmids. Transfected cells were harvested 
on the next day, and one fifth. of the crude cell extract was processed for CAT assay, 
followed by thin layer chromatography (TLC). In Vero cells, the ICP6 promoter was 
highly transactivated by ICPO, resulting in up to 30-fold increases of CAT activity over the 
basal level (Fig. 4.11). The highest activation of CAT gene expression in Vero cells was 
detected from the cells transfected with 5-20 ng of ICPO plasmid. In contrast, activation of 
. expression from pSS80 by ICPO was negligible in NT2 cells (Fig. 4.11B). It was noticed 
that ICPO was less well expressed in NT2 cells compared to Vero cells transfected with the 
same amount of the ICPO plasmid (Fig. 4.IIC). However, 200 ng of the ICPO plasmid in 
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Fig. 4.11 Comparison of the transactivation of an ICP6 expression cassette by ICPO 
in NT2 and Vero cells. 
Cells were co-transfected with reporter plasmid pSS80 (ICP6 promoter linked to the 
CAT gene) and the indicated amounts of ICPO expression plasmid pCI-rtag-cICPO 
(see Materials and Methods section). The western blot analysis of total cell proteins 
of samples transfected in parallel with the same amount of plasmid and probed for 
ICPO are shown below. The results of this single experiment were reproduced on 
several independent occasions. 
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NT2 cells gave greater expression oflCPO than 20 ng of the plasmid in Vero cells, yet this 
level of ICPO in NT2 cells failed to activate gene expression (Fig. 4.11 B, 4.11 C). 
The previous results from western blot analysis of infected cells found that in NT2 
cells, in addition to ICPO, the IE protein ICP4 was also expressed at higher levels than in 
HFL cells (Fig. 4.7). As ICP4 is a potent transcriptional transactivating protein that is 
essential for early and late gene expression (DeLuca & Schaffer, 1985), this implies that the 
transactivation function of ICP4 may also be repressed in NT2 cells. To obtain more direct 
evidence that ICP4 activates gene expression less efficiently in NT2 cells, the ICP4 
expression plasmid p 175 was co-transfected into NT2 cells with the pSS80 reporter. CAT 
assays were used to detect the activation of the ICP6 promoter by ICP4 in NT2 cells 
compared with that in Vero cells. Again, the activation of gene expression induced by 
ICP4 was much lower in NT2 cells than in Vero cells (Fig. 4.12). Similar results were 
obtained with plasmid pgDCAT (Everett, 1986) that contains a gO reporter gene cassette 
(Fig. 4.13). These transfection experiments suggest that ICP4 is a poor activator of Early 
gene expression in NT2 cells, although the transactivator function of ICPO is even worse 
than that ofICP4 as compared to that in Vero cells. 
4.6.3 The establishment of a quiescent infection in NT2 and hNT cells 
During latency, the HSV-l viral genome resides in neuronal cell nuclei in a 
transcriptionally quiescent form, and ICPO can influence the balance between lytic infection 
and latency (Cai et al., 1993, Clements & Stow, 1989, Preston, 2000). Previous studies 
showed that, at a lower MOl, a virus deficient for ICPO, ICP4 and VP16 could establish and 
maintain a quiescent infection in human fibroblast cells and the quiescent viral genomes 
can be reactivated by exogenously expressed ICPO (Harris et al., 1989, Samaniego et al., 
1998). The poor growth of both wild type and ICPO mutant viruses in NT2 cells and the 
inefficient activity of ICPO in NT2 cells imply that a quiescent infection might be 
established in these cells. To test this possibility, NT2 and hNT cells were infected with 
dlI 4031LacZ, a relatively viable virus carrying an ICPO deletion and a lac Z gene driven by 
the HCMV promoter. This virus retains fully functional ICP4 and VPI6. After infection at 
an MOl of 0.02 (based on the titre in BHK cells) for 2 days at 37°C, the infected cells were 
directly stained for j3-galactosidase. A long incubation length of two days allows the virus 
to replicate and to form plaques if efficient infection occurs. 
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Fig. 4.12 Comparison of the transactivation of an ICP6 expression cassette by ICP4 
in NT2 and Vero cells. 
Cells were co-transfected with reporter plasmid pSS80 (ICP6 promoter linked to the 
CAT gene) and the indicated amounts of ICP4 expression plasmid p175 (see 
Materials and Methods section). The western blot analysis of total cell proteins of 
samples transfected in parallel with the same amount of plasmid and probed for ICP4 
are shown below. The results of this single experiment were reproduced on two 
independent occasions. 
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Fig. 4.13 Comparison of the transactivation of an gDCA T expression cassette by 
ICP4 in NT2 and Vero cells. 
Cells were co-transfected with reporter plasmid pgDCA T (glycoprotein D promoter 
linked to the CAT gene) and the indicated amounts of ICP4 expression plasmid p175 
(see Materials and Methods section). The results of this single experiment were 
reproduced on two independent occasions. 
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However, if a quiescent infection is established and the viral genome repressed, expression 
of p-galactosidase does not occur. The results demonstrated that in both NT2 and hNT 
cells, infection with dl1403ILacZ did not lead to expression of p-galactosidase (data not 
shown). Subsequently, the cells that had been infected with d11403ILacZ were super-
infected with wild type HSV -1, ICPO RING finger deletion mutant FXE, ICP4 mutant IsK, 
or the ICP4 tsKlICPO double mutant in1330 at a multiplicity of 3. After super-infection for 
8 hr at 38.5°C, the reactivation efficiency of the quiescent d11403ILacZ virus into lytic 
infection was determined by the proportion of cells expressing p-galactosidase. The results 
showed that the HCMV promoter present in the initial dl1403ILacZ quiescent infection was 
reactivated by super-infection with both wild type and IsK viruses, resulting in the 
expression of p-galactosidase (Fig. 4.14). On average, the quiescent viral genome was 
reactivated in around 17% and 8% of total NT2 cells super-infected with wild-type HSV-l 
and IsK virus, respectively (Table 4.4). As the ICPO-deficient viruses FXE and in1330 
were unable to reactivate the quiescent virus efficiently, these data suggest that as in other 
cultured cell systems that study HSV -1 quiescence, ICPO is required for this effect. This 
experiment was also carried out in hNT cells, the only difference being that the super-
infection length was increased to 16 hours due to the relatively poor growth of 17+ in these 
cells (Fig. 4.14, Table 4.4). As with NT2 cells, ICPO was found to be an essential factor 
involved in the reactivation of quiescent infection in hNT cells (Fig. 4.14). Reactivation of 
the HCMV promoter by wild type 17+ was inhibited by addition of the proteasome 
inhibitor MG132, demonstrating that, as in a previous study (Everett et al., 1998b), this 
reactivation activity oflCPO requires active proteasomes (Fig. 4.14). 
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virus and reactivation by superinfecting ICPO-positive virus. 
Cells were infected as described in the text (section 4.6.3). NT2 (upper field) and hNT (lower 
field) cells were initially infected with d1l403/lacZ virus and then superinfected with HSV-l 
strain 17+ (A), tsk (B), FXE (C), in1330 (D), 17+ in the presence of MG 132 (E), or else were 
mock infected (F). NT2 and hNT cells were fixed 8 and 16 h post-infection, respectively, and 
stained for ~-galactosidase expression by immunofluorescence. 
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Table 4.4 The reactivation of the HCMV promoter in quiescently infected NT2 and hNT cells 
reactivation % 
virus· NT2 bNT 
17+ 17 24 
tsK 8 21 
FXE 0 0 
in1330 0 0 
mock 0 0 
a Cells were infected with d11403 virus for 2 days then were super-infected 
by 17+, 18K, FXE, in 1330 at 3 pfu per cell for 8 hours, or 16 hours for hNT 
cells. The reactivation efficiency was detennined by counting the 
proportion of cells expressing f3-galactosidase. On average, a total number 
of 200 cells were scored for each data point. 
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4.7 Discussion 
NT2 cells, from a neuronal precursor cell line, were chosen for these studies because 
of their human origin, in vitro inducible neuron differentiation, and suitability for 
transfection studies. These properties are suitable for studying HSV -1 infection, the 
functions of specific genes of interest, and the behaviour of ND 1 0 proteins in tenns of their 
interactions with viral proteins in a human neuronal cell context. 
The results illustrated that NT2 neuron precursor cells contain atypical NO 1 0 
structures with fewer PML and hDaxx foci, and no detectable Sp 1 00. In addition, the 
distribution of these NO 1 0 constituents was distinct from any other types of cells studied, 
for instance, the extraordinary track structures of PML foci, and large Daxx accumulations 
observed in many NT2 cells. During HSV -1 infection in NTI cells, the NO 1 0 components 
and centromere protein CENP-C were more resistant to the actions of ICPO, compared to 
HFL cells. Furtbennore, at early times of infection, ICPO strongly colocalised with NOlO 
in most cell lines, however it was noticed that in NT2 cells, a greater portion of ICPO was 
located in additional specific small foci that did not contain PML (Fig. 4.8). Co-staining 
with CENP-C revealed that these small foci were likely to be centromeres because ICPO 
strongly associated with CENP-C in infected NT2 cells. Therefore centromere structures 
could be a preferential site for ICPO localisation in NT2 cells due to the alterations in NO I 0 
composition. 
On differentiation of NTI cells into hNT neurons a typical NO 1 0 structure was 
developed, despite the retention in some cells of the remarkable track structure of PML foci 
detected in many hNT cells. In addition, SplOO was perfectly colocalised with PML in 
these peculiar structures in hNT cells (Fig. 4.2A). In western blot analysis of viral gene 
expression, ICPO was highly expressed in NT2 and hNT cells, but the infection did not 
progress efficiently to abundant Early gene expression. This directed further study toward 
the function ofICPO in these cells. 
Results using a CAT assay showed that, even at a high expression level, ICPO was 
unable to activate early gene promoters in NT2 cells. Although lower expression of ICPO 
and ICP4 was noticed during transfections of plasmids expressing these proteins. these 
results can not be explained by poor transfection of NT2 cells, since similar HCMV 
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enhancer-driven plasmids expressing PML and SUMO-l gave at least 30% positive 
transfected NT2 cells as estimated by IF A (Fig. 4.1SA), and similar amounts of these 
proteins were expressed in transfected NT2 cells compared to Vero cells, as detected by 
western blotting (Fig. 4.1SB). 
In infection of NT2 and hNT cells with d11403/lacZ virus at a low MOl, the HCMV 
promoter was shut down but it can be reactivated by super-infection with wild type and tsK 
virus. Analysis of reactivation efficiency between 17+ and t8K revealed that reactivation by 
tsK virus was slightly less efficient than wild type at 38.SoC (Table 4.4). In other 
experimental systems of HSV-l quiescence in cultured cells, 18K was as efficient as wild 
type virus at inducing reactivation (Russell el al., 1987) so it appears that in NT2 cells ICP4 
also contributes to (but is insufficient for) the reactivation process. However, results from 
CAT assays showed that the activation of the ICP6 promoter by ICP4 was less in NT2 cells 
than in Vero cells. These results suggest that, in addition to very poor function of ICPO, 
ICP4 also plays a part in the inefficient HSV-l infection in neuronally-related cells. 
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Fig. 4.15 Analysis of the transfection efficiency in NT2 cells compared with Vero cells. 
A. Vero (top panel) and NT2 (bottom panel) were transfected with plasmid p IPIC-I at a 
concentration 10nglLinbro-well or 100nglLinbro-well followed by immunostainjng for 
SUMO-I. 
B. Expression level of PML in Vero and NT2 cells transfected by various amounts, as 
labeled on the top of the gel, of plasmid PML(F). 
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Chapter 5 Characterisation of SUMO-1 and its conjugation 
mutants in NT2 and fibroblast cells 
The results from Chapter 3 showed that NO 1 0 proteins have potential effects on viral 
infection, since initiation of HSV -1 infection was slightly reduced in transfected cells 
expressing high levels of PML and SUMO-l compared to those in untransfected cells 
(section 3.3.2). The immunofluorescence analysis described in Chapter 4 revealed that 
NT2 cells lack detectable SpIOO and express lower amounts of PML and its SUMO-l 
modified isoforms than HFL cells. These observations led me to investigate whether 
transfection of plasmids expressing NO 1 0 and SUMO-l proteins into NT2 neuron 
precursor cells could lead to the development of expression patterns of NOlO proteins 
closer to those observed in HFL cells, and whether increased expression ofNDlO proteins 
in NT2 cells has any effect on HSV -1 infection. 
5.1 High level expression Qf SUMO-1, but not other ND10 
proteins, reduces HSV-1lnfectlon in NT2 cells 
5.1.1 The expression pattern ofPML in transfeded NT2 cells 
Firstly, NT2 cells were transfected with a plasmid expressing PML and examined by 
IF A to investigate whether exogenous PML introduced by transient transfection could lead 
to the development of NO 1 0 of nonnaI appearance. It was found that the expression 
patterns and distributions of PML in transfected cells were varied. Compared to 
endogenous PML (Fig. 5.1A), in some transfected cells, in which PML was moderately 
expressed, the size of PML foci was enlarged (Fig. 5.1 B). Moreover, an increase in the 
size and nwnber ofNDlO structures to the levels similar to those in Hep-2 or BHK cells 
was observed in some transfected NT2 cells expressing high levels of PML (Fig. 5.1 C). 
This implies that the exogenous PML was recruited into NO 1 0 resulting in ND I 0 
structures that were apparently more typical of those in fibroblast cells. However, it was 
noticed that in a portion of transfected cells, overexpressed PML was located throughout 
the nucleus and cytoplasm (Fig. 5.1D). 
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Fig. 5.1 High level expression of PML in transfected NT2 cells. 
NT2 cells were transfected and the expression of exogenou PML wa d tected u 109 a 
monoclonal antibody F3. 
A. The expression pattern of endogenous PML detected by u ing rabbit rum r . 
B. The sizes of the foci of exogenous PML were bigger than tho e of nd g n 1I PML. 
C. High expression levels of exogenous PML greatly incr a ed the av rag numb r r 
PML foci, and their sizes were much larger than tho e of ndog n 1I PML. 
D. Some transfected cells (indicated by an arrow head) e pre d very high I r 
PML, and in these cases the protein was located in both nll I u and ytopla m. 
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5.1.2 The effect of over-expression ofNDI0 on HSV-l infection in NT2 cells 
The methods used for this study were the same as described in section 3.3.2; plasmids 
expressing PML, Sp 1 00, and SUMO-l were singly transfected into NT2 cells via lipofection 
followed by infection with HSV -1 at 1 pfu per cell. Since progression of HSV -1 infection in 
NT2 cells is not efficient, only the IE protein ICPO was detected to estimate the infection 
efficiency in transfected NT2 cells compared to untransfected cells. Immunofluorescent 
results showed that most SUMO-l transfected cells (detected by green fluorescence) did not 
express ICPO (red fluorescence) (Fig. 5.2). At 2 hpa, 16% of untransfected cells were 
infected, whereas only 7% of the transfected cells were expressing ICPO (Fig. 5.2B). The 
reduction of initiation of HSV -1 infection was not overcome by increasing the time of 
infection, since at 8 hpa more than 50% of untransfected cells were infected, whereas only 
13% of SUMO-! transfected cells expressed ICPO (Fig. 5.2B). This reduction of infection 
was not observed in NT2 cells transfected by PML or Sp 1 00 plasmids (data not shown). 
5.2 Construction of SUMO-1 conjugation mutants 
SUMO-I, like ubiquitin, can be covalently linked to other proteins to alter their 
behaviour and function (reviewed by Saitoh et al., 1997). However the SUMO-! 
translation product has to be cleaved endoproteolytically to expose Gly97, the mature C-
terminus, which is critical for SUMO-l to be conjugated to protein substrates (Kamitani el 
al., 1997). Since it was found that high levels of SUMO-l caused modest but reproducible 
reductions in viral gene expression in BHK and NT2 cells (results from sections 3.3B and 
5.1), three SUMO-l mutants that would be expected to be defective for conjugation were 
made to investigate the potential role of SUMO-l in virus infection in more detail. As 
described previously, SUMO-l requires processing to remove four amino acid residues 
(His98-Ser-Thr-Val) from its C-terminus before it can undergo conjugation, and the 
Gly96-Gly97 residues are essential for the action of the protease that cleaves between 
Gly97 and His98 (Fig. S.3A). For construction of the various SUMO-l mutants, initially, 
one forward primer and four reverse primers were designed to amplify wild type 
(GGIHSTV), and three conjugation mutants in which the Gly96-Gly97 were either 
changed to Gly-Ala (GA-HSTV), or Ala-Gly (AG-HSTV), and with deletion of the most 
C-terminal four amino acids (AG) (Fig. 5.3B). The forward primer was designed to 
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ICPO% 
2hpa 
• untransfected cells 
SUMO-1 transfected cells 
Shpa 
Fig. 5.2 Effect of SUMO-Ion HSV -I infection in T2 cells. 
NT2 cells were transfected with plasmids expressing UMO-l followed by infection 
by HSV -1 on the next day. The transfected, infected NT2 cells were then fixed and 
imrnuno-stained after 2 and 8 hours of infection and examined by confocal 
microscopy, followed by statistical analysis. 
A. Images from IFA showing that most of the transfected cells expressing UMO-l 
were not infected by HSV -1. 
B. The proportion of cells expressing ICPO in untransfected cells are shown as • , 
and the proportion of UMO-l transfected cells expressing I PO are shown as 
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A. 
B. 
N'···· 
SUMO-1 precursor active form 
SUMO-1 
8amH I r+ SUMO-1 
primer F: ATGGCCGGATCC!ATGTCTGAC- 3' 
---. ---
5 
Xho I stop codon 
AAAACTCGAGCT AAACTGTTGAA TG-3' 
AAAACTCGAGCTAAACTGTTGAATGAGCCCC- 3' 
.. GG/HSTV 
.. GAlHSTV 
AAAACTCGAGCT AAACTGTTGAA TGACCCGCCGT - 3'" AGLHSTV 
TAAACTCGAGACTAACCCGCCGTTTG- 3' 
AG 
Fig. 5.3 Strategy for construction of SUMO-l conjugation mutants. 
""C' 
3' 
A. The C-terminal maturation process of SUMO-I. The four C-terminal amino acids 
H-S-T-V in the SUMO-I precursor molecule are cleaved to expose Gly96-Gly97, the 
mature C-terminus which is essential for SUMO-l conjugation to substrates. 
B. Five primers were designed for construction of SUMO-! conjugation mutants. 
Primer F is a universal forward primer for all mutants and reverse primers GGIHSTV, 
GAlHSTV and AGIHSTV were designed to generate wild type SUMO-! and two 
mutants in which the conserved Gly-Gly has been changed either to Gly-Ala or Ala-
Gly respectively. The other primer AG was designed for the construction of the Ala-
Gly mutant without the 4 amino acid extension. For the convenience of cloning, two 
restriction enzyme sites, BamH I and Xho I were introduced in the forward and 
reverse primers respectively. 
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include the myc epitope tag present in SUMO-I expressed from plasmid pCIPICI, and for 
the convenience of cloning, a BamH I and an Xho I site were introduced before the start 
codon of the myc tag in the forward primer and after the stop codon in the reverse primers 
respectively (Fig. 5.38). The original pCIPIC-I plasmid was used as the template for PCR 
to generate myc-tagged wild type and mutant SUMO-I fragments (described in section 
2.2.68) that were phenol/chloroform extracted (described in section 2.2.68, 2.2.1B) then 
digested with BomH I and Xho I. The SUMO-I fragments were purified from agarose gels 
and ligated with the Xho 1- Nde I fragment (containing pCIneo vector backbone) and Nde 1-
BamH I fragment (containing c-myc tag) obtained from plasmid pCIPIC-l and pCISUMO 
respectively. The plasmid pCISUMO was generated by subcloning the Sal IlNot I digested 
myc-SUMO-l fragments into the Xho IINot I sites of pCIneo vector to destroy the unique 
Xho I site in the vector for the convenience of further cloning. The structures of the four 
constructs were confirmed by nucleotide sequencing. The sequences of the myc-SUMO-l 
loci at the 5' end and the sequences of the substitution or deletion mutated loci in the 3' end 
of these plasmids are shown in Fig. 5.4. 
5.3 AnalysiS of SUMO-1 conjugation mutants 
5.3.1 Immunofluorescence assay 
Firstly, an indirect immunofluorescence analysis was used to confirm the expression 
and investigate the localisation of the SUMO-l mutant proteins in mammalian cells. Vero 
cells were transfected with plasmids expressing either wild type or mutant myc-tagged 
SUMO-I proteins and were stained with monoclonal antibody 9EIO that recognises the c-
myc sequence 24 hours after transfection. As expected, plasmid GGIHSTV expressed wild 
type SUMO-I, which was concentrated in NDlO and also distributed throughout the 
nucleus (Fig. 5.5A). When the conserved Gly-Gly residues were changed to Oly-Ala, 
SUMO-! lost its ND 1 0 localisation and only relatively diffuse nucleoplasmic staining was 
observed (Fig. 5.58). In contrast, the AGIHSTV mutant protein was distributed in a similar 
pattern to wild type SUMO-I, but in some cells the mutant SUMO-l was also present in the 
cytoplasm (Fig. 5.5C). The staining of SUMO-l expressed by the mutant plasmid AG, 
from which the C-terminal four amino acids had been deleted and GIy96 substituted with 
alanine, was similar to AGIHSTV, but large SUMO-l clumps were observed in the nucleus 
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A. 5' end c-myc tag: 
E Q K LIS E E 0 L N SUMO-1 
o 40 50 
B. 3' end 
plasmid: G G H S T V Xho I site GAHSTV Xho I site 
~C<1GAT( 
350 370 380 
~G H S T V Xho I site ~G Xho I site 
370 
Fig. 5.4 Sequences of wild type SUMO-l and the conjugation mutant constructs. 
A. The forward sequences of the c-myc tag and 5'-end of SUMO-I. The 5'-end 
sequences were the same for all the SUMO-l constructs. The start codons of c-
myc and SUMO-l are marked a """. 
B. The forward sequence of the 3' end in four UMO-I construct. Nucleotides 
encoding amino acids GGH TV, marked as - , w re pr nt as the equences in 
wild type SUMO-I . The nucleotides encoding for Gly-Gly changed to either Gly-
Ala or Ala-Gly in the mutants, are marked as - and the stop codon is shown asD. 
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Fig. 5.5 The expression patterns ofwild type SUMO-J and the conjugation mutant. 
Vero cells were transfected with plasm ids expressing wild type SUMO-J and with 
conjugation mutant plasm ids as labelled in the lower left corner of each image. Image 
were obtained by staining transfected cells using a monoclonal antibody 9E 10 again t c-
myc tagged SUMO-I. Most SUMO-I expressed from the wild type construct IH TV 
was located in nucleus and also accumulated in NDIO indicated by an arrow ign. 
SUMO-J expressed from the GAlHSTV plasmid did not localise at ND 10. Some but not 
all cells expressing the AG/H TV and AG mutant proteins contained SUM - I in NDIO-
like structures. 
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of some transfected cells (Fig. 5.50). Furthermore, in a small portion of AG plasmid 
transfected cells, the staining of the mutant SUMO-1 included a string-like pattern in the 
cytoplasm, very similar to cytoskeleton protein staining (Fig. S.6A). To investigate this 
further, cells transfected with AG plasmid were co-stained with a rabbit antibody A14 for 
the myc tag and a mouse antibody for either actin or tubulin, followed by IF A. However 
the string staining of actin and tubulin was more slender than SUMO-l and without 
significant co-localisation with SUMO-l (Fig. 5.68 and data not shown). 
5.3.2 Western blot analysis 
Like the ubiquitin system, SUMO-l can be covalently attached to target proteins by a 
similar but distinct enzymatic machinery. In an attempt to understand the consequences of 
the mutations introduced into SUMO-I, cell extracts from cells transfected with these 
SUMO-1 plasmids were processed for western blotting by using an antibody against the 
myc tag. Intriguingly, Gly97 is absolutely essential for the action of the C-terminal 
protease, since when Gly97 was replaced by Ala, only the SUMO-l precursor form, 
without any active form, was detected in cells transfected by GAlHSTV plasmids (Fig. 5.7). 
Similar to the case of wild type SUMO-I, most SUMO-l precursor proteins expressed from 
the Gly96 substitution mutant plasmid (AGIHSTV) was cleaved and exhibited a decreased 
gel mobility (the lower band) from that of the precursor SUMO-l (the upper band) in 
12.5% SOS-PAGE (Fig. 5.7). As expected, only the cleaved form of SUMO-l was 
obtained in the deletion mutant SUMO-l construct (Fig. 5.7). However the high molecular 
weight SUMO-! conjugation proteins produced by the three different SUMO-l mutant 
constructs were at a lower prevalence than those produced in wild type SUMO-l expressing 
cells, although similar amounts of the active form of SUMO-1 was expressed by the 
AGIHSTV construct (Fig. 5.7). 
5.3.3 Interaction of SUMO-l mutant proteins with NDIO 
As described previously, two NOlO proteins, PML and Sp100 can be post-
translationally modified by SUMO-1 (reviewed by Stemsdorf et aI., 1997) and SUMO-l 
modification of PML has been suggested to target this protein to NOlO (Muller et al., 
1998a). In addition, it has been reported that recruitment of hDaxx, another ND 1 0 
constituent, is controlled by SUMO-l modification of PML (Ishov et al., 1999). The 
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Fig. 5.6 Comparison of the expression pattern of mutant SUMO-I expressed from the 
AG construct with the staining oftubulin. 
A. The string-like distribution of AG mutant SUMO-I . 
B. The staining of tubulin. The expression pattern of AG mutant SUMO-] was 
different from that oftubulin. 
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marker 1 
(kO) } 
97- _ 
I . 
46 -
2 3 4 
1.GG/HSTV 
2. GAlHSTV 
3. AG/HSTV 
4. AG 
monomer SUMO-1-HSTV (precursor) 
,~ ....... ~onomer SUMO-1 (cleaved form) 
Fig. 5.7 Western blot analysis of SUMO-I expression. 
Vero celis, transfected with different SUMO-l constructs as labelled at the top of 
the blot, were directly lysed in 3x boiling mixture then process for SOS-PAGE 
followed by blotting for c-myc-SUMO-l. 
Most wild type SUMO-l protein molecules expressed from plasmid GGIHSTV 
were cleaved to generate the active form of SUMO-I, while the percentage of 
cleaved AGIHSTV molecules was reduced. None of the Gly97 mutant SUMO-I 
was processed to the mature cleaved form. The amount of SUMO-l conjugated 
to other high molecular weight proteins (as indicated as} ) was much greater 
with wild type SUMO-l compared to the three mutant forms. 
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question whether high level expression of the SUMO-} conjugation mutant proteins affects 
ND} 0 assembly and maintenance was tested by co-staining SUMO-l transfected cells with 
antibodies for the tagged SUMO-} and one of the NDIO proteins such as PML, Sp}OO, 
hDaxx, or the centromere protein CENP-C. Although the Gly·Ala mutant of SUMO·} was 
diffuse throughout the nucleoplasm and not present in typical ND 1 0, PML was still 
maintained in NDIO in these transfected cells, albeit in a lesser number of foci (Fig. 5.8A). 
In contrast to PML, staining of Sp} 00 was absent from ND} 0 in most transfected cells 
expressing the Gly-Ala mutant of SUMO·I (Fig. 5.8B). The Ala97 substitution mutant 
SUMO-l also affected the distribution of bDaxx since the number of hDaxx foci was 
decreased and the nucleoplasmic background staining in transfected cells was higher than in 
untransfected cells (Fig. 5.8C). This effect was also observed with the CENP·C staining of 
such transfected cells, a rather surprising result of unknown significance (Fig. 5.8D). 
SUMO-I, expressed from the AGIHSTV plasmid, had a staining pattern more typical of 
wild type SUMO-l, however fewer PML and hDaxx foci were detected in transfected cells 
(Fig. 5.9A, 5.9C). In those cells in which the exogenous SUMO·} distribution was diffuse, 
the staining of SplOO was also dispersed in many cases (Fig. 5.9B). In contrast to its 
apparent affects on ND 1 0, there was no significant effect of the Ala.Gly mutant SUMO-I 
on the centromere protein CENP-C (Fig. 5.9D). Similar resultS were obtained from the 
transfected cells expressing mutant SUMO-! with the Ala96 substitution and the 4 amino 
acid C-terminal extension deletion (Fig. 5.10). 
5.4 The effects of SUMO-1 mutants on HSV-1lnfectlon In NT2 
cells 
The results from section 5.1 showed that NT2 cells expressing high levels of 
exogenous SUMO-l were apparently less susceptible to HSV -1 infection compared to 
untransfected cells. If high levels of SUMO-! in some way impedes HSV -1 gene 
expression, one might predict that the three SUMO-l mutants, which lost or had less 
conjugation ability, would not confer this phenotype. To investigate this prediction, the 
four SUMO-l plasmid constructs (GGIHSTV, GAlHSTV, AGIHSTV, and AG) were 
individually transfected into NT2 cells for 24 hours, and then the expression levels of 
SUMO-I and ICPO were determined by IFA after a 8-hour infection (using the same 
method as described in section 3.3.2 and 5.1). In wild type SUMO-I transfected cells, up to 
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Fig. 5.8 The localisation of GA/HSTV mutant SUM - I and other N01 ° proteins in 
transfected cells. 
Vero cells transfected with plasmid GAIH TV wer double- tained for UMO-I and 
different NDI 0 proteins including PML, pI 00, or hOax, and also for the centromer 
protein CENP-C. The combinations of double- taining are indicated in the rightmost 
row, and are the same in each horizontal row of pan I . The labelled proteins are 
indicated in lower-right corner in each image and the merged view of UM -I with 
the other NDI 0 protein indicates the relative locali ation of the e two protein. 
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Fig. 5.9 The localisation of A 
transfected cells. 
Vero cells transfected with pIa mid A IH T 
different NO I 0 proteins including PML, pI 00, or h 
ubI - tain d for 
, and al 
In In 
M - I and 
protein CENP-C. The combination of d ubi - taining ar indi atcd in lh rightm 
row, and are the same in ach horizontal r f pan I . Th lab II d pr t in ar 
indicated in lower-right corner in ea h image and the m rg d vi w f M -I with 
the other NDl 0 prot in indicate th r lativ I ali ati n fth two pr 111 . 
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Fig. 5.10 The loeali ation f the A mutant r 
tran feet d cells . 
Vero cell tran fect d with pia mid M - I 
different NOlO prot in in ludin PML, pi 
protein -NP- . The eombinati n f d ubi 
In III 
r d lIbl '- ' loin 'd r r ' UM - I and 
indi at d in Ih ' ri ·hlm )Sl 
r pan L. Th' Ilb ' lI d PI'( I ' ins ur' row, and are th am in a h h riz ntal 
indicated in lower-right corn r in a h imag 
other NO I 0 protein indicat th r lali c I 
and th i ' \ )r:UM - I ith Ih ' 
ali ati n pr I ' ins. 
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40% of untransfected cells were infected, but only 20% of SUMO-l transfected NT2 cells 
were expressing ICPO (Fig. 5.11). In contrast, the reduction of infection was not significant 
in cells expressing the other three mutant fonns of SUMO-l (Fig. 5.11). 
5.5 Analysis of the effects of SUMO-1 conjugation mutants on 
HSV-1 infection by flow cytometry - fluorescence-actlvated cell 
sorter (FACS) analysis. 
Transient transfection of plasmids expressing proteins of interest and confocal 
microscopy examination of intracellular effects followed by statistical analysis of the 
images represents a reproducible and accurate way to explore the effects of proteins on viral 
infection. Nevertheless it was a time consuming method and the selection of IF A images to 
be examined could be construed as subjective. Instead of microscopy, FACS analysis could 
represent a more controllable and large scale method to analyse the effects of any protein 
expressed from a transfected plasmid on the efficiency of viral infection. 
5.5.1 Strategy and methods for FACS analysis 
Plasmids were introduced into cells via lipofection. Since FACS is able to process a 
large scale of sample, cells seeded in a 35mm Petri dish were used for each transfection to 
enlarge the sample size. To investigate the effect of expression of a particular protein, after 
infection the proteins of interest were labeled by staining with antibodies as for IF A, and 
the progression of infection was monitored by detecting fluorescent viral proteins. To 
avoid cell clumps blocking the cell sorter, a population of single cells is required. To 
achieve this, the antibody staining reactions was performed after trypsinising and dispersing 
the transfected and infected cell monolayer to a single cell status (see Material and 
Methods. section 2.2.15). 
This strategy is illustrated by an experiment using virus vEGIIOwt (see section 3.3.1). 
Three major groups of cells were sorted by flow cytometry dependent on their fluorescent 
signals (Fig. 5.l2A). In histogram A, group 1 shows the population of transfected cells 
expressing SUMO-l protein with a higher PE signal, group 2 shows the population of cells 
infected by the EGFP virus, and group 3 shows the population of cells that were neither 
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• untransfected cella 
o SUMO-1 tranafected cella 
GG/HSTV GAlHSTV AGJHSTV AG 
Fig. 5.11 The effects of the mutant SUMO-l proteins on HSV-l 
infection in NT2 cells. 
NT2 cells were transfected by plasmids expressing wild type and the 
mutant forms of SUMO-l followed by infection by HSV -I the next day. 
The transfected and infected NT2 cells were then fixed and immuno-
stained after 2 and 8 hours of infection and examined by confocal 
microscopy followed by statistical analysis. 
The proportion of cells expressing ICPO in untransfected cells is shown 
as • , and the proportion of SUMO-l in transfected cells expressing 
ICPO is shown as D . 
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Fig. 5.12 An example of the analysis of the FA data. 
104 
Vera cells transfected by the GG/H TV plasmid were infected by vEG-II Owt the next day 
followed by fixation and immuno- taining at 2 hpa for FA analy is. 
A. A dot plot diagram presenting three groups of cells from the sampl tran fee ted and 
infected. Group I illustrates the tran fected c II expre sing high I el of UM -1 which 
were labeled with PE det cted by FL2-H la r. Group 2 pre nt th c lis neith r tran fi ct d 
nor infected. Group 3 includes the infected cells pr ing high lev I of 
which was detected by FL I-H 1a er. 
B. A dot plot diagram of the negative control from which V ro c II w r tr n fi ted by an 
empty vector, pClneo, then infected by H V-I 17+ the ne t day . There i only ne group of 
cells without any significant fluore cence in thi dot plot diagram. 
C. Interpretation and analysis of F data. Four quadrant w r can truct d u ing th 
limit of the grouping of negative cells as th central a i. a h quadrant d m nstrat 
with different fluorescence d p nding on which prot in ar pre din th II . h 
in each area marked such a a, b, c, a and b w re d t t d by the oftwar and th inC! ti n 
efficiency in the transfl cted and untransfl cted c II wa cal ulated by fo llowing th imple 
equation as shown beside panel . 
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infected nor transfected (Fig. S.12A). As expected, the pattern of group 1 in histogram A 
was similar to histogram B in which cells were untransfected and infected by vEG 11 Owt, 
the HSV-l virus expressing EGFP-ICPO (Fig. 5.12B). The proportions of cells in each 
group can be detennined by the software when each group of cells was gated appropriately. 
For instance. four quadrants were constructed using the upper limit of the grouping of 
negative cells as the central axis (as shown in histogram B) and the other two triangles a' 
and b' contain transfected cells expressing above background levels of PE and EGFP 
respectively. The counts of each area marked were scored by the software and the infection 
efficiency in the SUMO-l transfected or in untransfected cells could be calculated as 
described in Fig. 5.12. 
5.5.2 Construction of a TK"IEGFP recombinant virus 
To detect the effect of proteins on HSV-l infection and viral gene expression, 
vEGllOwt virus, expressing ICPO fused to EGFP, was used to monitor the IE gene 
expression. However, another viral protein m~ker was required for assessing the 
progression of viral infection to the Early stages. Since the product of the thymidine kinase 
(TK) gene is not essential for HSV -1 replication, this gene could be deleted and replaced by 
the EGFP coding region downstream of the TK promoter. Therefore EGFP expression 
would act as a marker for transcription of a typical Early gene during infection. 
5.5.2A Construction of the TIC IEGFP recombinant plasmid, pTK IEGFP 
Plasmid pTKI, provided by Dr. C. M. Preston, contains the BamH I P fragment (from 
nucleotide 48634 to 45055) of HSV-l genomic DNA; the open reading frame of the TK 
gene is located from nucleotide 47802 to 46674. The EGFP fragment was obtained from 
pEGFP-Cl vector, digested with Not I, followed by treatment with Klenow enzyme to blunt 
the ends and then further digested with BamH I. To replace the TK gene from pTKl 
plasmid, the purified 0.8 kb blunt ended! BamH I EGFP fragment was ligated with the 7 kb 
vector fragment purified from pTKl plasmid codigested by Sac I (then blunted) and Bg/ II, 
resulting in expression of EGFP driven by the TK promoter (Fig. 5.13). One unique 
restriction enzyme site, Sca I, located in the vector backbone, can be used to generate a 
linear DNA, which is beneficial for homologous recombination. The linear plasmid DNA 
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pTK1 
TK 
I (3465) 
'-"""",foI' / (0/3658) 
BamHI Nco I 
(46293, 46397) 
UL23 
gH (46382- 43868) 
UL22 
Fig. 5.13 A schematic repre entation of th pTK-
47 
sri Br" 
1~(800bP) 
Not I ' _ _ I BamH I 
Nco I 
P onstruct. 
(3.5kb) 
The TK gene is located in pIa mid pTKI containing the BamHl P fragm nl (fr m 
nucleotides 45055 to 48634 of th H V - .1 genom . Th tran lat d regi n f the K 
protein is between nucleotides 47802 and 46674 indicat d by th blu arr w. 0 
construct the TK deleted EGFP recombinant pIa mid (pTK- . P), pia mid pTKl a 
co-digested with Bgl II/Sac I and the 500bp fragm nt ntaining 5' nd f th TK g n 
was replaced by the 800bp fragm nt containing th RF, indi ted a a grc n 
arrow, resulting in expression of E FP driv n by th TK g n prom t r. In rti n of lh 
EGFP fragment introduces an tra 0 I it lab II d in pink, in th r mbinant N . 
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was then co-transfected into BHK cells with infectious wild type HSV-I strain 17+ DNA, 
and the progeny virus used for plaque isolation. 
5.5.2B Southern blot analysis 0/ TK IGFP recombinant virus 
The green fluorescence plaques identified by phase contrast and fluorescence 
microscopy were cultured in BHK cells in medium containing ACG to select TK deleted 
viruses (described in Materials and Methods, section 2.2.16B). The total cell DNA 
extracted after three rounds of plaque purification was processed for Southern blot analysis. 
Initially, the DNA of recombinant virus was digested with either BamH I or codigested with 
different combinations of restriction enzymes, such as with BamH II Bg/ II, or BamH II Nco 
I followed by gel electrophoresis. To obtain a clear-cut pattern, various DNAs from wild 
type 17+ virus, pTKl plasmid, and pTK"IEGFP plasmid were also treated with the same 
restriction enzymes and applied to the gel as parallel controls. 
Parental pTKI plasmid was used as the template for the preparation of radioactive 
probes for Southern blotting (method as described in section 2.2.7 A). The sizes of the 
BamH I P fragments in recombinant virus and pTK-/GFP plasmid were larger than in 
plasmid pTKl and wild type virus, since the O.5kb fragment containing the TK gene was 
replaced by the 0.8 kb EGFP fragment (Fig 5.14A). As expected, results from Southern 
blotting showed that the BamH I fragment from the recombinant virus and pTK-IEGFP 
plasmid had a lower mobility than those of wild type viral DNA and pTKI plasmid (Fig. 
5.14B). Since the Bgl II site in the BamH I P fragment was destroyed after the insertion of 
the EGFP ORF in the UL23 locus, only one fragment (around 3.7kb) was detected in DNA 
from the recombinant virus and pTK'/EGFP plasmid when codigested with BamH I IBg/ II 
(Fig. 5.14B lane 5, 7). Two fragments (2.7kb and 0.78kb) were generated when the BamH I 
P fragment of wild type viral DNA was codigested with BamH I1Bg/ II. However only the 
2.7kb BamH I-Bg/ II fragment was observed on the blot and the small fragment was 
undetectable (Fig. 5.14B, lane 6, 8). One extra Nco I site, located at the beginning of the 
EGFP open reading frame, was introduced into BamH I P fragment when EGFP was 
inserted in the UL23 locus resulting in three fragments (1.7kb, 1.2kb, O.8kb) being obtained 
from recombinant DNA codigested with BamH I INco I (Fig. 5.14B, lane 9, 11). Without 
the EGFP insertion, only two fragments (1.2kb and 2.3kb) were detected from wild type 
viral DNA codigested with BamH I INco I (Fig. S.l4B, lanes 10, 12). Notably, in lanes 6 
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Fig. 5.14 Southern blot analysis of the TK-IEGFP recombinant viral DNA. 
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A. Illustration of the restriction map of the DNA of wild typ and TK- FP r ombinant 
viruses. The sizes of the BamH I P fragm nt w r 3.5 kb in wild typ and 3.7 kb in th 
recombinant viral DNA. A fragment of 0.78 kb in siz wa g n rat d when wild typ viral 
DNA was codigested with BamH II Bgl II. One extra Nco J it gen rated fr m in ertion of 
EGFP fragment results in the 2.5 kb of Nco I1BamH 1 fragm nt of recombinant DNA di ided 
into two fragments (1.7 and 0.8 kb). 
B. The result of outhern blotting. D A of the recombinant viru (appli d in I n 1, 5, 9) 
was digested with different restriction nzymes combinati n u h a BamH T BamH I1Bg/ II 
and BamH I1Nco I as labelled at th top of blot followed by hybridi ati n with a pr b 
prepared using plasmid pTK 1 a a templat. Th r ult w r ompar d with A f th 
original plasmid pTKl (applied in Ian s 2, 6 10) par ntal r mbinant pIa mid pTK- ~ FP 
(applied in lanes 3,7, 11) and wild type virus (appJi d in Ian 4 8 12). 
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and 10 there was one high molecular weight band observed, which may have been the 
pAT153 vector backbone of pTKl, because the probe was prepared from whole pTKl 
plasmid. After three rounds of plaque purification, the patterns ofTK"IEGFP recombinant 
viral DNA digested with various combinations of restriction enzyme were the same as 
expected and presented only one population of DNA, thus further plaque purification was 
not necessary. 
5.5.2C Characterisation ojthe TKIEGFP recombinant virus 
To characterise the TKIEGFP virus, firstly, a growth curve of recombinant virus at 
various MOls was constructed and the replication efficiency of recombinant virus was 
compared to that of wild type. To this end, BHK cells were infected by either 17+ or TK" 
IEGFP viruses at a multiplicity of 1 and 0.1 pfu per cell. The cells and medium were 
harvested after 12, 24, 36, and 48 hours of infection, followed by titration of progeny virus 
in BHK cells. The results of this single experiment indicated that the replication of the 
mutant virus was very similar to that of the parental control (Fig. 5.15). 
The expression of EGFP driven by the TK promoter in TK"IEGFP virus was further 
established by FACS analysis. Hep-2 cells were infected with the TK"IEGFP virus at an 
MOl of 5 and then fixed in a 5% formaldehyde solution after 2, 4 and 8 hours of infection 
followed by F ACS analysis. Detection of EGFP acquired from 10,000 events showed that 
the intensity of EGFP signal was increased with the prolongation of TK"/GFP virus 
infection. At 8 hpa, expression of EGFP was detected in more than 70% of Hep-2 cells 
(Fig. 5.16B), whereas no EGFP signal was detected in cells infected with wild type 17+ 
virus, as a negative control (Fig. 5.l6A). This implies that FACS is a reliable system for 
the detection of fluorescent signals from cells infected by the TK"IEGFP virus. 
5.5.3 Analysis of the effect ofSUMO-l and SUMO-l mutants on viral infection 
byFACS 
5.5.3A Vero cells 
Vero cells were chosen to establish a FACS method for this study, since preliminary 
tests showed that Hep-2 cells tended to form big clumps that caused technical problems 
during the analysis. Furthermore, HSV-I infection progresses more efficiently in Vero than 
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Fig. S.lS Comparison of the growth curve of the TK·IEGFP recombinant 
virus with wild type virus. 
BRK cells were infected with either 17+ or the TI(·IEGFP recombinant 
virus at MOl of 1 and 0.1. Both the infected cells and medium were 
harvest after 12,24, 36 and 48 hours of infection followed by titration of 
the progeny viruses on BRK cells. 
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in Hep2 cells. To optimise the conditions for FACS analysis, two SUMO-l constructs, 
GGIHSTV (wild type) and GAlHSTV (mutant), were transfected into Vero ceI1s seeded in 
three 35mrn Petri-dishes. To investigate the effects of SUMO-Ion infection progression, 
different stages of viral gene expression were analysed. One day after transfection, Vero 
cells were infected with vEG-II0wt virus (expressing EGFP linked to ICPO) or with TK-
IEGFP virus for 6 hours to monitor IE and Early gene expression respectively. Cells were 
prepared for FACS analysis as described in section 2.2.15A. In the vEG-I1Owt infection, at 
2 hpa, 3.8% of untransfected cells were expressing detectable levels of EGFP-ICPO, 
increasing at 6 hpa to 18%. In the TK-IEGFP infection, 17% of untransfected cells 
expressed EGFP from the TK promoter at 6 hpa. Less than 1 % and 6% of wild type 
SUMO-! transfected cells expressed ICPO at 2 hpa and 6 hpa respectively (Fig. 5.17). 
Furthermore, the progression of viral infection was relatively slower in SUMO-l 
transfected cells, since only 3.8% of SUMO-l transfected cells progressed to the EarJy gene 
expression stage as indicated by expression of EGFP from the TK gene (Fig. 5.17). These 
decreases in viral infection efficiency in cells expressing high levels of exogenous SUMO-l 
are consistent with the results of the previous experiments analysed by microscopy. 
However, inefficient expression of the IE and E genes was also observed from cells 
transfected with the SUMO-l conjugation mutant (GAlHSTV) construct (Fig. 5.18). On 
average, expression of IE and E genes in SUMO-l mutant transfected cells was 3-5 fold 
less efficient than in untransfected cells (Fig. 5.18). 
5.5.3B NT2 cells 
The results from section 5.4 revealed that wild type SUMO-} had a greater effect on 
viral infection than the other three SUMO-} conjugation mutants tested. This result was 
also confirmed using FACS. As with Vero cells, the proportion of transfected NTI cells 
expressing ICPO was lower than in the untransfected NT2 population, and there was no 
significant difference in this effect between the wild type and mutant SUMO-l 
experiments. At 6 hpa, } 0% of untransfected cells expressed ICPO, but only 2.5% of cells 
transfected by wild type SUMO-l expressed ICPO (Fig. 5.19). In other words, the infection 
efficiency was reduced about 4-fold when NT2 cells expressed high levels of exogenous 
wild type SUMO-I. However, such a reduction in infection efficiency was also observed in 
NT2 cells transfected with the other three mutant constructs. The expression of ICPO was 
4.9,2.6, and 3.4-fold reduced in cells transfected with the OAlHSTV, AGIHSTV, and AO 
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Fig. 5.17 Dot plot diagrams from the F ACS analysis of Vero cells transfected with the 
GGIHSTV plasmid. 
Vero cells, transfected with plasmid GGIHSTV, were infected by vEG-II0wt at an MOl of 
5 for 2 and 6 hours or TK-IEGFP virus for 6 hours (as labelled at the top of each diagram) 
followed by immunofluorescence staining for F ACS analysis. The histograms illustrating 
the infection efficiency of transfected and untransfected cells were calculated by analysis of 
the counts from each group of cells obtained from F ACS analysis. 
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Fig. 5.18 Dot plot diagrams from the F ACS analysis of Vero cells transfected with the 
GAlHSTV plasmid. 
Vero cells, transfected with plasmid GAlHSTV, were infected by vEG- t lOwt at an MOl of 
5 for 2 and 6 hours or TK-IEGFP virus for 6 hours (as labelled at the top of each diagram) 
followed by immunofluorescence staining for F ACS analysis. The histograms illustrating 
the infection efficiency of transfected and untransfected cells were calculated by analysis of 
the counts from each group of cells obtained from F ACS analysis. 
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plasmids, respectively (Fig. 5.19). Furthermore, the proportion of NT2 cells expressing 
EGFP driven by the TK promoter was very low in all transfection experiments, even at 6 
hpa (data not shown). This observation is consistent with the result in section 4.4 that 
HSV -1 infection in NTI cells progresses slowly. 
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Fig. 5.19 Dot plot diagrams from the FACS analysis ofNT2 cells transfected with wild type 
SUMO-lor conjugation mutant constructs. 
NT2 cells, transfected with plasmid GGIHSTV, GAlH TV AGIH V rAG (a labelled 
at the top of each diagram) were infected by vEG-II Owt at an MOl of 5 for 6 hour followed 
by immunofluorescence staining for F ACS analysis. The histograms illu trating th 
infection efficiency of transfected and untransfected cells were calculat d by analysis of th 
counts from each group of cells obtained from F ACS analysis. 
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5.6 Discussion 
SUMO-l was identified as a protein that is highly similar to ubiquitin and has been 
shown to be conjugated to a variety of proteins, which implies that SUMO-I modification 
may be involved in the correct functioning of a number of cellular processes (reviewed by 
Seeler & Dejean, 2001). However the specific functions of SUMO-l remain to be clarified. 
The results of the transfection assays described in section 5.1 suggest that the SUMO-I 
pathway might be involved in pathways that contribute to the efficiency of establishment of 
viral infection in NT2 cells, since infection of HSV -I was less efficient in NT2 cells in 
which SUMO-l was highly expressed. To gain a better understanding of the role of 
SUMO-I, three SUMO-I mutants, in which either Gly96 or Gly97, in the C-terminus of 
SUMO-I, were replaced by Ala, were employed to investigate whether conjugation is 
involved in the inhibitory effect of SUMO-I. The results from a transient transfection 
assay showed that none of these mutant constructs had a profound effect on HSV-I 
infection. The conserved C-terminal Gly97 residue has been demonstrated to be required 
for efficient C-terminal processing, which enables substrate protein conjugation (Kamitani 
et al., 1997). However western blot analysis of cell extracts transfected by the Gly-Gly to 
Ala-Gly mutation construct revealed that, although most of these mutant SUMO-I 
precursor proteins were processed to the active form of the SUMO-I monomer, the 
formation of high molecular mass bands, which identify SUMO-I conjugated proteins, was 
greatly decreased. Therefore Gly96 appears not to be essential for precursor cleavage, but 
it is required for subsequent conjugation reactions. The results with the other mutants 
illustrate that Gly97 is required for both precursor cleavage and conjugation. Taken 
together, the results of the transient transfection assays in NT2 cells imply that substrate 
conjugation ability is important for the effects of high levels of expression of SUMO-Ion 
the progress of viral infection, at least as analysed using microscopy. 
Why high levels of SUMO-l expression should impede viral infection is unclear. 
Many cellular processes may have regulatory steps that depend on SUMO-l modification, 
and it is possible that increasing the pool of free SUMO-l could affect the proper 
functioning of these pathways. SUMO-l modification is known to be involved in the 
metabolism of ND 1 0 structures and constituent proteins, and altered equilibria induced by 
high levels of wild type or mutant SUMO-I protein expression could induce biochemical 
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and morphological changes in NOlO. Notably, in over 80 % of cells overexpressing 
SUMO-I mutant constructs, the staining of hDaxx was dispersed and Sp 1 00 apparently 
disappeared. Investigation of the staining of SUMO-l and other NO 1 0 proteins in detail 
found that loss ofhDaxx staining from NOlO is dependent on the localisation of SUMO-I, 
since if the SUMO-l was in part present in NOlO, hDaxx staining was also present. Unlike 
hDaxx, staining ofPML still remained in NOlO-like foci in cells transfected by GAlHSTV, 
suggesting that the distribution of PML was affected to a lesser degree by the conjugation 
mutant or dislocated SUMO-I. However, overall the number of PML foci in each 
transfected cell was lower than in untransfected cells. Loss of hDaxx staining and a 
deCrease the number of PML foci could be due to the mutant SUMO-l proteins competing 
with endogenous SUMO-I and having a dominant negative effect of SUMO-I conjugation 
pathways, resulting in diminution of SUMO-I conjugated PML. This idea is supported by 
recent studies reporting that SUMO-I modification of PML is critical to target this protein 
to NOlO (Muller et 01., 1998a), and is also required for recruitment ofhDaxx to NOlO (Li 
et 01., 2000). Furthermore, proper SUMO-l function also seems important for the 
localisation of Sp 100, since Sp 100 staining was absent from NO lOin many transfected 
cells expressing high levels of SUMO-I, although the proportion of transfected cells 
without Sp 1 00 staining varied between constructs. Loss of Sp I 00 was detected in up to 
75% of cells transfected with the GAlHSTV mutant and only in 22% of cells transfected 
with AGIHSTV constructs. 
However, the situation is yet further complicated by the observation that a proportion 
of transfected cells expressing high levels of wild type SUMO-I have a diffuse distribution 
of SUMO-I, and in these cells NO I 0 structures are also abnormal. It could be that a 
proportion of all cells have abnormal NO I 0, and if such cells are transfected it follows that 
the SUMO-I can not be located at NOlO. It is also possible that excessive expression of 
wild type SUMO-I could in some way have an effect similar to expression of the mutant 
proteins. 
The preliminary experiments described here show that F ACS analysis presents an 
efficient way to distinguish infected and transfected cells. However, the results from two 
separate series of F ACS experiments show that wild type SUMO-l and also all the 
conjugation mutants reduced viral infection when expressed at high levels, in contrast with 
results described in section 5.5 using the original method based on microscopy. Although 
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the stocks ofNT2 cells used for the studies in Chapter 4 remained in good condition, during 
the later stages of my PhD studies considerable problems were experienced in maintaining 
robust NT2 cell cultures. It was noticed that after lipofection followed by infection, a 
significant proportion of NT2 cells were dying and the rest of the cells tended to fonn big 
clumps after suspension in solution throughout the procedures used for staining and F ACS 
analysis. The influences of low transfection efficiency, inefficient infection and poor 
viability of cells generates an unsatisfactory condition for samples to undergo FACS 
analysis. Despite obtaining fresh stocks of NT2 cells from the original supplier, these 
problems were not overcome entirely, and therefore this particular result from the FACS 
analysis remains to be clarified. 
It could be argued that the transfection and analysis procedures of the F ACS approach 
might introduce artifacts. However, FACS analysis of Vero cells transfected with a 
plasmid expressing f3-galactosidase was used as a negative control, and no effect on the 
progress of viral infection was observed (data not shown). Shortage of time prevented 
further exploration of this potentially general method for studying the effect of expression 
of proteins from transfected plasmids on the efficiency of viral infection. 
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6.1 Interferon, ICPO, and ND10 
In last half century, interferons (IFNs) were discovered as proteins secreted by viral-
infected cells to prevent further infection of uninfected neighbouring cells (Isaacs & 
Lindenmann, 1957, Stark et al., 1998). It has been indicated that the antiviral activity of 
IFNs is through a set of intracellular signal transductions, which are stimulated by IFN 
receptors, resulting in inductiop of gene expression. Among hundreds of genes 
transcriptionally regulated by IFNs, three families of genes which encode the double-
stranded RNA-activated protein kinase (PKR), the 2', 5'-oligoadenylate synthetases 
(OAS)lRNase L, and the Mx proteins respectively, have been extensively studied with 
respect to their antiviral activities (reviewed by Shtrichman & Samuel, 2001). 
Mossman et al. (2001) reported that UV-inactivated wild-type HSV-l~ IFN treatment, 
and HSV-1 mutant KMll0 (a double-deletion of ICPONPl6 which fails to express any 
viral genes in human embryo lung cells) block plaque formation by superinfecting VSV. In 
addition, analysis of DNA micro array data revealed that the profile of cellular genes up-
regulated by IFN shares high similarity to that induced by mutant KMllO, whereas wild 
type HSV -I did not induce expression of any of these IFN-inducible proteins. suggesting 
that an antiviral response induced by HSV -I infection occurs in the absence of de novo 
viral gene expression (Mossman et al .• 2001). Most recently, Mossman and Smiley (2002) 
further identified that expression of ICPO and ICP34.5 compromised the lFN-induced 
antiviral state against viral transcription and translation (Mossman & Smiley, 2002). 
Together with the observations that ICPO initially localises to NOlO and subsequently 
triggers the disruption of NOlO structures by degradation of two IFN inducible NDIO 
proteins, PML, Sp 100 and their SUMO-I modified forms (Everett et al., 1998a), the results 
suggest a possible interaction between IFN pathways. NOlO proteins. and ICPO. Briefly, 
infection by HSV -1 triggers the antiviral state mediated by IFN that induces the expression 
of cellular proteins (such as PKR, Mx, OAS, and PML) that antagonise viral replication, 
and on the other hand, the virus has evolved it own defense mechanism by encoding viral 
proteins such as ICPO and ICP34.5 to counteract the effect of IFN-inducible proteins (by 
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degradation of those proteins) and maybe interfere with the expression of cellular proteins 
stimulated by IFNs. 
6.2 Does PML confer resistance to HSV·1 Infection? 
At the same time while I was approaching the effect of ND 1 0 proteins on HSV-l 
infection, PML has been implicated in IFN-mediated antiviral defence. As described in the 
Introduction chapter (section lE.S), recent studies performed in various experimental 
systems have demonstrated that over-expression of PML confers resistance to viral 
infections e.g. the infection of VSV, influenza A virus, HFV and HCMV. However, the 
results illustrated in Chapter 3 showed that over-expression of PML (and other NO 1 0 
proteins) by a transient transfection method, had no apparent affect on wild-type HSV-I 
replication and viral gene expression. Given the differences in terms of the methodology 
employed, these results should be carefully interpreted. Three aspects involved in this 
study are discussed in greater depth below. 
6.2.1 The localisation of over-expressed NDI0 proteins 
The immuno-staining with fluorescence revealed a nuclear diffuse pattern of the over-
expressed NO 10 proteins in a large proportion of cells transfected by both electroporation 
and lipofection. This result raises the question whether these proteins could function 
normally in transfected cells when they are not located in NOlO. Chelbi-Alix and 
Hayward's groups performed similar studies in PML- stable-expression cell lines (CHO, 
U373, or mouse embryo fibroblast cells) in which the exogenous PML is targeted to NOlO 
in a high proportion of cells (Ahn & Hayward, 2000, Chelbi-Alix et al., 1998, Regad et al., 
2001). SUMO-l modification has been shown to be required for recruitment of PML into 
ND 10 and the SUMO-l modified PML promotes another ND 10 constituent, hDaxx to 
localise into ND I 0 (li et al., 2000, Muller et al., 1998a). As shown in Fig. 3.11, although 
PMl was highly expressed in BHK cells, only a small fraction of the exogenous PML was 
modified by SUMO-I. These observations indicated the exogenous NOlO proteins 
expressed by transient transfection methods might not be post-translationally modified 
properly and therefore not exert their normal functions. 
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In addition to transient expression systems, a tetracycline-inducible (He La) cell line 
expressing Spl00 was used to address this question in my study. Although SplOO was 
induced and localised to NOW, the viral gene expression (ICPO and UL29) in tetracycline-
induced HeLa cells were similar in those in uninduced HeLa cells (data not shown). 
Coincidentally, Regad et aJ. (2001) reported that stable expression of PML in U373MG 
cells confers resistance to HFV whereas PML induction in a tetracycline-inducible cell line 
did not significantly interfere with HFV gene expression, suggesting that only high levels of 
PML expression affect HFV infection. Taken together, to study the effect of NOW proteins 
requires an expression system by which exogenous protein can be expressed in high levels 
with proper localisation. 
Furthennore, as described in Chapter 4 that the expression levels of NO 10 proteins are 
distinct between neuron precursor NT2 and differentiated hNT cells (Fig. 4.2, 4.5). If ND 10 
mediate the antiviral state against HSV -I infection, then infection by HSV -I shouJd be 
more efficient in NT2 cells, which express only low levels of NO 1 0 proteins. However, in 
hNT cells, the infection susceptibility of wild type HSV-I is only slightly lower than that in 
NT2 (Table. 4.1), although hNT cells express much higher levels of NOlO proteins than 
NT2 cells. Indeed, hNT cells share a similar profile of PML and SplOO expression with 
that in fibroblast (HFL) cells (Fig. 4.2). This seems contrary to the hypothesis previously 
described. However considering the function of ICPO is compromised in NT2 and hNT 
cells, based on the observation that NO 1 0 are relatively stable in these two cell lines during 
HSV-I infection (Table 4.3), NOlO proteins may be able to exert their hypothetical 
repressive functions even when present in relatively low amounts in NT2 cells. 
6.2.2 The effect of IFN on HSV -1 infection 
If the hypothesis that PML (or possibly other NO 10 associated proteins) plays a role in 
the lPN-induced antiviral state is reasonable, one aspect that should be initially considered 
is the response ofHSV-1 to IFNs' activities during infection in an in vitro system. In other 
words, if HSV -1 infection is resistant to IFNs, induced expression of PML or other ND 1 0 
proteins may not affect HSV -1 infection. 
Studies of the effect of lPN-a on viral gene expression in individual cells in Chapter 3 
(section 3.2.2) demonstrated that in lPN-treated cells, infected with HSV-I at an MOl of 5, 
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expression of ICPO and UL29 was inhibited by 2- to 3-fold at all infection times tested 
(Table 3.2). These observations are consistent with recent studies in Smiley's group that 
IFN-a only has a modest effect on wild-type HSV-l infection (Mossman et al., 2000). 
Additionally, studies using various MOls (5, 2, 0.5 pfu per celJ) revealed that at an early 
time of infection (2 hpa), the inhibitory effect of IFN-a on ICPO expression was slightly 
stronger when a lower virus input was used (Table 3.3). Taylor et ai. (2001) reported that 
IFN repressed gene expression from the ICP4 promoter of HSV -I and this effect was 
dependent on IFN type, cell type, and MOl. Given the findings from these studies, pre-
treatment with a high dose of IFN (lOOOU/ml) inhibits viral gene expression when cells 
were infected with HSV-l at a low MOl (0.05) (e.g. treatment with IFN-a repressed the 
ICP4 promoter approximately by 2.5-fold). Once the system for expression of ND 1 0 
proteins is optimised, at least a mild inhibition of viral infection in cells over-expressing 
NDIO should be observed ifPML or other NOlO proteins playa part in mediating the IFN-
induced antiviral state. 
6.2.3 Isoform specific effects 
Different splicing variants of PML isoforms (I-VII, to date) have been implicated in 
mediating particular effects resulting from their specific interactions with certain cellular 
proteins (reviewed by Jensen et ai., 2001). For instance, p53 is recruited into NOlO 
through the interaction with a specific PML splicing variant, the isoform III (Fogal et al., 
2000). Furthermore, the antiviral effects of PML that have been demonstrated so far have 
been performed using different isoforms, for instance: PML III (641 a.a.) confers resistance 
to VSV, influenza, and HFV infection (Chelbi-Alix et al., 1998, Regad et al., 2001), and 
PML VI (560a.a) is capable of inhibiting HCMV replication (Ahn & Hayward, 2000). In 
addition, Burkham et al. demonstrated different PML isoforms have various intracellular 
localisations and during HSV-l infection, and some, but not all, PML isoforms were 
recruited into replication compartments (Burkham et al., 2001). Taken together, these 
findings imply that various PML isoforms may undergo different fates, for instance, 
recruitment to NO 1 0, or localisation at sites district from NO 1 0, and interactions with 
specific cellular proteins, subsequently leading to different effects on viral infections. 
Two different forms of PML were used in the studies in this thesis. Plasmid pPML(F) 
encodes the 633 a.a. isoform IV, while the isoform expressed by PML-RH was not 
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identified by the authors. Both highly expressed PML (Fig. 3.11, and Fig. 4.15), however 
only the PML encoded from the PML (F) construct was greatly modified by SUMO-l (Fig. 
4. 15). This phenomenon has been routinely observed in other lines of research in our 
laboratory. Although all the PML isoforms contain the three SUMO-l modification sites, 
the observation described above indicates that the different expression machinery (or 
different PML isoforms) may affect post-translation modification of PML by SUMO-l, 
which possibly influences their biological functions. Thus, in the future, it will be 
important to use several different isoforms to elucidate the effect on viral replication or the 
fate of PML during viral infection. 
6.3 The possible role of SUMO-1 in HSV -1 infection in NT2 cells 
Results in Chapter 5 showed that in transfected NT2 cells over-expressing SUMO-I, 
infection by HSV-I was decreased by 3- to 5-fold at all infection times tested (Fig. 5.2). 
Pathways involving SUMO-l have been implicated in an antiviral effect by Engelhardt et 
al. (2001) using the IFN-induced Mxl protein, which has been found to inhibit a wide 
range of viral infections (Engelhardt et al., 200 I, reviewed by Haller el al., 1998). Mx 1 
was found to interact with several proteins associated with SUMO-l pathways. In 
particular SUMO-l and its El enzyme (Aos2IUba2) as well as some NOlO components 
strongly interacted with the Mxl protein. In addition, results of immunofluorescence 
assays revealed that the staining of both endogenous and exogenous Mx I protein partially 
overlaps with SUMO-l and NOlO proteins (hDaxx, PML and SplOO) in HeLa cells treated 
with IFN. These observations suggest that when the expression of Mx I was stimulated by 
IFN, it may accumulate close to NOlO, where some viruses initially localise, and facilitate 
its antiviral effect. This indicates a role for SUMO-I and NOlO in the antiviral action of 
Mxl. However, Mxl is a mouse protein and there is no known equivalent in humans. 
As described in the Introduction, SUMO-l has been found to covalently modify ND 1 0 
and a number of cellular proteins (reviewed by Seeler & Dejean. 2001). Recent studies 
have described that a number of viral early gene products such as lEI and IE2 (from 
HCMV), El (from BPV), and BZLFI (from EBV) are substrates of SUMO-l modification, 
however, to date, no HSV-l viral protein has been shown to be conjugated by SUMO-I. 
Thus over-expression of SUMO-! does not seem to directly affect HSV-I proteins, but 
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there may be an effect through other SUMO-l substrates. In contrast to ubiquitination, 
conjugation to SUMO-l does not lead to degradation, but can alter substrate intracellular 
localisation, protein-protein interactions, and functional activity. The possible effect of 
SUMO-Ion HSV -I infection in NT2 cells with respect to these aspects is discussed in the 
following sections. 
6.3.1 The effect of SUMO-l modification ofPML 
Although the precise significance of SUMO-I modification remains unclear, it has 
been demonstrated to directly contribute to recruitment of proteins (e.g. PML and p53) into 
ND I O. As illustrated in Fig. 4.5, SUMO-I modified forms of PML were hardly detected in 
NT2 cells, which indicates that either less endogenous SUMO-l exists in NT2 cells or, 
somehow, SUMO-I is not able to be conjugated to PML efficiently. However there is a 
possibility that high levels of SUMO-l may simultaneously increase the proportion of PML 
modified by SUMO-I, resulting in more of the diffuse nucleoplasmic form of PML being 
recruited into NO 1 0 where PML executes its function. Although over-expression of 
exogenous PML did not affect HSV -1 infection in NT2 cells (data not shown), again the 
interpretation of this result should consider the fact that PML was largely expressed in the 
nucleoplasm and cytoplasm (but not in NO I 0) of transfected cells (discussed in section 
6.2.1). 
Some lines of evidence have shown that SUMO-l modification of Sp I 00 stabilises the 
interaction of SplOO with heterochromatin protein HPI implying a role of SUMO-I in the 
dynamic interplay between chromatin and NOlO (Seeler et al., 2001). In addition, SUMO-
I conjugation of PML has been demonstrated to be required for the targeting of proteins 
(e.g. hDaxx and p53) to NDIO structures, and to modulate their functions in transcription 
regulation and cell survival control (Li et al., 2000, Fogal et al., 2000). SplOO was 
undetectable in NT2 cells, therefore the effect of SUMO-I modification on viral infection is 
unlikely to be through the effect of Sp 100. As the results in Chapter 3 showed that transient 
transfection of HP I or hDaxx strongly repressed the transactivation activity of ICPO in 
Vero cells, similar studies using different combinations of constructions expressing hDaxx 
and HPI with or without PML or SUMO-I will allow the elucidation of the effect of 
SUMO-I and SUMO-l modified PML on the regulation of viral gene transcription. 
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6.3.2 The potential role of SUMO-! modification of other substrates 
SUMO-l has been shown to conjugate to a number of transcriptional regulators such 
as p53 (Rodriguez et al., 1999), c-jun (Muller et al., 2000), and TIF-Ia (Seeler et al., 
2001). It has been demonstrated that the effect of SUMO-Ion transcriptional regulation is 
in substrate- and promoter- specific manners. For example, SUMO-l modification 
enhanced p53 transactivation from the PIG3 promoter, but not the p21 promoter (Rodriguez 
et al., 1999), whereas SUMO-I functions as a repressor of the transcriptional activation 
function of c-jun (Muller et al., 2000). Since the precise function of SUMO-l modification 
remains unclear, more specific studies are required to determine its possible effect on 
transcription regulation during HSV -I infection in NT2 cells. 
6.4 The effect of SUMO-1 modification on the maintenance of 
ND10 
Punctate staining of Spl00 and hDaxx was absent from a large proportion of cells 
over-expressing SUMO-l conjugation mutants (Fig. 5.8- 5.10). In particular, substitution 
of Gly (97) to Ala of SUMO-l results in loss of punctate Sp 100 staining from ND lOin over 
75% of transfected cells, implying that SUMO-} might be involved in Sp 1 00 localisation 
into ND 1 0 at a certain level. However, this result is contrast to the observations in 
Sternsdorf et al. (1999) that mutation of the SUMO-I modification site, lysine (297), 
abolished SUMO-l conjugation to SplOO, but did not affect its NDlO localisation. As 
SplOO has been shown to form a homodimer and a region (residues 33-149) has been 
identified to be required for this function (Sternsdorf et al., 1999), it is possible that 
endogenous Sp 100 modified by SUMO-l forms a homodimer with the mutant Sp I 00 
molecule and subsequently directs it to ND I O. Thus the Sp 1 00 (K297 A) mutant could be 
detected in ND 1 0, although it was not itself SUMO-l modified. The loss of punctate Sp 100 
and hDaxx staining was also observed in cells transfected with other SUMO-l mutants 
(AGIHSTV, AG) which express partially active forms of SUMO-I, when these proteins 
were distributed in a nuclear diffuse pattern. These results indicate that the ND I 0 
localisation of SUMO-l is important for recruitment of proteins into NDIO and for 
maintenance ofNDI0 structure. 
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In summary, there are intriguing hints that the pathways of SUMO-modification, PML, 
NDIO and IFNs may be inter-connected and contribute to an intracellular antiviral defense, 
but precise details at present remain elusive. 
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